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Biodegradable metals have been widely studied in recent years as potential biomedical implant 
materials which exhibit higher mechanical properties than degradable polymers while corroding 
over time to alleviate known complications such as stress-shielding, infection, permanent 
physical irritation and secondary removal/revision surgeries that is inherent to permanent and 
bio-inert metallic biomaterials. Specifically, iron (Fe), magnesium (Mg), and their alloys are the 
two main classes of metals that have been considered as promising candidates for degradable 
load and non-load bearing bone implants, cardiovascular stents, and other implantable medical 
devices. However, most of the research on Fe and Fe based alloys have reported very slow 
degradation rate in physiological environments while Mg and Mg based alloys under rapid 
degradation. Hence, controlling the degradation rates of these metals has been a key challenge 
limiting the technological development and implementation of these systems requiring more 
fundamental studies to be conducted. There is therefore the need to modify the chemical 
composition and microstructural characteristics through the appropriate alloying techniques with 
suitable alloying elements. Some studies have been conducted to overcome these limitations but 
the degradation rates and cytocompatibility of the two main classes of metals are still far from 
levels necessary for implementation in clinical applications. An alternative approach is therefore 
needed to develp metallic materials with improved degradation behavior wihle maintaining ithe 
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desired biocompatibility. Although Fe and Mg have been studied separately as degradable 
implants, there are no reports on the Fe-Mg binary alloy system for use as biodegradable metallic 
materilas because of the thermodynamic immiscibility of Fe and Mg under ambient conditions. 
In this dissertation, novel non-equilibrium alloys, particularly in the Fe-Mg binary system with 
additional elements, have been proposed and studied for their desirable corrosion and 
cytocompatible properties. 
The first part of this dissertation focuses on the formation of amorphous alloys in the Fe-
Mg binary alloy system through the process of high energy mechanical alloying (HEMA) 
followed by pulsed laser deposition (PLD) in order to overcome the limitations of the 
immiscibility of Fe-Mg. In the second part of this dissertation, an alloy development strategy to 
accomplish high degradation rates, antiferromagnetic behavior and good cytocompatibility is 
presented. Thus, manganese (Mn), calcium (Ca) and zirconium (Zr) were selected and added as 
alloying elements, which include the following two aspects: (i) Electrochemical considerations to 
increase the corrosion rates by electrochemical modification of the Fe matrix; (ii) addition of Mn 
to introduce anti-ferromagnetic characteristics to the alloy for exploring biological applications. 
Powders and thin layers were characterized for their composition/structure and evaluated 
potential for biomedical applications using preliminary in vitro cytocompatibility and corrosion 
experiments. For Fe-Mg binary alloy, uniform corrosion of Fe70Mg30 amorphous thin layer was 
observed and the corrosion current density value was approximately 8 fold higher than pure Fe. 
The direct and indirect cytotoxicity results indicated that Fe70Mg30 amorphous thin layer has no 
cytotoxicity to MC3T3-E1, hMSCs, HUVECs and NIH3T3 cell lines. Similarly, addition of Ca, 
Zr and Mn indicate good cytocompatibility with suitable modifications in the corrosion rates 
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1.0  INTRODUCTION 
1.1 BIODEGRADABLE METALS 
During the past few years significant advances have been made in the development of 
biodegradable metallic materials for biomedical applications, such as temporary prostheses, 
cadivascular stents, and three-dimensional porous structures such as scaffolds for tissue 
engineering [1-7].  
1.1.1 Classical biomaterials 
Biomaterials are used to make devices to replace a part or a function of the body and it has had a 
long history of clinical employment [8]. Initially, the most important biomaterial was metal for 
the skeletal applications including wires and pins made from iron (Fe), gold (Au), silver (Ag) 
and platinum (Pt) [9]. These early metal devices were used to fix bone fractures [10]. 
Subsequently, the evolution of medical implants was closely linked to the development of new 
materials. In the 1930s, stainless steels and cobalt-chromium alloys were introduced and these 
metallic “bio-inert” alloys are associated with permanent applications such as bone fixation 
devices and joint replacements [9]. Metal has excellent combination of strength, stiffness and 
ductility, which are superior to that of polymers or ceramics at the site of high mechanical 
loading. Therefore, they are used for the clinical employment as implants in the treatment of 
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temporary clinical problems, which are mainly includes two applications. One area is the 
prosthesis such as a tooth, a facial bone, the palate, hip, or knee, and another is the fixation of 
structures such as screws, plates, wires, intramedullary nails and stents [2, 3, 11-13]. Their high 
strength guarantees good primary stability after surgery, and their fracture toughness, ductility 
and high fatigue limit are also beneficial in applications. 
 
Table 1.1. Commonly used biomaterials for biomedical applications [9]. 
Material Advantages Disadvantages Examples 
Metals 
Strong 
Tough 
Ductile 
Corrosion 
Density 
Processing 
Joint replacement 
Dental roots 
Orthopedic fixation 
Stents 
Polymers Resilient Easy to fabricate 
Not strong 
Not rigid 
Time-dependent 
deformation (creep: 
stress relaxation) 
Degradation 
Dental implant 
Blood vessels (e.g. vascular grafts) 
Joint socket (knee, shoulder) 
Ear, nose 
Soft tissues in general 
Ceramics 
Biocompatible 
Inert 
Strong in 
compression 
Brittle- fractures easily in 
tension 
Dental implants 
Orthopedic implants (some) 
Composites Strong Tailor made Processing 
Joint implant 
Heart valves 
 
At present, not only metals but all classes of materials, which includes ceramics, 
polymers and composites, are used as biomaterials for various purposes. Table 1.1 lists the 
various applications and their advantages and disadvantages in the human body [9]. However, as 
the medical science has advanced to fulfil the demand for better implant devices, it is desirable 
that implantable medical devices also possess bioactivities or bio-functionalities such as blood 
compatibility and bone conductivity [14]. Each material is selected and deployed for its specific 
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advantages. For example, the hydroxyapatite coatings on dental implants provide excellent bone 
ingrowth and consequently stable long-term tissue integration despite poor mechanical strength 
[15] and for the need to modify surface of metals in order to improve blood compatibility with 
polyethylene terephthalate [16]. Recently many researchers continue to study about novel 
metallic biomaterials includes those composed of nontoxic and allergy free elements like Ni-free 
stainless steel [17]. 
Polymeric biomaterials offer the main advantage over metals or ceramics in processing to 
form various shapes. Basically, there are two kinds of these biomaterials: (i) classical inert 
polymers such as polymethylmethacrylate (PMMA), poly amide or nylon, polyethylene (PE), 
etc. and (ii) absorbable polymers such as polyglycolic acid (PGA) and polylactic acid (PLA), etc 
[14]. Besides being employed in their bulk, they are often made into thin layer or coating onto 
metal surfaces with tailored mechanical and physical properties. The recent development exploits 
absorbable polymers for use as drug delivery carriers loaded with a specific drug in the form of 
coating, for example drug eluting stents [14, 18]. 
Ceramics biomaterials provide inertness, high compressive strength and aesthetic 
appearance. They can be classified into: (i) inert bio-ceramics such as zirconia, alumina, 
aluminum nitrides and carbon, (ii) bioactive ceramics such as hydroxyapatite, bio-glass, etc. and 
(iii) biodegradable/ resorbable ceramics such as calcium aluminates, calcium phosphates, etc. 
The inherent surface qualities of ceramics have been exploited to make implants such as dental 
crowns. The high specific strength and blood compatibility of carbon makes carbon often used 
for heart valves leaflets. Many bio-ceramics have been also applied as coating onto metal 
surfaces including diamond like carbon, nitrides, bio-glasses and hydroxyapatites [19]. 
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  Composite biomaterials can be made with metals, polymers or ceramics as their matrix, 
and reinforced with one of these materials. Composites allow control over material properties 
where a combination of stiff, strong, resilient but lightweight can be achieved all together. Bone 
is a composite of the low elastic modulus organic matrix reinforced with the high elastic 
modulus mineral “fibers” permeated with pores filled with liquids. Other examples include 
orthopedic implants with porous structures, dental filler, and bone cement composed of 
reinforced PMMA and ultra-high molecular weight PE [20].  
1.1.2 Concept for biodegradable metals 
Traditionally, most metallic implants are developed from corrosion resistant materials 
such as stainless steels, titanium (Ti) and cobalt (Co)-chromium (Cr) based metallic “bio-inert” 
alloys. They are associated with permanent applications which includes joint replacements and 
stents. However, some implants must be removed when they are no longer needed, e.g. 
osteosynthesis plates and screws. Permanent implants are also accompanied by long-term risks 
and side effects. In cardiovascular stents, for example, these include permanent physical 
irritation, chronic inflammatory reactions, in-stent restenosis, and mismatches in mechanical 
behavior between stented and non-stented vessel areas [21-23]. Therefore, patients with these 
permanent implants suffer from these kinds of unavoidable short and long term clinical problems 
and additional pain and discomfort from implant removal or revision surgeries [24-26]. In many 
osteosynthesis applications, for example, the implant needs to be removed after one or two years 
and the patient has to undergo the pain of a second surgery and accept risks such as re-fracture, 
neurovascular injuries or even implant failure. From an economic point of view this also means 
considerable costs for health care systems and implant removal accounts for up to 30% of 
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orthopedic procedures [27]. Stainless steel or Co–Cr alloys contain allergens such as nickel (Ni), 
Co or Cr. Although these alloys possess high corrosion resistance, wear or unfavorable 
conditions in the area of metal to metal contact like screw heads on plates can increase the 
release of metal ions. This may stimulate sensitivity to the various metal components or allergic 
reactions, e.g. localized eczema near the implant site [28]. A prominent current example of 
permanent implant application is the coronary stent. This field is booming since the first attempts 
were conducted by Sigwart et al [29]. Stents are metallic wire meshes which by means of a 
balloon catheter are introduced into narrowed arteries to keep the lumen open. Although stents 
are successfully and widely deployed they do have some risks. Bare metal stents are associated 
with a 20~30% restenosis rate, which requires re-intervention [30]. Drug eluting stents were 
developed to minimize the risk of restenosis. However, there are indications that these stents 
present a higher risk of late thrombosis, which can lead to a heart attack or sometimes death [31]. 
It has also been observed that remodeling of the vessel occurs within a period of 6~12 months, 
meaning that after that period the supporting function of the stent is actually no longer required 
[32, 33]. For these reason, in a number of clinical applications a metal that degrades when no 
longer needed would be highly desirable to circumvent the disadvantage of permanent implant 
materials. 
Biodegradable metals, on the other hand, degrade in vivo, either via hydrolytic reactions, 
resorption or electrochemical reactions [9]. In general, this can be described as the breakdown of 
a material mediated by a biological system [34], with appropriate host response elicited by 
released corrosion products, and then dissolve completely upon fulfilling the mission to assist 
with tissue healing with no implant residues [14]. This concept is similar with the context of 
polymeric materials and ceramics [9]. Recently, however, a concept of biodegradable metals has 
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been developed which questions the traditional paradigm that metallic biomaterials must be 
corrosion-resistant [35, 36]. Ideally biodegradable metals should feature a tradeoff between 
mechanical integrity and degradation. The temporary support should be maintained until healing 
is completed and hence the degradation progress must be tailored such that mechanical integrity 
does not deteriorate too fast [37]. In the case of bone fracture, the required time for hard bone 
union should be varied greatly depending on the configuration or location of fracture, soft tissues 
and patient characteristics [35]. Therefore, biodegradable metals use their corrosion properties as 
an advantage, flying in stark contrast to the convention of developing metals which are designed 
to be as inert as possible. This degradation must occur in a controlled manner so that while the 
implant is degrading and its strength diminishes, load is gradually transferred to the healing bone 
tissue until it completely disappears once the tissue has fully healed. This profile of gradual 
degradation and reduction in mechanical support from a high initial point is shown in Figure 1.1 
[35]. 
In addition, the degradation progress may not cause any accumulation of degradation 
products around the implant or in systemic organs, and degradation products may not produce 
any adverse effects. In these respects, it is obvious that biodegradable metals can only be used in 
small, lightweight implants. Accordingly, research has mainly focused on the development of 
degradable stents or small screws or plates for osteosynthesis. Figure 1.2 gives an overview of 
the selected examples. 
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Figure 1.1. The schematic diagram of degradation behavior and the change of mechanical 
integrity of biodegradable metallic implants during the bone healing process. Used with 
permission of [35]. 
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(a)
(b) (c)
 
Figure 1.2. (a) different orthopedic implant geometries made of magnesium alloys. Used with 
permission of [38], (b) Fe-35Mn stents at three conditions: (up) as descaled, (middle) as crimped 
over balloon, and (bottom) as expanded [39] and (c) The two cannulated screws with the same 
design. 1) The titanium screw (Fracture compressing screw, Königsee Implantate GmbH, Am 
Sand 4, 07426 Allendorf, Germany), 2) MAGNEZIX® Compression Screw (Syntellix AG 
Schiffgraben 11, 30159 Hannover, Germany). Used with permission of [40]. 
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1.2 IRON AND ITS ALLOYS AS BIODEGRADABLE METALS 
Both polymeric and metallic materials possess the property profile required for the above-
mentioned applications. Metals, however, are superior to polymers in mechanical performance 
[2, 3]. Among metals, Mg and Fe have both been considered for degradable implants because 
they are essential trace elements in the human body [7, 13, 21, 41-43]. On the other hand, 
superior mechanical properties of pure Fe or Fe-based alloys are more attractive as 
biodegradable implants compared to Mg-based alloys [35, 44]. 
1.2.1 General remarks 
Fe has several vital functions in the body. It serves as a carrier of oxygen to the tissues from the 
lungs by red blood cell hemoglobin, as a transport medium for electrons within cells, and as an 
integrated part of important enzyme systems in various tissues [45]. The physiology of iron has 
been extensively reviewed [46]. Most of the iron in the body is present in the erythrocytes as 
hemoglobin, a molecule composed of four units, each containing one hemoglobin group and one 
protein chain [47]. The structure of hemoglobin allows it to be fully loaded with oxygen in the 
lungs and partially unloaded in the tissues (e.g. in the muscles). The iron-containing oxygen 
storage protein in the muscles, myoglobin, is similar in structure to hemoglobin but has only one 
hemoglobin unit and one globin chain [48]. Several iron-containing enzymes, the cytochromes, 
also have one hemoglobin group and one globin protein chain. These enzymes act as electron 
carriers within the cell and their structures do not permit reversible loading and unloading of 
oxygen. Their role in the oxidative metabolism is to transfer energy within the cell and 
specifically in the mitochondria [49]. Other key functions for the iron-containing enzymes 
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include the synthesis of steroid hormones and bile acids; detoxification of foreign substances in 
the liver; and signal controlling in some neurotransmitters, such as the dopamine and serotonin 
systems in the brain [46]. Fe is reversibly stored within the liver as ferritin and hemosiderin 
whereas it is transported between different compartments in the body by the protein transferrin 
[50]. 
The suitability of Fe as a degradable implant material has been studied in various in 
vitro and in vivo settings using variety of cells and animal models [13, 21, 26, 42, 43, 51-54]. In 
an initial in vivo study by Peuster et al. [21], stents produced from pure iron were implanted in 
the descending aorta of New Zealand white rabbits. The main findings were that no pronounced 
neointimal proliferation and no significant inflammatory response in the stented vessel occurred 
during the 18-month follow-up but the concentration of Fe ions in the body should not reach 
higher than 50µg/ml to avoid cell toxicity and death [54, 55]. A subsequent study over 12 
months reported on the biocompatibility of Fe stents implanted in the descending aorta of mini 
pigs [42]. It was concluded that Fe is a suitable material for degradable stents and does not cause 
local or systemic toxicity. However, it was also concluded that its overall degradation rate is too 
low, and is not matched with the tissue healing period. It has become the major drawback to limit 
their further applications [42, 56].  
Different degradation behavior between Fe and Mg depends on the oxygen availability. 
Generally, Fe is corroded in an oxygen absorption corrosion mode based on the following 
reactions: 
Fe  Fe2+ + 2e- (anodic reaction) (1.1) 
2H2O + O2 + 4e-  4OH- (cathodic reaction)      (1.2) 
2Fe + 2H2O + O2  2Fe(OH)2 (overall formation) (1.3) 
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The anodic partial reaction usually proceeds rapidly in media [57]. In oxygen-containing 
aqueous solutions in the pH-range between 4 and 10, the reduction of dissolved oxygen is the 
cathodic reaction. These conditions apply to most of the potential implantation sites in a living 
body. The reduction reaction (1.2) and, coupled to it, the oxidation reaction (1.1) proceed as 
rapidly as dissolved oxygen reached the metal surface [56]. The formation of Fe oxides has been 
identified as the major inhibitor for a faster degradation [58]. Additionally, other degradation 
products layers (Fe hydroxides, Fe carbonates and Fe phosphate), which are relatively denser 
than Fe oxide, greatly hinder transport of the oxygen toward the fresh Fe surface which would be 
necessary for further degradation [56, 59, 60] . Attempts to accelerate the degradation kinetic of 
Fe have been explored through alloying with other elements, thermomechanical treatment, 
surface modification, composites and novel/new fabrication methods [35, 61]. It will be 
introduced in the next section. 
Moreover, there is another challenge to overcome limitations of Fe and Fe based alloy as 
biodegradable material. Its ferromagnetic characteristics that can seriously limit magnetic 
resonance imaging (MRI) capabilities of Fe based alloy. Therefore, ideal alloying elements 
should change this natural property to make Fe alloys compatible with high magnetic field that 
generated by MRI which has become widely used for post implantation monitoring and 
diagnostic [62].     
1.2.2 Recent developments of biodegradable Fe-based alloys 
In the field of biodegradable metals mainly Fe and Mg and their alloys have been investigated in 
a number of in vitro and in vivo studies [39, 63]. Both Fe and Mg are essential elements in the 
human body; adult men normally contain approximately 3~5g of Fe [45] and 21~28g of Mg - 
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muscle and soft tissues accounting for almost half of this and bone for slightly more than half 
[64]. Mg based alloys are well established as material for temporary implant applications, and 
have already undergone human clinical trials in the field of osteosynthesis [40] and in particular 
stent applications [65-67]. However, Mg based alloys are known to exhibit too rapid degradation 
rates in physiological environments. 
 In addition, hydrogen gas may be formed during the degradation process. This can 
generate gas cavities at the implantation side which can be problematic in healing [68]. Although 
Mg based alloys have been developed which have acceptable strength and ductility values, 
materials with better mechanical performance would also be strongly desirable. Compared with 
Mg based alloys, Fe based alloys have similar mechanical properties to stainless steel and are 
more attractive from a structural point of view which are summarized in Table 1.2.  
In this respect, Fe and in particular its alloys have been proposed as a promising 
alternative [39, 63]. Fe based alloys possess superior mechanical properties compared to Mg, 
enabling versatile implant design and fabrication of filigree structures. Compared to Mg based 
alloys, Fe is also radio opaque, which in stents facilitates placement via coronary angioplasty. 
The main drawback of Fe in contrast to Mg, however, is its rather slow degradation rate in 
physiological media [39, 63]. Hence, research has focused on the development of new kinds of 
Fe based biodegradable materials by modifying the chemical composition, microstructure, and 
surface of Fe with diverse manufacturing process technologies including casting, powder 
metallurgy, electroforming, and 3D printing, to achieve a faster degradation and improved MRI 
compatibility, as illustrated in Figure 1.3. For example, powder metallurgy Fe–Mn alloy had a 
faster in vitro degradation compared to the same alloy produced by casting because of the 
powder metallurgy process porosity increasing the degradation rate. 
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Table 1.2. Summary of the properties of reported Fe-based biodegradable metals. Used with 
permission of [35]. 
 
Material  YS (MPa) 
UTS 
(MPa) 
Elongation 
(%) 
χ0 
(µm3/kg) 
Ref. 
Pure Fe Cast – – – –  
 Annealed (550 °C) 140 ± 10 205 ± 6 25.5 ± 3 – [52] 
 Electroformed 360 ± 9 423 ± 12 8.3 ± 2 – [52] 
 ECAPed (8 passes) – 470 ± 29 – – [43] 
 P/M – – – – [69] 
 SPS – – – – [70] 
Nitride Fe 561.4 614.4 – – [71] 
Fe–10Mn/forged + ht2a 650 1300 14 – [72] 
Fe–10Mn–1Pd/forgerd + ht2a 850 1450 11 – [72] 
Fe–30Mn/cast 124.5 366.7 55.7 – [73] 
Fe–30Mn–6Si/cast 177.8 433.3 16.6 – [73] 
Fe–30Mn/forged 169 569 60 0.16 [74] 
Fe–30Mn–1C/forged 373 1010 88 0.03 [74] 
Fe–3Co/rolleda 460 648 5.5 – [61] 
Fe–3W/rolleda 465 712 6.2 – [61] 
Fe–3C/rolleda 440 600 7.4 – [61] 
Fe–3S/rolleda 440 810 8.3 – [61] 
Fe–20Mn/P/M 420 700 8 0.2 [75] 
Fe–25Mn/P/M 360 720 5 0.2 [75] 
Fe–30Mn/P/M 240 520 20 0.2 [75] 
Fe–35Mn/P/M 230 430 30 0.2 [75] 
Fe–0.6P/P/M – – – – [69] 
Fe–0.05B/P/M – – – – [69] 
Fe–5W/SPS – – – – [70] 
Fe–1CNT/SPS – – – – [70] 
316L  SS 190 490 40 0.5 [75] 
a The chemical composition was in atom percentage, while the others were in weight percentage. 
 14 
 
Figure 1.3. Status of present research on Fe-based biodegradable metals. Used with permission 
of [35]. 
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alloys, Fe is also radio opaque, which in stents facilitates placement via coronary angioplasty. 
The main drawback of Fe in contrast to Mg, however, is its rather slow degradation rate in 
physiological media [39, 63]. Hence, research has focused on the development of new kinds of 
Fe based biodegradable materials by modifying the chemical composition, microstructure, and 
surface of Fe with diverse manufacturing process technologies including casting, powder 
metallurgy, electroforming, and 3D printing, to achieve a faster degradation and improved MRI 
compatibility, as illustrated in Figure 1.3. For example, powder metallurgy Fe–Mn alloy had a 
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faster in vitro degradation compared to the same alloy produced by casting because of the 
powder metallurgy process porosity increasing the degradation rate. Electroformed iron also 
showed a faster in vitro degradation compared to Armco Fe fabricated by casting since the 
electroformed material had a much finer microstructure with increased volume of grain 
boundaries, which are more susceptible to corrosive attack [13]. Alloying, subsequent 
processing, and heat treatment are common approaches to modify the mechanical, corrosion, and 
ferromagnetic properties of pure Fe [58]. Table 1.3 gives an overview of the various strategies 
proposed. 
 First, for alloying, Hermawan et al.[7, 75] developed a Fe-Mn alloy containing 35wt.% 
Mn using powder metallurgy methods which have an increased corrosion rate with respect to 
pure iron [5] and these alloys, showed low inhibition of fibroblast cell metabolic activity in cell 
viability test. Fe-Mn-Pd alloys are also showed to reveal a degradation resistance that is one 
order of magnitude lower than observed for pure iron by Schinhammer et al. [72]. Xu et al. 
added 1 wt.% of carbon into Fe-30Mn alloy that showed lower magnetic susceptibility and better 
mechanical properties than Fe-30Mn alloy [74]. Moreover, the effect of various alloying 
elements of pure iron has been reported to recommend suitable elements for iron biomaterials 
such as Co, W, C, and S [61]. However, Alloying Fe with other elements such as Mn, C, Si, and 
Pd improved its degradation rate, but their biocompatibility is uncertain at higher concentrations 
of the alloying elements [76]. Wegener et al. [69] investigated binary Fe–X (X= P, B, Ag) alloys 
using a powder metallurgical fabrication route. B and P were chosen as they can increase the 
sintering density. Ag was selected because Ag and Fe are not soluble and Ag particles were 
expected to act as local galvanic corrosion spots. Feng et al. [71] used plasma nitriding to 
improve the strength of Fe and thus to decrease implant dimension. They also expected that fine 
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dispersed particles of Fe and N could induce micro-galvanic corrosion. Huang et al. investigated 
Fe-5Pd and Fe-5Pt alloys produced via spark plasma sintering (SPS). They observed that the 
materials investigated exhibit a greatly increased degradation rate and improved mechanical 
properties compared to Fe [77]. 
Second, surface modifications, as proposed by Zhu et al [78] for surface modification, 
Fe-O thin films synthesized on a pure iron surface by plasma immersion ion implantation and 
deposition (PIII&D), which effectively improved both the corrosion resistance and 
biocompatibility. Lanthanum (La) ion implanted pure Fe by metal vapor vacuum arc (MEVVA) 
[79] have been shown in improvement of corrosion resistance and biocompatibility. In addition, 
Fe was also coated with micro-patterned Au disc arrays and produced a more uniform corrosion 
with an almost four times higher degradation rate than the uncoated ones [80]. Chen modified the 
microstructure of commercial pure Fe using plasma nitride and then showed the improvement in 
corrosion resistance [81]. 
Finally, some novel and new fabrication methods such as electroforming technique [51, 
52], powder metallurgy [69], equal channel angular pressing (ECAP) technique [43] and 3D 
printing [82] are suggested to fabricate pure Fe foil or Fe-based alloys which showed faster 
degradation than pure iron obtained from conventional casting technique. Recently researchers 
reported that newly designed biodegradable Fe-X composites (X= W, CNT, Pd, Pt, Mg, 
Bioceramic) were prepared by spark plasma sintering (SPS) [70, 77], powder metallurgy [76] 
and cold drawn method [83-85]. Another attempt was making composite of Fe with Fe2O3 to 
create more phase/grain boundaries which theoretically act as active sites for accelerating 
degradation [86]. 
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Table 1.3. Overview of various strategies for developing a biodegradable Fe based alloy. 
System Method Approach/Aim Ref. (year) 
Fe-Mn Alloying by HEMA 
Addition of Mn within solubility limit of 
Fe, to reduce standard electrode 
potential of Fe–Mn alloys compared to 
pure Fe 
[6] 
(2007) 
Fe Plasma nitride 
The microstructure of commercial pure 
Fe modified by plasma nitride and 
corrosion resistance is improved 
[81] 
(2008) 
Fe metal vapor vacuum arc (MEVVA) 
Lanthanum ion was implanted into pure 
Fe by MEVVA to improve its corrosion 
resistance and biocompatibility 
[79] 
(2009) 
Fe 
plasma immersion ion 
implantation and 
deposition (PIII&D) 
Fe-O thin layer was synthesized by 
PIII&D in order to improve corrosion 
resistance and biocompatibility 
[78] 
(2009) 
Fe-Mn-Pd Alloying + heat treatments 
Addition of Mn to reduce standard 
potential and minor addition of Pd to 
form noble precipitates to induce micro-
galvanic corrosion. Improved strength 
via heat treatments to reduce implant 
dimensions 
[72] 
(2010) 
Fe  Electroforming of Fe sheets Evaluation to increase degradation rate of Fe via electroforming 
[52] 
(2010) 
Fe 
Commercial pure iron was 
fabricated via ECAP through 
severe plastic deformation 
Study corrosion rate and enhance 
biocompatibility through nano- 
crystalline Fe produced by ECAP 
[43] 
(2010) 
Fe–X (X= Mn, Co, 
Al, W, Sn, B, C, S) Alloying 
Feasibility of different binary Fe alloys 
for use as degradable biomaterial 
[61] 
(2011) 
Fe–30Mn–1C Vacuum induction melting 
Show high degradation rate compared 
with Fe-30Mn, lower hemolytic ratio, 
better anticoagulation property and less 
platelet adhesion as well as good cell 
compatibility 
[74] 
(2011) 
Fe–X (X= P, B, 
Ag) and Fe-Ag-P 
Alloying by powder 
metallurgy 
Development of a degradable Fe‐based 
alloy with the idea of using them as 
matrix material of cellular structures 
producible via powder metallurgy 
[69] 
(2011) 
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Table 1.3 (continued) 
Fe-Mn-C 
Fe-Mn-C-Pd 
twinning-induced 
plasticity(TWIP) steel via 
vacuum induction furnace 
Combination of high strength and 
ductility by strain hardening. 
Exceed the performance of SS, Ti or Co-
Cr alloys 
[87] 
(2012) 
Fe based bulk 
metallic glass 
(BMG) 
Arc-melting and cold suction 
casting with water cooled 
Cu mold 
More corrosion resistance than 316L SS 
and high cell viability value of Fe based 
BMG 
[88] 
(2012) 
Fe‐X composites 
(X=W, CNT)  spark plasma sintering (SPS) 
Improve strength and induce galvanic 
corrosion through the incorporation of 
the X‐Phase [70] (2013) 
Fe-Mn Inkjet-3D printing 
Generate complex, customizable parts 
from powder 
Corrode more rapidly than pure Fe 
Good in vitro cytocompatibility 
[82] 
(2013) 
Fe–N Alloying via vacuum plasma nitriding of Fe 
Improve strength via nitriding to reduce 
implant dimension; formation of 
Fe/N‐particles to induce galvanic 
corrosion 
[71] 
(2013) 
Fe–Fe2O3 
composite spark plasma sintering (SPS) 
Fe–5Fe2O3 composite is a promising 
alternative for biodegradable stent 
material with elevated corrosion rate, 
enhanced mechanical properties, as well 
as excellent biocompatibility 
[86] 
(2014) 
Fe–Pd, Fe–Pt Alloying via spark plasma sintering (SPS) 
Acceleration of degradation rate through 
the addition of Pd or Pt 
[77] 
(2014) 
hydroxyapatite(HA) 
coated porous Fe 
Porous Fe sheet via the 
polymer 
space holder method 
HA coating via dip coating 
method 
effect of HA in enhancing 
cytocompatibility of the surface 
inhibition effect of the coating on 
degradation 
[89] 
(2014) 
Fe-bioceramic 
composites 
powder metallurgy and 
sintering 
Slightly increased their corrosion rate 
compared to that of pure Fe and increase 
of cellular activity 
composites have the potential to be used 
for biodegradable bone implant 
applications 
[76] 
(2014) 
Fe coated with 
micro-patterned Au 
disc arrays 
vacuum sputtering 
more uniform corrosion with an almost 
four times higher degradation rate than 
the uncoated ones 
[80] 
(2015) 
Fe–Au / Fe–Ag 
composites 
powder metallurgy and 
sintering 
increase the corrosion rate of the iron 
matrix and change the corrosion mode 
into more uniform one 
No significant toxicity for cells 
[90] 
(2015) 
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1.2.3 Degradation behavior of Fe based alloys in physiological media 
When a metal is implanted it comes into contact with soft or hard tissue and is continuously 
exposed to corrosive body fluid, which among other things contains dissolved oxygen, sodium 
chloride, phosphate, carbonates, calcium, other salts, and complex organic compounds such as 
proteins. In order to simulate in vivo conditions in lab-scaled tests, simulated physiological 
media are used, such as Hank’s solution (HS), simulated body fluid (SBF), and phosphate 
buffered saline (PBS). Degradation behavior is typically investigated by means of immersion 
tests, where mass loss or dissolved ion concentrations as a function of immersion time are 
measured to evaluate degradation rates. Electrochemical methods including potentiodynamic 
polarization measurements and impedance spectroscopy are also often utilized to determine 
degradation rates. These methods also allow characterization of the corrosion process involved. 
Table 1.4 summarizes the degradation rates of Fe and various Fe based alloys which were 
introduced in the previous sections.  
There are big discrepancies in measured degradation values of Fe in Table 1.4.   These 
may relate to differences in the measurement conditions employed, such as the test media (HS, 
SBF or PBS), buffering system, test method (immersion or potentiodynamic polarization), 
dynamic or static test conditions, and the time periods investigated. However, despite the lack of 
comparability between the different investigations it is clear that alloys containing Mn and/or Pd 
as alloy elements exhibit an increased in vitro degradation rate compared to Fe.  
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Table 1.4. Comparison of the in vitro degradation rates of Fe and various Fe based alloys. 
 
 
Alloy Test medium Test method 
Degradation rate 
Ref. 
Reported Converted (mm/year) 
Pure Fe Cast – – – 0.008  
Fe HS PD 16 µA/cm2 0.2 
[75] 
(2010) Fe–25Mn HS PD 40-90 µA/cm
2 0.52 
Fe–35Mn HS PD 37-55 µA/cm2 0.44 
Fe SBF IM 0.0026 mg/cm2h 0.03 
[72] 
(2010) Fe–10Mn SBF IM 0.011 mg/cm
2h 0.12 
Fe–10Mn–1Pd SBF IM 0.038 mg/cm2h 0.42 
Fe HS PD 8.96 µA/cm2 0.1 
[73] 
(2011) Fe–30Mn HS PD 10.7 µA/cm
2 0.12 
Fe–30Mn–6Si HS PD 24.7 µA/cm2 0.29 
Fe PBS PD 10.887 µA/cm2 0.13 [71] 
(2013) Nitride Fe PBS PD 19.365 µA/cm2 0.225 
Fe HS PD 0.652 µA/cm2 0.016 
[70] 
(2013) Fe–5W/SPS HS PD 6.392 µA/cm
2 0.138 
Fe–1CNT/SPS HS PD 8.397 µA/cm2 0.177 
Fe HS IM 0.044 mg/cm2h 0.02 
[77] 
(2014) Fe-5Pd HS IM 0.074 mg/cm
2h 0.03 
Fe-5Pt HS IM 0.120 mg/cm2h 0.06 
HS: Hank’s solution SBF: Simulated body fluid PBS: Phosphate buffered saline  
PD: Potentiodaynamic polarization method IM: Immersion test  
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For example, according to Hermawan et al.[75] the following mechanisms are involved 
during the degradation of Fe-Mn alloys in physiological media (Figure 1.4). The initial reaction 
after immersion of the alloy in the fluid involves the dissolution of the metal (oxidation) given by 
the two anodic partial reactions in Figure 1.4(a): 
Fe  Fe2+ + 2e- (anodic reaction) (1.4) 
Mn  Mn2+ + 2e- (anodic reaction) (1.5) 
In aerated aqueous solutions, the reduction dissolved oxygen is the partial cathodic reaction: 
2H2O + O2 + 4e-  4OH- (cathodic reaction)      (1.6) 
The partial anodic or cathodic reactions, however, can only proceed as fast as one of the two 
limiting reactions. The dissolved metal ions may further react with hydroxyl ions (OH‐ ) forming 
hydroxide layers (hydrous metal oxides in Figure 1.4(b)). In the following the reactions are given 
for the main constituent Fe:  
Fe2+ + 2OH-   Fe(OH)2 or FeO⋅H2O (product formation) (1.7) 
4Fe(OH)2 + O2 + 2H2O   4Fe(OH)3 or 2Fe2O3⋅6H2O (product formation) (1.8) 
From the literature it is known that the corrosion products of iron in aqueous solutions typically 
comprise a layered structure which consists of Fe2O3⋅nH2O on surface layer, Fe3O4⋅nH2O in the 
middle and FeO⋅nH2O at the bottom [75]. A similar structure has been revealed in many in vitro 
studies, where a layer of brownish red degradation products, indicating the formation of hematite 
(Fe2O3), has been observed over a black layer reflecting the formation of magnetite (Fe3O4) or 
wustite (FeO).  
During the course of degradation, pits on the metal surface emerge, along with an 
increased concentration of Cl‐  at the degradation surface. Hermawan et al. proposed that Cl‐  
ions from the immersion media diffuse through the porous oxide layers to the metal surface to 
 22 
compensate for the increased Fe2+ or Mn2+ concentration in Figure 1.4(c). The Cl‐  ions may 
subsequently react with metal ions, according to the following equation: 
Fe2+ + 2Cl‐   FeCl2 (1.9) 
The metal chloride may also react with water to form hydroxide and free hydrochloric acid: 
FeCl2 + H2O  Fe(OH)2 + HCl (1.9) 
The pH value locally decreases and it leads to the formation of pits. As the degradation process 
continued, the precipitation of Ca and P rich layers deposit onto the hydroxide layers in Figure 
1.4(d).  
 
(a) (b)
(c) (d)
 
Figure 1.4. Illustration of the corrosion mechanisms for Fe–Mn alloys: (a) initial corrosion 
reaction, (b) formation of hydroxide layer, (c) formation of pits, and (d) formation of 
calcium/phosphorus layer. Used with permission of [75]. 
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1.2.4 Electrochemical considerations in alloy design for Fe based degradable materials 
As mentioned above for the degradation behavior of Fe-Mn system by way of example, metallic 
degradation response occurs via the electrochemical reaction upon introducing the metal to an 
aqueous environment wherein metals give away electrons and form positive ions during the 
anodic dissolution of the metal and a cathodic reaction takes place, leading to the formation of a 
corrosion product. In keeping with the concept of development of new compositions for 
controlling the corrosion of the Fe alloys, various alloy systems have been investigated to date in 
Table 1.3. The purpose of adding alloying elements to Fe as discussed earlier is mainly to 
increase the corrosion resistance. It is closely related with design strategy for Fe based 
degradable material which are proposed by Schinhammer et al [72].  
The approach to achieving increased degradation rates takes into account two criteria 
which influence the corrosion susceptibility of the metal: 
1. The addition of less noble alloying elements within the solubility limit in Fe to 
make the Fe matrix more susceptible to corrosion. 
2. The addition of noble alloying elements to generate small and finely dispersed 
precipitates that act as cathodic sites towards the Fe matrix, inducing micro-
galvanic corrosion. 
To satisfy criterion (1), the standard electrode potentials listed in Table 1.5 must be taken into 
account. This is an orderly arrangement of potentials for all metals; the more negative values 
correspond to more reactive metals [91, 92]. The position of a given element in the series is 
determined by the equilibrium potential of the metal in contact with an aqueous solution with its 
ions at a concentration equal to unit activity. Although this situation rarely occurs in practice, it 
is a useful aid in establishing a ranking among the different elements. 
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Many metals listed in the standard electrode potentials are less noble than Fe. Usually, most of 
these were not considered further, however, as either their solubility in Fe (e.g. Li, Mg, Ti) or 
their biocompatibility (e.g. Al, Cr) is limited [72]. However, in line with this observation, Mn 
was chosen in first to meet criterion (1) because it possesses a distinctly lower reduction 
potential (EMn = –1.18 V) than Fe (EFe = –0.44 V) and shows high solubility in Fe. Because Fe 
and Mn form a solid solution, the standard potential of the Fe–Mn alloy is expected to decrease 
with increasing Mn content [93]. The same approach was previously reported by Hermawan et 
al. [6, 7] and was based on metallurgical and toxicological considerations. It corresponds to 
criterion (1) by considering Mn a suitable alloying element, and is clearly a step in the desired 
direction.  
The potential of criterion (2) has already been illustrated in systems such as Al-Cu, where 
precipitates (Al2Cu) are formed that are nobler than the Al matrix and thus reduce the alloy’s 
corrosion resistance [94]. The efficiency of such an approach can be enhanced by reducing the 
size of the precipitates and distributing them homogeneously in the matrix. Here the degradation 
rate is expected to increase, while the material maintains homogeneous "macroscopic" 
degradation behavior. The elements available for pursuing criterion (2) are all those in the 
standard electrode potential which are nobler than Fe (Table 1.5). The requirement that small and 
homogeneously distributed precipitates be formed imposes additional restrictions on the choice 
of element. Despite no consideration being reported in the literature for use of Mg as an alloying 
elements to meet criterion (1) [72], for this dissertation Mg is used as alloying element of these 
Fe alloy, which will be discussed in the following section. 
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Table 1.5. Selected standard electrode potentials of metal in aqueous solution at 25 °C relative to 
the standard hydrogen electrode [92, 95]. 
Electrode reaction E°(V) 
Pt2+(aq) + 2 e–    Pt(s) ≈ 1.2 
Pd2+(aq) + 2 e–    Pd(s) 0.987 
Ag2+(aq) + 2 e–    Ag(s) 0.800 
Cu+(aq) + e–    Cu(s) 0.521 
Cu2+(aq) + 2 e–    Cu(s) 0.342 
2H+(aq) + 2 e–    H2(g) 0.000 
Sn2+(aq) + 2 e–    Sn(s) -0.136 
Ni2+(aq) + 2 e–    Ni(s) -0.25 
Co2+(aq) + 2 e–    Co(s) -0.28 
Cd2+(aq) + 2 e–    Cd(s) -0.403 
Cr3+(aq) + e–    Cr2+(aq) -0.41 
Fe2+(aq) + 2 e–    Fe(s) -0.44 
Ga3+(aq) + 3 e–    Ga(s) -0.53 
Cr3+(aq) + 3 e–    Cr(s) -0.74 
Zn2+(aq) + 2 e–    Zn(s) -0.763 
Cr2+(aq) + 2 e–    Cr(s) -0.91 
Mn2+(aq) + 2 e–    Mn(s) -1.18 
V2+(aq) + 2 e–    V(s) -1.18 
Zr4+(aq) + 4 e–    Zr(s) -1.53 
Ti2+(aq) + 2 e–    Ti(s) -1.63 
Al3+(aq) + 3 e–    Al(s) -1.66 
Mg2+(aq) + 2 e–    Mg(s) -2.37 
Na+(aq) + e–    Na(s) -2.714 
Ca2+(aq) + 2 e–    Ca(s) -2.87 
Sr2+(aq) + 2 e–    Sr(s) -2.89 
Ba2+(aq) + 2 e–    Ba(s) -2.9 
Rb+(aq) + e–    Rb(s) -2.925 
K+(aq) + e–    K(s) -2.925 
Li+(aq) + e–    Li(s) -3.045 
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1.3 IRON-MAGNESIUM: AN IMMISCIBLE SYSTEM 
1.3.1 Thermodynamic phase diagram in Fe-Mg system 
According to the common phase diagrams in Figure 1.5, Fe and Mg are almost 
immiscible at ambient pressure [96]. In the liquid phase, the solubility of Mg in Fe is on the 
order of 0.025 atomic percent (at. %). The maximum solid solubility of Fe in Mg is 0.00041 
at. % and the Fe content in Mg at the eutectic point is less than 0.008 at. % [97]. Moreover, 
below 1273 K, the solubility of Mg in α-Fe is below the detection limit and only about 0.25 at. % 
Mg is soluble in δ-Fe at the monotectic temperature [98]. Solubility of Mg in Fe is possible only 
at high pressures and temperatures [96]. Below 1000° C, Mg does not dissolve in Fe. The 
immiscibility of Fe and Mg at ambient conditions is in line with the well-known Hume-Rothery 
rules, in which atomic size difference above 15 % between the alloy constituents limits solid 
solution formation [99]. The enthalpy of mixing in the Fe-Mg system is +18 kJ/mol [98]. This 
system is convenient for Mӧssbauer studies since it contains Fe [100]. Indeed, based on semi-
empirical thermodynamic calculations, Yelsukov et al. obtained 6 kJ/mol for the enthalpy of 
formation for Fe0.93Mg0.07, compared to 20 kJ/mol calculated for the corresponding Fe-Mg 
nanocomposites [101]. 
1.3.2 High energy mechanical alloy (HEMA) of immiscible Fe-Mg system and other 
system. 
Despite the negligible solubility of Mg in Fe, several Fe-rich metastable Fe-Mg solid solutions 
have been synthesized. According to the pioneering work by Hightower et al. [102] mechanical 
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alloying produced Fe-Mg substitutional solid solutions with up to 20 at. % Mg in α-Fe. Later, 
Dorofeev et al.[100, 101] found the formation of about 5~7 at. % Mg in α-Fe supersaturated 
solid solution [101]. Additionally, Dubrovinskaia et al, found that pressure can facilitate the solid 
solution formation and then reported that the solubility of Mg in α-Fe was increased to 4 at.% at 
pressures around 20 GPa and temperature up to 2273 K [103]. The solution of Mg in the bcc-
structured Fe-based alloy increases the lattice parameter by approximately 2.4% with respect to 
that of pure iron [103].  
 
 
Figure 1.5. Assessed Fe-Mg phase diagram in the Mg-rich region. Used with permission of  [96]. 
 
In contrast to systems with negative heats of mixing, in the great majority of systems with 
positive heats of mixing non-equilibrium processing results in the formation of supersaturated 
solid solutions rather than amorphous phases [104]. Examples are systems which have very 
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limited equilibrium solid solubility and which do not form intermetallic phases, such as Cu–Co, 
Cu–Fe, or Ag–Cu, which can nevertheless be obtained as thermodynamically unstable solid 
solutions over wide composition ranges by HEMA [105-107]. Additionally, HEMA has been 
reported to result in the formation of either solid solution in Ge–Al [108] and Ag–Bi [109] 
systems or supersaturated solid solutions between elemental pairs exhibiting positive heat of 
mixing in Fe–Mg [100], Pb–Al [110, 111], Ni–Ag [112], Fe–Pb [113], and Cu–V [114] systems. 
Formation of solid solutions rather than amorphous phases in such systems is understandable 
from a thermodynamic viewpoint, in particular in systems which exhibit immiscibility even in 
the liquid state. 
1.3.3 Formation of an amorphous phase in the immiscible system. 
Although amorphous phases are unlikely to occur in alloy systems with positive heat of 
mixing as outline above in section 1.3.2, there are a minor number of investigations that report 
on amorphous phase formation is system such as Ag-Fe [115, 116] ,  Ag-Co [117], Ag-Ni [117], 
Ag-Cu [118], W-Cu [119, 120] and Ta-Cu [120], some of which are immiscible even in the 
liquid state. In the classical thermodynamic perspective, the formation of amorphous phases in 
systems which are immiscible even in the liquid state is exceptional, and is in contrast to the 
current understanding of the thermodynamics of liquid phases. Recently, non- equilibrium 
processing of materials, especially HEMA, has been employed to produce a variety of novel and 
advanced materials, which include amorphous, quasicrystals, metastable intermediate phases, 
and nano-crystalline materials, among others [121]. The heavy mechanical deformation during 
HEMA induces particle refinement and consequently decreased diffusion distances. Further, 
mechanical deformation generates a wide variety of crystal defects, including grain boundaries, 
 29 
stacking faults, and vacancies, which enhance diffusion. All these effects result in intimate 
mixing of fine powder particles, and possibly alloying [122]. This has been shown to occur even 
between difficult to alloy mixtures, which exhibit a positive heat of mixing [109]. Therefore, 
fully amorphous phases were synthesized by HEMA in elemental pairs such as W-Cu [123], Cu-
V [124], Cu-Ta [125, 126], and Nb-Zr [127] which are considered as immiscible system. 
The theoretical and experimental precedence of Fe and Fe based alloy for biodegradable 
medical applications discussed earlier along with the advantages in terms of the physical, 
chemical and biological properties make Fe alloys suitable for degradable load and non-load 
bearing bone implants, cardiovascular stents, and other implantable medical devices. This work 
seeks to optimize a system of alloys featuring elements such as Mg, Mn, Ca, and Zr primarily for 
biomedical applications. Accordingly, four specific aims have been crafted as discussed 
henceforth. 
1.4 SPECIFIC AIMS 
During the past few years significant advances have been made in the development of 
biodegradable metallic materials for biomedical applications, such as temporary prostheses, 
cardiovascular stents, and three-dimensional porous structures as scaffolds for tissue engineering. 
The commonly used stainless steels, titanium and cobalt-chromium based metallic “bio-inert” 
materials have had a long history of clinical employment as implants in the treatment of 
temporary clinical problems such as fractured bones, narrowed arteries and congenital 
cardiovascular defects [11, 12]. However, these permanent implants suffer from some 
unavoidable short and long term clinical problems such as disease/trauma, permanent physical 
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irritation, chronic inflammatory discomfort or implant removal/revision surgeries [24-26]. To 
alleviate these permanent implant related problems, biodegradable materials have received 
considerable attention in recent years for their unique degradable characteristics [44, 128, 129]. 
Clinically used degradable biomaterials are typically made of polymer but these polymer-based 
implants usually possess poor and unsatisfactory mechanical properties [130-134]. As a result, 
many recent studies have indicated that there is a high demand to design and develop 
biodegradable metallic materials with controlled degradation rates and suitable mechanical 
properties for orthopedic, cardiovascular and pediatric applications including bone fixation 
screws/pins and coronary stents [35].  
Up until now, Iron (Fe) and Magnesium (Mg) based alloys are essentially two classes of 
metals that have been considered for degradable implant applications [1, 7, 22, 53]. Most of the 
research on Fe and Fe based alloys have reported a very slow degradation rate in physiological 
environments [26, 54, 76], while Mg and Mg based alloys degrade too rapidly [23, 25]. Fe alloys 
containing elements such as Mn, C, Si, and Pd show improvement in degradation rates, but their 
biocompatibility is still unclear especially when alloys contain concentration of the alloying 
elements [7, 58, 61, 72, 135]. Therefore, it is necessary to develop Fe-based alloys exhibiting 
improved degradation behavior while also retaining good in vitro and in vivo biocompatibility 
and cytocompatibility.  
The main focus of this thesis is thus to design and develop Fe-based biodegradable alloys 
employing appropriate alloying techniques displaying tailored corrosion and improved 
cytocompatible properties using suitable alloying elements. Accordingly, four specific aims have 
been designed and a summary of the specific aims of this thesis to achieve the work described 
above are given below: 
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1.4.1 Specific Aim 1: Synthesis and optimization of the processing parameters for the 
generation of Fe-Mg binary alloy powders utilizing high energy mechanical alloying 
(HEMA). 
Hypothesis: To date, only two classes of metal alloys have been explored as biodegradable 
materials for medical devices. They include Fe and Mg-based alloys. However, to the best of our 
knowledge, there is no study exploring the Fe-Mg binary alloy system as biodegradable metallic 
materials because of the thermodynamic immiscibility of Fe and Mg under ambient conditions. 
Thus, synthesis of Fe-Mg binary alloys with high Mg content using HEMA can be very useful. 
These high magnesium containing alloys may show improved degradation characteristics as well 
as improved cyto/biocompatibility. 
Rationale: Fe is an essential nutrient present in the human body and plays an important role in 
vital biochemical activities such as oxygen sensing and transport, electron transfer and catalysis 
[45]. It also exhibits good mechanical properties [58], biocompatibility [42] and 
hemocompatibility [136]. On the other hand, Mg is a lightweight metal with mechanical 
properties similar to bone. It is biocompatible and essential to the human metabolism present, as 
a cofactor for many enzymes [137]. Mg also forms soluble and non-toxic oxides in the body 
fluid that is harmlessly excreted with the urine [64]. Theoretically, bimetallic (galvanic) 
corrosion may occur when dissimilar metals, with different potentials, are in contact. Mg is most 
anodic (less noble) element than Fe, and there is a difference in the electronegative potentials of 
these two elements. Thus, it can be expected that alloying Fe with high Mg content may result in 
alloys that are more susceptible to electrochemical corrosion. Although both elements are 
already known to have high potential for biodegradable materials, there is no report that Fe-Mg 
alloys have been synthesized and studied for biomedical applications to date. In spite of the 
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negligible solubility of Fe and Mg, several Fe-rich metastable Fe-Mg solid solutions have been 
synthesized by HEMA, [100-102] a solid state powder processing technique, known to generate 
and stabilize thermodynamic non-equilibrium phases and systems [122]. However, these solid 
solutions (alloys of Fe-Mg system) are formed under very stringent conditions, and further, most 
studies were focused only on the formation of these rare solid solutions. Additionally, there are 
very few reports on Fe-Mg binary system over the past few years and the use of Fe-Mg binary 
system alloys as biodegradable scaffolds is yet to be explored. 
1.4.2 Specific Aim 2: Synthesis and optimization of the processing parameters for the 
deposition of thin layers of Fe-Mg alloys using pulsed laser deposition (PLD) and 
identification of the potential use of these alloys as biodegradable systems using in vitro 
characterization methods. 
Hypothesis: PLD can be used to deposit thin layer or films from any material, starting from pure 
elements to multi-component compounds, and moreover, a major advantage of this techniques is 
that the stoichiometry of the target material can be reproduced in entirety in the deposited films 
[138]. Therefore, it is possible to synthesize thin layers of Fe-Mg alloy from targets formed 
either using the Fe-Mg alloy powder generated by HEMA (Specific Aim 1) or using blended 
mixture prepared from the elemental powders of Fe and Mg corresponding to alloy composition 
in Specific Aim 1 (SA1).  
Rationale: There are two approaches for use of PLD in this proposed work. First, PLD is only 
considered as one of the alloying methods similar to conventional melting or HEMA. In other 
words, the laser energy provided by the PLD and other related process parameters will be 
utilized to form alloys in-situ. As mentioned in SA1, Fe and Mg are almost immiscible under 
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ambient conditions, and it is almost impossible to generate alloys using a conventional method. 
In the literature, some reports exist on the formation of metastable phases in the immiscible 
systems using PLD [139-141]. In line with these results, Fe-Mg alloy will be synthesized as a 
thin layer from targets made of blended mixtures of Fe and Mg elemental powders by PLD, and 
the generated layers will be evaluated to understand the influence of the processing parameters 
during PLD. Second, PLD will be used to ablate the Fe-Mg alloy targets to form thin films of the 
same alloy composition used in the target. However, the phase and structure of the deposited thin 
layers may vary depending on the deposition conditions. In order to identify the potential use of 
Fe-Mg alloy as a biodegradable system using in vitro characterization methods, it is necessary to 
form bulk shapes or thin layers from the HEMA derived Fe-Mg alloy powders as described in 
SA1. Sintering by thermal treatment below the melting temperature of the main constituent 
material usually transforms a metallic or ceramic powder (or a powder compact) into a bulk solid 
typically executed in powder metallurgy. However, conventional sintering technique does not 
permit sintering of Fe-Mg alloy powders as described in SA1 due to the large melting 
temperature difference between Fe and Mg, namely, 1530°C and 650°C, respectively. Hence, it 
is impossible to use conventional sintering method to form substrates without inducing any 
change in composition and structure. Therefore, formation of thin film is one of the solutions to 
generate dense structures from HEMA derived Fe-Mg powders as part of the next section of the 
proposed work. There are several possible techniques used to synthesize thin films. Among the 
different techniques, pulsed laser deposition (PLD) has several characteristics that distinguish it 
from other film growth methods [138]. We already reported [142] that by controlling optimal 
deposition parameters in PLD; it is possible to tailor the structural properties of the deposited 
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thin films in Mg-based amorphous alloys for biomedical applications. These results are also 
included in this thesis. 
1.4.3 Specific Aim 3: Study the effect of addition of manganese (Mn) as an alloying 
element in the Fe-Mg alloy system and understand the in vitro response to explore the 
potential of these alloys as novel biodegradable material systems. 
Hypothesis: One of the serious limitation of using Fe-based alloy as biodegradable material is its 
ferromagnetic characteristics that can seriously limit magnetic resonance imaging (MRI) 
capabilities of Fe based alloys. On the other hand, austenitic Fe-Mn alloys are already known as 
nonmagnetic and are reported to have higher degradation rates than pure Fe. The degradation 
rates however can be adjusted further by varying the Mn content [58] in these alloys. 
Accordingly, it is expected that antiferromagnetic behavior can be achieved by adding Mn to the 
Fe-Mg alloy as discussed in SA1.  
Rationale: Alloying and heat treatment are typically the two possible ways to overcome 
limitations posed by the ferromagnetic characteristics of pure Fe for biological applications [7]. 
Austenite, also known as gamma phase iron (γ-Fe), is a metallic, non-magnetic allotropic form of 
Fe  or Fe based alloys [143]. Austenitic Fe–Mn alloys are considered as viable substitutes from 
the conventional Fe–Cr–Ni austenitic stainless steel alloys, wherein the expensive alloying 
elements such as chromium (Cr) and nickel (Ni) are replaced by a more inexpensive Mn. 
Alloying with more than 29 wt-% Mn results in the stabilization of the complete austenitic phase 
[144, 145] which exhibits antiferromagnetic behavior [146, 147]. Furthermore, Mn is one of the 
essential trace elements required for the normal development and body function during the life 
span of all mammals [148]. In addition, Mn contributes to better biological functions than other 
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austenite stablizing elements such as  nickel which is also a suspect carcinogen [149]. Excess Mn 
is also not reported to be toxic in the cardiovascular system since the extensive plasma protein 
binding counteracts the effect of Mn toxicity [150, 151]. Therefore, it is hypothesized that adding 
Mn to Fe-Mg alloy will perform a role that can potentially transform Fe-Mg ferromagnetic alloys 
into the nonmagnetic form for biological applications. 
1.4.4 Specific Aim 4: Study the effect of addition of calcium (Ca) and zirconium (Zr) 
alloying elements to Fe-Mg or Fe-Mg-Mn alloys and understand the in vitro response to 
explore the potential of these alloys as novel biodegradable material systems. 
Hypothesis: The addition of Ca and Zr to Fe-Mg (Specific Aim1) and Fe-Mg-Mn (Specific 
Aim3) alloys will improve the bioactivity of these biodegradable alloys in addition to tailoring 
the biodegradable characteristics. Hence, their alloys can be considered as potentially viable 
temporary implants.   
Rationale: For biomedical applications, the composition of the metal is considered to be 
extremely crucial since many of the elements that are used in commercially available metals for 
industrial applications are extremely toxic to the human body. Therefore, in addition to meeting 
the advanced properties needed for a particular biomedical application, the metal must also be 
biocompatible. Ideally, a biodegradable medical device should be composed of materials or 
alloying elements that are nontoxic (bio/cytocompatible) as well as considered non-carcinogenic. 
It would also be very advantageous if the material is composed of elements and minerals that are 
already present and known to be compatible within the body. Ca and Zr are considered to be 
essential trace elements for human life. Ca, in particular, is a major component of the human 
bone and is essential to the chemical signaling of cells [152]. Also, it is an important element 
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involved in the muscular action and nerve conduction, and its level in the body is closely 
monitored and regulated by a process called homeostasis [153]. Therefore, Ca was reported to be 
the most favorable non-toxic alloying element for biomedical applications [154, 155]. It has also 
been reported that the addition of Ca significantly enhances the mechanical properties of Mg-
based alloy [154]. Zr, on the other hand, is known as a powerful grain refiner and improves the 
mechanical properties of Mg alloys [156, 157]. More importantly, Zr exhibits low ionic 
cytotoxicity in vitro, and excellent biocompatibility in vivo with no evidence contributing to any 
mutagenic or carcinogenic response [158-160]. However, there are only few studies reported on 
the effect of the addition of Ca and Zr to biodegradable Fe-based alloys in the literature to date. 
Based on the published literatures it is, therefore anticipated that Ca and Zr will induce positive 
effects on the degradation rates and cytocompatibility of the Fe-Mg and Fe-Mg-Mn alloys. 
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2.0  SPECIFIC AIM 1: SYNTHESIS AND OPTIMIZATION OF THE PROCESSING 
PARAMETERS FOR THE GENERATION OF FE-MG BINARY ALLOY POWDERS 
UTILIZING HIGH ENERGY MECHANICAL ALLOYING (HEMA) 
2.1 INTRODUCTION 
Interest in biodegradable metals and metal alloys for use as temporary implant materials in 
vascular intervention and osteosynthesis has been continuously increasing over the past few 
years [1-7]. It has been reported that degradable implants in fact, may overcome the 
disadvantages of permanent devices in certain cases, known to cause prolonged physical 
irritation and chronic inflammation. At present, Iron (Fe) [7, 53, 72, 75, 78] and magnesium 
(Mg) [1, 22, 161-164] based alloys are the two prominent classes of metals that have been 
considered as promising candidates for degradable implantable devices. Mg-based alloys have 
already been successfully tested in vivo and also pursued for clinical studies [68]. However, the 
major weakness of theses alloys is the low corrosion resistance [23, 25], especially in electrolytic 
and aqueous environments, leading to the formation of hydrogen gas pockets [165], hemolysis 
and alkalization of body fluid which might limit their future biomedical application [25]. In 
addition, their low strength and hardness also limit clinical application for load bearing bone 
fixation devices such as screws and plates [166, 167]. On the other hand, superior mechanical 
properties of pure Fe or Fe-based alloys are more attractive as biodegradable implants compared 
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to Mg-based alloys. Recent in vivo results have showed that pure Fe is a suitable metal for the 
generation of biodegradable stents without causing stent particle embolization, thrombosis of 
excess inflammation, fibrin deposition, local or systemic toxicity and significant obstruction of 
the stented vessel due to inflammation, neointimal proliferation, or short and long term 
thrombotic effects [21, 42, 54, 168]. However, it has also been shown that iron alloys are 
ferromagnetic [37, 42, 72] and exhibit very slow degradation rates in physiological environments 
[26, 54, 76]. Therefore, there is vital need to increase the degradation rate and improve the 
mechanical properties for each specific application of these Fe-based alloys by modifying the 
chemical composition and microstructural characteristics.  
As outlined above Section 1.2.2, Some researchers have reported possible ways to 
overcome these limitations by alloying, heat treatment, or surface modification as well as novel 
fabrication methods [61]. Hermawan et al.[7, 75] developed a Fe-Mn alloy containing 35 wt.% 
Mn using powder metallurgy. This alloy displayed an increased corrosion rate compared to pure 
iron [5] and also showed low inhibition of fibroblast cell metabolic activity in cell viability tests. 
Fe-Mn-Pd alloys were also produced by Schinhammer et al. [72] that reveal a degradation 
resistance that is one order of magnitude lower than that observed for pure iron. Xu et al. added 1 
wt.% of Carbon into a Fe-30Mn (wt.%) alloy resulting in lower magnetic susceptibility and 
better mechanical properties compared to the Fe-30Mn alloy [74]. Moreover, Schinhammer et al. 
proposed two criteria for alloying in order to achieve an increased degradation rate [72]: First is 
the addition of less noble alloying elements within the solubility limit of Fe to make the Fe 
matrix more susceptible to corrosion. The other is the addition of the noble alloying elements to 
generate small and finely dispersed intermetallic phases (IMPs) to generate micro galvanic 
corrosion with Fe matrix. Following these criteria, various different alloying elements (Co, Al, 
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W, Sn, B, C,S, Si and Pd) have been used but little effect on corrsion was found, and the 
biocompatibility of alloys with these elements is uncertain, particularly at higher concentrations 
of the alloying elements [61, 76]. A number of novel fabrication methods such as electroforming 
[51, 52], powder metallurgy [69], equal channel angular pressing (ECAP) [43] and 3D printing 
[82] have resulted in pure Fe foil or Fe-based alloys which show faster degradation compard to 
pure Fe obtained from conventional casting techniques. Recently some researchers reported 
newly designed biodegradable Fe-X composites (X= W, CNT, Pd, Pt, Bioceramics) prepared by 
spark plasma sintering (SPS) [70, 77], powder metallurgy [76] and cold drawing [83-85].  As 
opposed to the above mentioned strategy for development of new Fe based alloys, surface 
modification has also been used to the increase the degradation rate of Fe as well as improve the 
biocompatibility. It was found that pure Fe stents maintained a supporting function during the 
first several weeks or months after implantation for cardiovascular applications because the 
lower Fe concentration might produce a favorable effect on the metabolic activity of endothelial 
cells [54] but it started to show signs of in vivo corrosive degradation within a month [53]. In 
line with this veiwpoint,  the Fe-O thin films synthesized on a pure iron surface by plasma 
immersion, ion implantation and deposition, Lanthanum (La) ion implanted pure Fe, and 
modified pure Fe by plasma nitriding have been shown in related literatures [78, 79, 81] to 
effectively improve both the corrosion resistance and biocompatibility. 
In spite of these efforts, the degradation rates, and cytocompatibility of Fe based alloys 
are still far from levels necessary for implementation in clinical applications. An alternative 
approach is therefore needed to develop Fe-based alloys with improved degradation behavior 
while maintaining its biocompatibility. In the present studies, one of the motivations is the 
formation of non-equilibrium alloy phases, particularly in the Fe-Mg binary system, by High 
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Energy Mechanical Alloying (HEMA). It has been found that HEMA of elemental mixtures can 
be employed to synthesize various metastable phases, such as supersaturated solid solutions that 
are immiscible [169]. These include  nanostructured, intermetallic[170], quasicrystalline, and 
amorphous phases [171].  
Although Fe and Mg have been studied separately as temporary degradable implants in 
biological applications, there are no reports on Fe-Mg binary alloys used as biodegradable 
metallic materials. Mg is a good candidate as an alloying element in Fe due to its lower standard 
electrode potential (E°) than Fe, making it more anodic and less noble.  
The main problem with the synthesis of a Fe-Mg alloy is the immiscibility of Fe and Mg 
under ambient conditions [96]. Clearly, an even larger thermodynamic driving force is needed 
for the formation of supersaturated solid solutions between immiscible components since the 
enthalpy of mixing in such systems is positive [100]. In spite of these process limitations, several 
Fe-rich metastable Fe-Mg solid solutions have been synthesized by HEMA [100-102, 172], a 
solid state powder processing technique known to generate and stablize thermodynamic non-
equilibrium phases and systems [122, 173]. However, these solid solutions (alloys of Fe-Mg 
system) are formed under very stringent conditions, and further, most studies were focused only 
on the formation of these rare solid solutions. It should be noted that this is the first report of Fe-
Mg binary alloy systems for bio-degradable metallic materials to the best of the authors’ 
knowledge. The present work therefore reports the new alloying composition of Fe-Mg 
amorphous systems synthesized by HEMA. 
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2.2 MATERIALS AND METHODS 
2.2.1 Alloy synthesis by high energy mechanical alloying (HEMA) 
The alloy powders corresponding to Fe100-xMgх (х=1, 5, 10, 20, 30, 40 and 50) atomic % 
compositions were produced by high energy mechanical alloying (HEMA). Commercial 
elemental powders of pure Fe (99.9+%, <10 μm, Alfa Aesar) and pure Mg (99.8%, <325 mesh, 
Alfa Aesar) were chosen as the starting materials. These were weighed corresponding to the 
desired compositions, mixed and added into stainless steel (SS) vials containing 45 stainless steel 
balls 2 mm in diameter as the milling media. The ball to powder weight ratio (BPR) was 15 to 1, 
and the total weight of the starting mixture was 3 g. HEMA was carried out through two 
sequential process of dry and wet milling. The mixture was subjected to dry milling in a 
planetary SPEX 8000 high energy Shaker Mill for up to 14 hours with 30 minutes resting 
intervals after every 1 hour of active milling. After dry milling, 1.5 ml of toluene (anhydrous, 
99.8%, Sigma-Aldrich) was loaded in the vial and the as-dry milled powder was subsequently 
wet milled for a period of up to 17 hours to reduce the adhesion of powders on the balls and the 
inner surface of the milling vial. Handling of the powders and loading of toluene were conducted 
inside an argon-filled glove box in which the oxygen concentration was kept below 1.0 ppm. 
2.2.2 Characterizations of HEMA derived Fe-Mg binary amorphous powder 
The microstructure and qualitative phase analysis of milled powders was examined by 
conventional X-ray diffraction (XRD; PANalytical X'pert Pro with Cu-Kα radiation). The phase 
evolution during dry and wet milling was characterized by XRD. The analysis of XRD peaks 
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was conducted using Pseudo-Voigt shape function to determine the Lorentzian and Gaussian 
contribution of peak. Lattice parameters were determined with the Nelson-Riley extrapolation 
method [174, 175]. The International Centre for Diffraction Data’s Powder Diffraction File 
(PDF) database was used for peak identification. The morphology of the powder was observed 
via scanning electron microscopy (SEM, JEOL, JSM-6610LV) with energy-dispersive X-ray 
(EDX; EDAX Genesis, Mahwah, NJ) to conduct elemental analysis. A JEOL JEM2000FX 
operating at 200 kV was used to conduct transmission electron microscopy (TEM) and obtain 
conventional bright field images. High resolution (HR) TEM observations were carried out using 
a JEOL JEM-2100F and image processing was carried out using the software package Gatan 
Digital Micrograph for Fourier transform. TEM samples were obtained by spraying powder onto 
carbon grids (Ted Pella, USA) using an aerosolizing spray nozzle for the as-milled powder. The 
thermal properties of the final milled powder were studied by differential scanning calorimetry 
(DSC, Netzsch STA 409) at a heating rate of 10°C/min under an ultra high purity Ar gas flow.  
2.3 RESULTS  
2.3.1 Microstructural characterization of Fe-Mg powder after dry milling 
Figure 2.1 shows the XRD scans of blended mixtures prepared from the elemental powder of Fe-
Mg and as prepared post dry milled powder corresponding to the nominal compositions of Fe100-
xMgx (х=1, 5, 10, 20, 30, 40 and 50). In Figure 2.1(a), the XRD patterns show only predominant 
bcc Fe phase up to 20 at.% Mg (x=1~20) and peaks from hcp Mg are observed after Mg 
composition exceeds 30 at.% (x= 30, 40 and 50). The peak from Mg (101) is faintly visible 
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around 37° for Fe70Mg30 but other peaks from residual Mg emerge and become shaper with 
increase of intensity for Fe60Mg40 and Fe50Mg50 in Figure 2.1(a). For all samples, there is an 
increased broadening of the bcc phase diffraction peaks compared to Fe raw powder and 
especially they are shifted to smaller diffraction angles between x=5 and 40 powders (Fe95Mg5, 
Fe90Mg10, Fe80Mg20, Fe70Mg30 and Fe60Mg40) in Figure 2.1(b). For the Fe50Mg50 powder in 
Figure 2.1(a) and (b), the bcc phase peaks shift back to the pure α-Fe positions with observation 
of hcp peaks. This result suggests that Mg dissolves into the Fe bcc lattice for concentration less 
than 50 at.% [102] but indicates that not all of the Mg have dissolved for Fe70Mg30 and Fe60Mg40 
powders. In the case of Fe50Mg50, the microstructure formed after the dry milling for 14 hours 
consists of two phase mixtures of bcc Fe and hcp Mg without any peak shifting in Figure 2.1(a). 
Further dry milling does not lead to microstructural changes of all composition compared to 
Figure 2.1(a) with the increased milling time up to 50 hours (Figure 2.2), indicating that it 
approaches steady state in this milling conditions.  
The structural evolution in the course of post dry milling can be further characterized by 
the changes in the lattice parameters. Figure 2.3 compares the lattice parameters of the bcc phase 
determined in this study and those reported in literature [100, 102, 172]. Alloys with Mg 
concentration below 50 at.% had X-ray peaks which are shifted to lower angles (Figure 2.1(b)), 
corresponding to an increase in bcc lattice parameter. It shows that the lattice parameter of the 
bcc phase, initially 0.2866 nm (Iron, PDF# 01-071-4648) as pure α-Fe, is increased with the 
addition of Mg and reaches a maximum (a = 0.2897 ± 0.0004 nm) at 10 at.% Mg and then it 
gently decreases as the Mg content of the starting mixture exceeds 20~30 at.%, although it 
remained larger than for pure α-Fe in Figure 2.3. This trend can be interpreted as the formation 
of solid solutions of Mg in α-Fe during post dry milling.  
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Figure 2.1. The X-ray diffraction patterns of (a) raw Fe-Mg blended mixture powder and 
Fe80-xMgx powder (x = 1-50) after post dry milling and (b) enlargement of (200) and (211) 
profiles from (a); the dash lines indicate the position of the α-Fe (200) and (211) reflection. 
(PDF# 01-071-4648). 
 45 
30 40 50 60 70 80 90
2θ (deg)
Fe 80Mg 20 (tmilling=50hrs)
Fe 80Mg 20 (tmilling=14hrs)
Fe 50Mg 50 (tmilling=70hrs)
Fe 50Mg 50 (tmilling=14hrs)
No
rm
ali
ze
d 
In
ten
sit
y
 
Figure 2.2. The X-ray diffraction patterns of the Fe80-xMgx powder (x = 20, 50) with the 
increased dry milling time up to 50 and 70 hours. 
 
Eventually, it becomes close to the initial lattice parameter at 50 at.% Mg. Notice that the 
bcc phase lattice parameter continuously decreases with increasing Mg content in as-dry milled 
powder beyond 10 at.%, as it should if the Mg concentration in the bcc phase were to increase. 
This means that the Mg supersaturation in solid solution phase decreases with increasing Mg 
content in this study. 
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Figure 2.3. Variation of lattice parameter for the bcc phase as a function of nominal composition 
of the post dry milled powder, with reference data from Hightower et al. [102], Dorofeev et al. 
[100], Yoneda et al. [172]; the horizontal dash line indicates the lattice parameter of α-Fe. (PDF# 
01-071-4648) 
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2.3.2 Microstructural characterization of Fe-Mg powder after wet milling 
Figure 2.4(a) shows the collected XRD patterns of as prepared milled powder after wet milling 
corresponding to Fe100-xMgx along with simulated patterns for bcc-Fe and hcp-Mg. Surprisingly, 
all of the Bragg peaks due to bcc phase of solid solutions of Mg in α-Fe and hcp-Mg after dry 
milling have disappeared at x = 10, 20 and 30 (Fe90Mg10, Fe80Mg20and Fe70Mg30) which are 
shown in Figure 2.1(a) and it exhibits the typical broad diffraction pattern corresponding to the 
fully amorphous phase with no indication of any residual crystalline phases. This means that it 
has been completely transformed to a homogeneous amorphous phase and it was observed to be 
initiated by diffusive mixing mechanism [122, 176].  For x < 10 powders (Fe99Mg1and Fe95Mg5),  
the intensity of the peak corresponding to bcc (110) is decreased and its width increased due to a 
reduction in crystallite size and introduction of lattice strain [122, 177] and the peaks from 
residual bcc (200) and (211) are still faintly visible without amorphization. For Fe60Mg40 powder, 
the XRD pattern also shows the presence of unreacted bcc (110) over the amorphous peak at 
around 45° and all Mg peaks completely disappear. This unreacted bcc peak becomes 
significantly sharper with increasing Mg content (x=50) and another three distinct peaks from a 
crystalline phase which begin to emerge at around 37°, 65° and 82°. These crystalline phases are 
identified to be Mg (101), α-Fe (200) and (211) phases depending on the composition. Here, it 
should be noted that diffraction peaks corresponding to unreacted bcc (110) phase are different 
between x=5, 40 (Fe95Mg5 and Fe60Mg40) and x=1, 50 (Fe99Mg1 and Fe50Mg50) each other in 
Figure 2.3(b). The peaks corresponding to bcc (110) of the former composition are shifted to a 
lower angle indicating lattice expansion and formation of solid solutions of Mg in α-Fe. 
However, the same peaks from the other (x=1, 50) have same position with pure α-Fe. 
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Figure 2.4. The X-ray diffraction patterns of (a) Fe80-xMgx powder (x = 1-50) after 
subsequent wet milling by HEMA and schematic diffraction patterns of bcc-Fe and hcp Mg. (b) 
enlargement of (110) profiles from (a); the dashed lines indicate the position of the α-Fe (110) 
reflection. (PDF# 01-071-4648) 
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    The morphologies of the Fe and Mg raw element powders used in this work as well as 
the as milled Fe70Mg30 powder by HEMA are shown in Figure 2.5 (a-d). The SEM images 
indicate that the initial Fe and Mg powders consisted of particles below 10μm and 50μm, 
respectively. These results are in good agreement with the manufacturer's information. During 
the HEMA process, the powder particles are repeatedly flattened, cold welded, fractured and re-
welded such that the final products usually show large changes in shape, size and distribution 
from their initial state [122]. Particle shapes also varied significantly after HEMA, with both 
spherical and plate-like morphologies being found in the starting powders. The as-dry milled 
powder has a relatively broad distribution of particle size from ~2 to ~40 μm and agglomeration 
of powder particles with formation of tiny flaky structure is observed as shown in Figure 2.5(c). 
The final Fe70Mg30 amorphous powder after wet milling consisted of irregular shaped particles 
which were smaller than ~5μm with the presence of much finer particles (< 1μm). Some 
agglomeration of particles was also found but the powder had a relatively homogeneous 
distribution from the steady-state conditions is achieved, as shown in Figure 2.5(d). EDX 
analysis in Table 2.1 indicates that the chemical composition of the amorphous powder is very 
similar to the starting composition. It is also found that the constituent elements are 
homogeneously distributed at the atomic scales. Figure 2.5(e) and (f) show the bright-field TEM, 
HRTEM images with corresponding selected-area diffraction (SAD) pattern and the Fourier 
transform of Fe70Mg30 amorphous powder. It can be seen that the particles show a very 
fine/homogeneous microstructure with amorphous halo SAD pattern in Figure 2.5(e). The 
HRTEM image and the Fourier transform present a maze like pattern/central halo and diffuse 
rings which is characteristic of an amorphous structure, also consistent with the XRD results of 
amorphous powders shown in Figure 2.4(a).  
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Figure 2.6 shows the corresponding DSC thermograms of the amorphous powder of 
Fe70Mg30 by HEMA. It is apparent from the DSC thermogram that the glass transition 
temperature (Tg), the crystallization temperature (Tx) and the super-cooled liquid region (∆T=Tx-
Tg) are about 246.5°C, 364.7°C, 118.6°C, respectively. Moreover, one exothermic peak, marked 
as Tp, is observed in the trace, and is identified as the crystallization reaction peak. 
 Result from HEMA indicate that an amorphous phase is obtained through a solid 
solution forms first which upon continued milling becomes amorphous. In the literature, it has 
been also reported that a solid solution forms first which upon continued milling becomes 
amorphous [178-180].  
 
Table 2.1. Chemical composition the as milled Fe70Mg30 amorphous powder by HEMA. 
Element Chemical composition 
Fe K (at%) 70.94 ± 1.88 
Mg K (at%) 29.06 ± 1.88 
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Figure 2.5. SEM images of powder precursors to fabricate Fe-Mg amorphous powder. (a) 
Pure Fe <10μm, (b) Pure Mg <325 mesh, SEM image of as milled Fe70Mg30 powder (c) by post 
dry HEMA, (d) by sequential wet HEMA with overall chemical composition, (e) Bright field 
TEM image with corresponding SAD pattern and (f) HRTEM image with the Fourier transform 
of the HRTEM image for HEMA derived amorphous Fe70Mg30 powder. 
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Figure 2.6. DSC thermogram for the Fe70Mg30 amorphous powder by HEMA. 
2.4 DISCUSSION 
2.4.1 Formation of solid solution of Mg in α-Fe during HEMA 
The present results provide conclusive evidence that HEMA of Fe and Mg leads to the formation 
of fully amorphous phase at the Fe100-xMgx (х=10, 20 and 30 at.%) composition through two 
sequential process which are dry and wet milling. After the dry milling process, XRD showed 
that the samples were entirely bcc phase for Mg concentrations less than 30 at. % in Figure 
2.1(a). This suggests solubility of Mg in α-Fe phase , as do the two observations that (1) there is 
a increased broadening and shift of the bcc diffraction peaks to small angle which are shown in 
Figure 2.1(b), and (2) the single phase bcc alloy shows an increase in lattice parameter in Figure 
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2.3 indicating lattice expansion and formation of a solid solution. It can be interpreted that Mg 
atoms subsitituted for the Fe atoms in the bcc lattice and the lattice parameter of this alloy was 
larger than that of a pure Fe bcc lattice due to the larger atomic radius of Mg [172]. The 
formation of supersaturated solid solutions is one of the important metastable constitutional 
effects observed in alloys by HEMA.  
There have been many reports on the extension of solid solubility limits but the reasons 
are not yet clear [122, 181]. In the literature for Fe-Mg system, HEMA has led to the generation 
of substitutional solid solutions with up to 20 at. % Mg within the bcc of α-Fe [102]. Later, 
Dorofeev et al. found that about 5~7 at. % Mg in α-Fe forms in supersaturated solid solution 
[100, 101, 182] and a single phase bcc alloy was produced using Mg concentration up to about 
15 at. % by Yoneda et al [172]. These are consistent with present results even though there is a 
slight difference in the observed solubility limit. Above the solubility limit observed in this study 
(>~20 at.% Mg), the as-dry milled powders comprised two-phase (solid solution of Mg in α-Fe 
and hcp-Mg) mixtures which are shown on XRD results of Fe70Mg30 and Fe60Mg40 in Figure 2.1. 
These results can be rationalized in terms of the Hume-Rothery rules that was previously 
proposed for a planetary SPEX 8000 high energy shaker mill [183] and it is reported for limits of 
solubility of the Fe-Mg system [102]. This rule states that ~25 at.% solubility is achievable for 
powders prepared by mechanical alloying when the radii of metallic elements differs by <15%, 
and the electronegativity difference between the two elements is not too large, typically within a 
range of ± 0.4. Here, the metallic radii of Fe and Mg atoms are 0.126 and 0.16 nm [184], 
respectively, and their electronegativities are 1.83 and 1.31 [91], respectively. They differ by 
~21% in metallic radius and 0.52 in electronegativity. Therefore, the dissolution of Mg in α-Fe 
alloys was expected to be low in this study and accords closely with predictions.  
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2.4.2 Formation of amorphous powder by HEMA in Fe-Mg system 
It appears from these results that in the post dry milling process that no pronounced amorphous 
phase formation was achieved using these milling conditions, suggesting that they were not 
intense enough to destabilize the crystalline phase and allow the formation of an amorphous 
phase. This is due to the fact that severe plastic deformation, in general, facilitates the formation 
of an amorphous phase due to the introduction of fresh interfaces that raise the free energy of the 
system [127], but true alloying among ductile powder particles can occur only when a balance is 
maintained between cold welding from heavy plastic deformation and fracturing of particles [122, 
173]. This balance is controlled mostly by the addition of a process control agent (PCA) [122, 
181]. During HEMA, the PCA is absorbed on the surface of the particles and invariably lowers 
the surface tension of solid materials. In this Fe-Mg system, Mg elemental powder is too ductile 
to minimize the effect of cold welding and it becomes the dominant factor during post dry 
milling. Thus, it appears that the increase in free energy of the crystalline phase was not 
sufficient to exceed that of the hypothetical amorphous phase.  
By post dry milling in the absence of the PCA, only solid solution was formed for 
concentrations less than 50 at.% Mg with an enlarged lattice parameter as shown in Figure 2.1 
and the particles appearing as elongated into flake-shaped morphology with large agglomeration 
observed in Figure 2.5(c). For the sequent wet milling, toluene is added to the as-dry milled 
powders, as PCA, to reduce the effect of cold welding, thereby inhibiting agglomeration and 
welding on the vial wall. In this case, the supersaturated α-Fe solid solution becomes unstable 
and transforms to an amorphous phase, as seen in Figure 2.4(a) from the complete disappearance 
of the Bragg peaks.  
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Thus, it can be concluded that the addition of PCS achieves the appropriate balance 
between cold welding and fracture rate and thus the milling energy reaches a critical value to 
form the amorphous phase. Increased milling energy is normally expected to introduce more 
strain and increase the free energy in crystalline powder in HEMA and thus make amorphization 
easier [122]. This observation clearly confirms that it has been possilbe to produce an amorphous 
phase in this immiscible Fe-Mg system. One of the interesting results in the present study is the 
formation of solid solution of Mg in α-Fe at Fe95Mg5, which is formed in dry milling but also 
observed after wet milling wihtout transfromation to amorphous phase. As summarized earlier, 
starting from blended Fe100-xMgx (х=10, 20, 30 and 40) elemental powders, an amorphous phase 
can be formed through the formation of supersaturated solid solution, as seen in Figure 2.1 and 
2.4. However, it doesn’t form any amorphous phase at Fe95Mg5 though HEMA conducted 
through two sequential process of the dry and wet milling. This can be rationalized in terms of 
known mechanisms of amorphous phase formation. Amorphization is also facilitated by the 
strain energy induced into the alloy system due to the size differences between the solvent and 
solute elements in a binary system. It achieves the critical amount of distortion in lattice which 
destabilizes the crystal lattice resulting in the formation of the amorphous phase [185-187]. 
Egami et al. [188] have proposed the criteria (Equation 1) from empirical results to determine the 
concentration range of binary system where amophrization will occurs. It was originally 
developed for rapid quenching processing but can be applied to amorphization by HEMA [186]. 
Some researchers have shown that this criteria is applicable to the immisicle Nb-Zr system which 
forms amorphous phase by HEMA [109, 127]. The minimum solute concentration, , 
necessary to form amorphous phase is inversely related to atomic size mismatch: 
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                                                                                           (1) 
Where rB and rA represent the atomic radius of the solute (B) and solvent (A), 
respectively. In the case of the Fe-Mg system, the radii of the Fe and Mg atoms are 0.126 and 
0.16 nm. Thus the theoretical minimum concentration of Mg for the formation of the amorphous 
phase is calculated to be 9.54 at. % Mg. Thus, it is worth noticing that this value is very close the 
composition range of 10~40 at.% Mg for the formation of amorphous phase and it is not 
surprising that no amorphous phase was obtained at Fe95Mg5 by HEMA (Figure 2.4).  
2.5 CONCLUSIONS 
This work is the first to demonstrate the formation of an amorphous Fe-Mg alloy, through 
the process of HEMA from the immiscible Fe-Mg system that show a positive heat of mixing 
between the constituent elements. It is obtained through the sequential process of dry and then 
wet milling under the milling conditions described for this study. The formation of the 
amorphous phase is verified and confirmed by XRD and TEM analysis. Therefore, we can 
summarize the amorphization process at the Fe100-xMgx (х=10, 20, 30 and 40 at.%) composition 
as follows :  
Mixture of elemental powders → solid solution → amorphous 
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3.0  SPECIFIC AIM 2: SYNTHESIS AND OPTIMIZATION OF THE PROCESSING 
PARAMETERS FOR THE DEPOSITION OF THIN LAYERS OF IRON-MAGNESIUM 
ALLOYS USING PULSED LASER DEPOSITION (PLD) AND IDENTIFICATION OF 
THE POTENTIAL USE OF THESE ALLOYS AS BIODEGRADABLE SYSTEMS 
USING IN VITRO CHARACTERIZATION METHODS 
3.1 INTRODUCTION 
Following the synthesis and materials characterization experiments for amorphous Fe70Mg30 
powder reported in Section 2, amorphous thin layers were prepared by PLD from HEMA derived 
amorphous powder in order to identify the potential use of Fe-Mg alloy as a biodegradable 
system using in vitro characterization methods. As shown by the extensive studies over the last 
three decades [122], HEMA using elemental metals is an efficient way for  creating metastable 
states in particular, supersaturated solid solutions or amorphous structures of immiscible 
components. However, the approach has one major limitation; to form bulk material from the as 
synthesized ball milled powders, additional processes such as sintering are necessary. As 
mentioned in the Section 1.3.2, a major impediment to the use of sintering in the Fe-Mg system 
is the large temperature difference in the melting points of Fe and Mg. Therefore, formation of 
thin layer can be one of the solutions that can be explored to overcome this limitation.  
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There are several possible techniques that can be used to prepare amorphous thin films. 
Among the different techniques, pulsed laser deposition (PLD) has several characteristics that 
distinguish it from other film growth methods [138]. These include: (a) attainment of near 
stoichiometric composition of the target in the deposited film; (b) flexibility and fast response; 
(c) higher deposition rate; (d) lower synthesis temperature and highly oriented growth of films; 
(e) in-situ deposition of multilayer films; and (f) ease of control of the film thickness. For 
obtaining metallurgical thin films, other deposition techniques are competitive, but PLD can be 
used to deposit thin films from any material, from pure elements to multi-component compounds 
and moreover, a major advantage is that the stoichiometry of the target material can be 
reproduced in its entirety in the deposited films [138]. PLD has recently been used to direct the 
plume of material ablated from a biocompatible ceramic target onto substrate materials to form a 
thin biocompatible coating that may be used for dental or orthopedic implant applications [189]. 
In particular, PLD has been demonstrated to be an effective method for producing thin films of 
crystalline calcium hydroxylapatite (HA), the primary mineral constituent of natural bone and 
one of the most ubiquitous biocompatible materials known [190-192]. Therefore, PLD is 
especially well suited for metal/ceramic thin films deposition. 
 Accordingly, in this dissertation, two-pronged approaches employing PLD will be used 
for biological applications. In the first case, PLD will be used for the synthesis of thin films from 
the metastable alloys generated by HEMA. In the second approach, PLD will be employed to 
synthesize the alloy utilizing a mixture of the pure elements. The former technique to generate 
thin films is one way to solve the limitation of the sintering process for  HEMA derived Fe-Mg 
alloy powders described in Section 1.3.2. In the second, thin film alloying using PLD is one of 
the preferred paths exploited to synthesize metastable alloys involving immiscible elements 
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[193-196]. The thermalization rate of the deposited material in PLD is extremely high and lies 
between <ε>/τ = 1011~1018 K/s, where <ε> ~100eV is the mean ion energy and τ the is relaxation 
time. Under such extremely non-equilibrium formation conditions, the kinetic factors (diffusion 
rates) rather than thermodynamic driving force (potential barrier heights) play a major role in the 
formation and stablization of the physical form and structure of the growing films. It thus makes 
the formation of metastable phases in PLD highly probable [139]. The following examples 
support this inference. Krebs and Bremert [140] reported on the formation of Fe50M50 (M=Zr, Nb, 
Ti, Hf), Cu50Zr50 and Pd80Si20 amorphous alloys deposited by PLD. Instead of the decomposition 
of the immiscible materials systems such as Fe-Nb, Fe-Ag, and Fe-Cu, a continuous series of 
polycrystalline supersaturated solid solutions were formed. A homogeneous non-equilibrium 
crystalline alloy with a super-saturation of > 44 at.% Ag in Ag-Ni system on PLD deposited Ag-
Ni was reported by van Ingen et al. [141]. It is remarkable that this material system though 
possessing such a high driving force for decomposition despite the constituents being insoluble 
in both the solid and the liquid equilibrium states, it is possible to generate the alloys without 
inducing any precipitation or second phase formation. In line with these reports, it was 
hypotheseized that the synthesis of Fe-Mg alloying films is possible either by using PLD from a 
Fe-Mg alloy target derived by powder made by HEMA or from the targets prepared by blending 
a mixture of the elemental powder of Fe and Mg corresponding to the alloy composition. The 
present work therefore reports the results of a study conducted to explore the influence of 
processing parameters/ target on the microstructures of the Fe-Mg amorphous thin film layers by 
PLD and accordingly, evaluate these layers using preliminary in vitro cytocompatibility and 
corrosion experiments for biomedical applications. Prior to conducting the PLD studies to 
generate amorphous films corresponding to the Fe-Mg alloys studied in the previous chapter, 
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attempts were made to explore the efficacy of the PLD approach by conducting pilot studies on 
the Mg-Ca-Zn system. These studies were conducted to explore and validate the use of the PLD 
approach to generate amorphous films mimicking the structure and composition of the 
amorphous targets. The studies then paved the way for generating the various classes of 
materials and systems described and outlined in the various four specific aims. 
3.2 MATERIALS AND METHODS 
3.2.1 Pilot and main PLD studies 
In this section, we first performed pilot studies to confirm the suitability of the experimental 
setup using the Mg-Zn-Ca based systems; these served as a basis for the subsequent main studies 
for the Fe-Mg system. The Mg-Zn-Ca based systems are one of the representative system with 
good glass forming ability (GFA) and are ideal candidates for controlling the degradation of 
metal implants [164, 197].  
3.2.2 Alloy synthesis by HEMA  
The targets corresponding to Mg60Zn35-хCaх (х=1, 3, 5) composition have been produced by high 
energy mechanical alloying (HEMA) and compaction although powders corresponding to 
Mg60Zn35-xCax (x =0~20) have been generated. Commercial elemental powders of pure Mg 
(99.8%, <325 mesh, Alfa Aesar), Zn (97.5%, 6-9 μm, Alfa Aesar) and Ca (99.5%, <16 mesh, 
Alfa Aesar) were chosen as the starting materials which were accurately weighed corresponding 
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to the desired compositions. The mixture of elemental powders was loaded into stainless steel 
(SS) vials containing 2 mm diameter SS balls as the milling media. The ball to powder weight 
ratio (BPR) was 15 to 1, and the total weight of the starting mixture was 4g. The mixture was 
subjected to dry milling in a SPEX 8000 high energy Shaker Mill for up to 3h. Post dry milling, 
2ml of toluene (anhydrous, 99.8%, Sigma-Aldrich) was loaded into the vial and the mixture was 
subsequently wet milled for an additional period of up to 3 h to reduce the adhesion of powders 
on the balls and the inner surface of the milling vial. Handling of the powders and loading of 
toluene were conducted inside an argon-filled glove box in which the oxygen concentration was 
kept below 1.0 ppm. The Fe70Mg30 amorphous powder were synthesized by similar methods in 
Section 2.2.1. Post ball milled Mg and Fe based powders were dried and then compacted at a 
pressure of 60 kpsi using a Flow Autoclave System cold isostatic compaction press to produce 
25.0 mm diameter discs to be used as targets for subsequent PLD deposition. 
3.2.3 PLD system and thin films production 
All the thin films were produced by PLD utilizing a 248 nm KrF excimer laser (Lambda Physik 
EMG 201) irradiation pulsed at 25 ns FWHM in a high vacuum chamber with a base pressure of 
10-6 Torr. In all depositions the spot size was approximately 1×3 mm, the fluence was 8.3~9.6 
J/cm2, the laser pulse frequency was maintained at 10 Hz and the deposition rate was 
approximately 2.3 Å/s determined as a mean value. The cold stage, which was supplied with 
liquid nitrogen, was installed for deposition of films at low substrate temperatures. The target to 
substrate distance was maintained that substrate was placed opposite to the target at a distance of 
58 and 80 mm, with targets rotated during deposition. The 25 mtorr of Argon partial pressure 
was introduced to the vacuum system with initial base pressure of 2×10-7 torr using a needle 
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valve gas controller. Films were deposited at -90 °C for a deposition time of 30min on Si wafer 
and at room temperature for a deposition time of 5, 10 and 30 minutes on three different 
substrates. The first was amorphous SiO2 thermally grown on Si wafer for use in glancing angle 
X-ray diffraction (XRD). The second substrate was a regular cell culture dish for 
cytocompatibility tests, and the third substrate was fused silica glass for bio-corrosion tests.  
3.2.4 Characterization of powders and films 
The microstructure and phase assemblage of thin films and milled powders were examined by 
glancing angle (Philips PW 1830 with Cu-Kα radiation) and conventional X-ray diffraction 
(PANalytical X'pert Pro with Cu-Kα radiation). The thickness of the deposited films was 
measured by surface profile measuring system (Veeco Dektak3ST). A JEOL JEM2000FX 
operating at 200kV was used for conducting transmission electron microscopy (TEM) and 
obtaining conventional bright field images. High resolution (HR) TEM observations were carried 
out using a JEOL JEM-2100F equipped with attachments for X-ray energy dispersive 
spectroscopy (XEDS) analysis from Oxford Instruments (Inca platform). The Gatan Digital 
Micrograph (Gatan software, USA) and the Image-pro plus (Media Cybernetics, Inc., USA) were 
used to analyze TEM images. TEM samples were obtained by directly depositing the film by 
PLD on silicon nitride supported window grids (Ted Pella, USA) for observation under the TEM. 
Additionally, samples were made by depositing the films on oxidized silicon wafer containing a 
photo-resist following the above method. Films were lifted off from the substrate by stripping the 
photo-resist and transferring onto standard TEM copper membrane grid (Ted Pella, USA) for 
observation under the TEM. The thermal properties of the final milled powder and thin layer 
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were studied by differential scanning calorimetry (DSC, Netzsch STA 409) at a heating rate of 
10°C/min under an ultra high purity Ar gas flow. 
3.2.5  Electrochemical bio-corrosion study 
Potentiodynamic polarization was used to test the electrochemical corrosion of the Fe-Mg 
alloy thin layer compared to the film and bulk (99.8+%, 1 mm foil, Goodfellow) of pure Fe. All 
alloy and pure Fe thin film samples were deposited on fused silica glass for 30 minutes by PLD, 
with thickness in the range of ~1.3 µm.  These films were connected to a Cu lead wire with silver 
paste and then electrically insulated with epoxy resin leaving an exposed working area of 2 cm2, 
so that only one side was exposed for conducting the electrochemical tests. Samples of bulk pure 
Fe were also prepared by connection to a copper wire lead, mounting in epoxy resin, and one 
side mechanically polished down to 1 μm flatness. This surface, ~2.25 cm2, was cleaned with 
isopropyl alcohol, then immediately exposed to the electrolyte and tested. Testing was carried 
out utilizing a three-neck jacketed flask (ACE Glassware) filled with the electrolyte of 125 ml 
DMEM growth media containing 1% penicilin/strepomycin (P/S) and 10% fetal bovine serum 
(FBS), equilibrated to 37°C. It should be noted that there are some reports that higher corrosion 
rate may be attributed to higher L-glutamine, which varies depending on cell culture media, since 
it can form complexes with Mg ions [198, 199] but no similar study has been completed with Fe 
ions. Ag/AgCl reference electrodes (4.0M KCl, Accument) and a platinum wire counter 
electrode were employed. All samples were immersed in the electrolyte to reach a stable open 
circuit potential (OCP) for 40 minutes, before initiating the potentiodynamic polarization at a 
scanning rate of 0.3 mV/s using a CH instruments potentiostat (CHI 604A). The Tafel plots were 
extrapolated to determine the corrosion current density, icorr, at the intersection point with the 
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corrosion potential, Ecorr. Corroded samples were rinsed with DI water and ethanol and air dried, 
and subsequently characterized using glancing angle XRD and EDX to assess the formation of 
corrosion products. 
3.2.6 Cytocompatiability tests 
 In order to explore the cell cytocompatibility of the alloy systems, each alloy system was 
deposited on the cell culture dish and silica glass by PLD, then cell viability tests were conducted. 
3.2.6.1 Cell culture 
Murine pre-osteoblast cells (MC3TC-E1, American Type Culture Collection, Rockville, MD), 
human mesenchymal stem cells (hMSCs, Lonza, USA), human umbilical vein endothelial cells 
(HUVECs, Linza, USA) and murine fibroblast cells (NIH3T3, American Type Culture 
Collection, Rockville, MD) were utilized for cell culture studies. Cells were cultured under 37 °C, 
5% CO2, and 95% relative humidity in α-MEM (Gibco, Grand Island, NY) growth media 
containing 1% P/S (Gibco, Grand Island, NY) and either 10% FBS (Atlanta Biologicals, 
Lawrenceville, GA), for MC3TC-E1, or 20% FBS for hMSCs, EBM-2 bullet kit (Lonza, USA) 
for HUVEC and DMEM (Cellgro, Manassas, VA) growth media containing 1% P/S and 10% 
FBS for NIH3T3. The MC3T3 and NIH3T3 cells cultured at third to seventh passage, and 
hMSCs and HUVECs cultured at second to third passage were used in this experiment. 
3.2.6.2 Direct cell viability and adhesion test (Live/dead assay) 
For direct cytocompatibility and cell adhesion testing, MC3TC-E1, hMSC, HUVEC and NIH3T3 
cells were cultured directly on the surface of Fe-Mg alloy thin layer deposited by PLD. Fe-Mg 
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alloys were deposited on fused silica glass by PLD with the film area approximately 9mm x 
9mm. The samples were sterilized on all sides by UV for 60 minutes and incubated in cell 
culture media for 10 minutes, after which time cells were seeded on the samples directly at a 
density of 80,000 cells per well. Live and dead cells were stained using live/dead staining kit 
(Life Technologies, Grand Island, NY) on days 1 and 3 post seeding following the 
manufacturer’s protocol. Cells were then imaged by an inverted microscope with the 
fluorescence illuminator (CKX41, Olympus, Olympus America Inc.). For each substrate images 
were taken from three to six different locations to obtain an overview of cell attachment. After 
fluorescence imaging, cells on the samples were fixed by 2.5% glutaraldehyde then subjected to 
alcohol dehydration. Fixed cells on samples were air-dried, after which they were imaged by 
SEM. 
3.2.6.3 Indirect cell viability test (MTT assay) 
Indirect cell viability test was assessed using the MTT activity assay (Vybrant MTT Cell 
Proliferation Assay Kit). Extraction medium was prepared using each cell growth media 
supplemented with serum in a surface area/extraction medium ratio 6 cm2 ml-1, in accordance 
with ISO 10993-12 [200], at 37 °C in a humid atmosphere with 5% CO2 for 72 hours. The 
extracted medium was stored at 4°C until the cytocompatibility testing. This extraction was 
designated as 100% extract solution. The control groups involved the use of media without 
extract as a negative control and media containing 10% dimethyl sulfoxide (DMSO) as a positive 
control. The cells were seeded in 96-well plates at 6000 cells/well with 200μl media in each well 
and incubated for 24 hours to allow for attachment. After pre-cell culture, the media was then 
replaced with 100μl of 100% extract medium and incubated for 1, 3 and 7 days.  After that, 
media and extracts were replaced with fresh cell culture media and 10μl of MTT were added to 
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each well. The samples were incubated with MTT for 4 hours at 37°C and then 100μl of 
formazansolubilization solution (10% sodium dodecyl sulfate in 0.01M HCl) were added to each 
well for 12 hours in the incubator under the cell culture atmosphere. The spectrophotometrical 
absorbance of the samples was measured with the Synergy 2 Multi-Mode Microplate Reader 
(Bio-Tek Instruments, Winooski, VT) at 570 nm, with a reference wavelength of 630 nm. 
3.2.6.4 Ion release 
The thin layer samples of Fe70Mg30 and pure Fe on glass were immersed in each cell 
growth media containing serum, equilibrated to 37°C for 72 hours. All conditions for immersion 
test are same with cell viability test including the surface area/extraction medium ratio 
(according to the ISO 10993-12 [200]).  After immersion for 72 hours, the media was collected 
and then diluted in 0.03 M Tris buffer solution to be analyzed using inductively coupled plasma 
optical emission spectroscopy (ICP-OES, iCAP duo 6500, Thermo Fisher). The Fe and Mg ion 
concentrations in solution were compared to media and each other. Samples were prepared in 
triplicate for each condition. 
3.2.6.5 Statistical analysis 
The experimental values were analyzed using the Student’s t-test and one-way analysis of 
variance (ANOVA). They were expressed by mean values ± standard deviation (SD) and 
statistical significance was considered as P < 0.05. 
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3.3 RESULTS 
3.3.1 Mg-Zn-Ca system; HEMA and processing parameter for PLD (Pilot study) 
Figure 3.1 shows the XRD patterns of as prepared milled powder corresponding to Mg60Zn40-
xCax and the targets generated from the milled powders. The XRD patterns of the powder for x=5 
shows the typical broad diffraction pattern corresponding to the fully amorphous phase but x=0, 
1, 3 and 10 powders show a few narrow peaks that begin to emerge over the amorphous peak at 
around 20° and 40°. This result indicates that the HEMA process can generate phases that are 
fully (or mostly) amorphous from these compositions. Also it is found that the constituent 
elements are homogeneously distributed at atomic scales, from the result of a XEDS (not shown 
here). However, at other compositions, X-ray diffraction patterns exhibit low-intensity sharp 
peaks from a crystalline phase which were found together with a broad diffraction peak from an 
amorphous phase. These crystalline phases are identified to be an inter-metallic phase of Mg-Zn, 
Ca-Zn, pure Mg, Zn and Ca depending on the composition (Fig. 3.1). The amorphous phase 
formation by HEMA is known to be critically dependent on the milling conditions, the detailed 
history of the starting materials, milling container, grinding medium, and finally the BPR [122]. 
Results from HEMA indicate that a fully amorphous phase is obtained from only the 
Mg60Zn35Ca5 composition using the milling condition described for this study, and the formation 
of the amorphous phase is verified and confirmed by XRD analysis. 
Details of the target, including crystal structure, distribution of elements, surface 
roughness, or optical properties can affect the quality of amorphous films, particularly when the 
formation of the amorphous phase depends on the deposition rate or kinetics of the flux. 
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Figure 3.1. The X-ray diffraction patterns of Mg60Zn40-хCaх (х=0~20) powder obtained following 
6 h of milling time that were used to generate the targets: (a) x=0, (b) x=1, (c) x=3, (d) x=5, (e) 
x=10, (f) x=15 and (g) x=20, respectively. 
 
 
 69 
In addition, clusters delivered to the deposited film in the form of a) ejected solid fragments 
[201], or b) molten droplets can also result in unwanted crystalline phases [140]. In the pilot 
study, the PLD of Mg60Zn35Ca5 film was carried out by varying the crystal structure of the target, 
as well as varying the deposition time and controlling the substrate temperature.  
Figure 3.2 shows the influence of the properties of the target on the characteristics of the 
deposited Mg-Zn-Ca films. All the thin films were deposited by PLD for 5 minutes from fully 
amorphous targets as well as targets comprising low and highly crystalline compositions. The 
thickness of the deposited film is ~ 500 nm corresponding to 5 minutes of deposition time shown 
in Figure 3.2(d). XRD patterns of all deposited films are shown in Figure 3.2(a). This figure 
shows broad amorphous diffraction patterns even though the HEMA powders corresponding to 
x=1 and 3 exhibit a few narrow crystalline peaks according to the XRD profile as shown in 
Figure 3.1 (b) and (c). These results imply that the amorphous phase is readily formed by PLD 
from a fully amorphous target in this composition range. Further studies were therefore focused 
on the Mg60Zn35Ca5 composition since the starting powder, target, and the deposited films as 
shown in Figures 3.1(d) and Figure 3.2(a) corresponding to this composition was confirmed to be 
amorphous. In order to evaluate the influence of the structure of the target on the synthesis of 
amorphous thin films, the amorphous HEMA derived Mg60Zn35Ca5 target was annealed at 200 °C 
for 20 hours in Ar atmosphere to form crystalline phase(s) of pure Mg, Zn, Ca and Mg-Zn 
intermetallic as shown by the XRD pattern (#2) in Figure 3.2(b).  
In addition, a target comprising a blended mixture prepared from the elemental powder of 
Mg, Zn and Ca corresponding to Mg60Zn35Ca5 was also prepared, and the corresponding XRD 
pattern (#3) is shown in Figure 3.2(b). In comparison to Figure 3.2(a), the XRD profiles of 
deposited thin films from highly crystalline target as shown in Figure 3.2(b) are displayed in 
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Figure 3.2(c). Sharp crystalline peaks appear over the broad background peaks even though the 
peak intensities were decreased compared to Figure 3.2(b) for both targets #2 and #3. These 
sharp peaks are distinctively identified as pure Zn, Ca and Ca-Zn intermetallic in the XRD 
pattern of the thin film obtained from target #2. In addition to pure Zn and Ca, an inter-metallic 
phase of Mg-Zn are observed in the XRD pattern of the thin film from target #3. The chemical 
composition of each thin film was measured by XEDS and shown in Figure 3.2(c). Each 
chemical composition is very similar to the target composition.  
Figure 3.3(a) and (b) show the XRD patterns of PLD derived films for different 
deposition time and substrate temperature, respectively. For the deposited film corresponding to 
a PLD time of 10 minutes at 22 oC (room temperature) shown in Figure 3.3(a), a few narrow 
peaks start to emerge at around 40°. These narrow peaks become significantly sharper with 
increasing deposition time (or film thickness), indicating the formation of a greater amount of 
crystalline phase. This behavior can be due to the diffusional processes leading to nucleation and 
growth of crystalline regions in the otherwise amorphous film during deposition. Additionally, 
this can be due to the solid particulates or molten droplets which are ejected from the target and 
accumulate on the top of the amorphous films. Formation and accumulation of these particulates 
and droplets are well known in PLD processes and have been reported for other systems [138].   
The targets used in this study are made by powder compaction and the roughness of the 
target surface is higher than the targets made by melting, casting and sintering of the elemental 
metals. This roughness may lead to the ejection of solid particulates or liquid droplets from the 
surfaces, which are then deposited on the substrate. Nonetheless, it is important to determine 
whether these crystalline phases result from these direct transport mechanisms, or were formed 
on substrate surface after deposition.  
 
 71 
15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90
No
rm
ali
ze
d 
In
ten
sit
y
2θ (deg)
Mg
Mg
Ca
Zn
Zn
Zn
Ca
Zn
MgMgMg
Zn
CaCa
Mg
Ca
Ca
Ca
ZnZn
MgZn2MgMg
Mg
MgZn2
MgZn
Zn
Mg4Zn7
(b)
#3
#2
#1
Mg60Zn35Ca5
MgZn2
MgZn
Mg4Zn7
15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90
No
rm
ali
ze
d 
In
ten
sit
y
2θ (deg)
Ca5Zn3
Ca
Mg=66.68, Zn=29.73, Ca=3.59 (at%)
Mg=66.79, Zn=28.17, Ca=5.04 (at%)
Mg=63.55, Zn=31.18, Ca=5.27 (at%)
ZnZn
ZnZn
ZnZn
Zn
Zn
Zn
Ca ZnMgZn2
Zn
Zn
Zn
MgZn2
From #3
From #2
From #1
tPLD=5 minutes 
Mg60Zn35Ca5(c)
0 5 10 15 20 25 30
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Th
ick
ne
ss
 (µ
m
)
(d)
Deposition Time (min)  
Figure 3.2. The X-ray diffraction patterns of (a) Mg60Zn40-хCaх (х=1, 3 and 5) films deposited for 
5min by PLD and of bare substrate, (b) different crystal structure targets in Mg60Zn35Ca5 
composition; as-milled amorphous target (#1), 200 oC annealed target from #1 (#2) and blended 
mixture starting precursors powders (#3), (c) deposited thin films for 5min by PLD from #1, 2 
and 3 target and chemical composition of each films and (d) thickness of the films on normal 
stage for various time from as-milled amorphous target (#1). 
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Therefore, if an amorphous film instead of the crystalline film is grown on cold substrate, then it 
could be expected that the film morphology would reflect to a greater extent the conditions of the 
plume. Moreover, assuming that solid particulates are indeed ejected directly from the target, 
they should retain the same properties of the target after being incident on the cold substrate.  
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Figure 3.3. The X-ray diffraction patterns of Mg60Zn35Ca5 (a) PLD deposited films on normal stage for 
various time from as-milled amorphous target (#1) and (b) PLD derived films for 30 minutes on cold 
stage from target #1 and target #2 (see text for details).  
 
A dramatic influence of the substrate temperature on the deposited films is shown in 
Figure 3.3(b). Figure 3.3(b) shows the XRD patterns of the films deposited from targets #1 and 
#2 at a low temperature (-90 oC) using a cold stage for 30 minutes by PLD. In both cases, the 
intensity of pure Zn peaks are found to have disappeared or reduced compared to the XRD 
patterns of room temperature deposited films as shown in Figure 3.2(c) and 3.3(a), respectively. 
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These results suggest that crystalline phase formation in the deposited film was kinetically 
suppressed when the substrate temperate is lowered. The crystalline peaks are identified to be 
pure Zn as shown in Figure 3.3. It seems that Zn can form coarse particles easily on thin films 
because it has a relatively high vapor pressure and low melting temperature compared to Mg and 
Ca. This result thus indicates that the substrate temperature is the dominant parameter for 
formation of amorphous thin films corresponding to Mg60Zn35Ca5 composition.  
3.3.2 Fe-Mg system; processing parameter to synthesize amorphous films by PLD  
The pilot studies revealed that the substrate temperature during deposition is a dominant 
parameter contributing to the formation of amorphous thin films of Mg60Zn35Ca5 composition 
when the substrate is cooled to -90 °C. As mentioned in the section 3.3.1, many experimental 
parameters can be changed, which then have a strong influence on film properties during PLD.    
In order to evaluate the influence of the structure of the target on the synthesis of 
amorphous thin films, the amorphous HEMA derived Fe70Mg30 target (#1) and a target 
comprising a blended mixture prepared from elemental powder of Fe and Mg corresponding to 
same composition (#2) were prepared, with XRD patterns are shown in Figure 3.4(a). Deposited 
films from amorphous target (#1) in Figure 3.4(b) shows broad amorphous diffraction patterns. 
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Figure 3.4. The X-ray diffraction patterns of (a) different crystal structure targets in Fe70Mg30 
composition; as-milled amorphous target (#1) and blended mixture starting precursors powders (#2), (b) 
deposited thin films for 30min by PLD from #1 and 2 target and chemical composition of each films.   
 
This result imply that the amorphous phase is readily formed by PLD from a fully 
amorphous target in Fe70Mg30 composition. It is good agreement with those obtained from the 
Mg-Zn-Ca system in pilot study. In comparison to amorphous film from target #1, the XRD 
profiles of deposited thin film from highly crystalline target (#2) as shown in Figure 3.4(a) is 
displayed in Figure 3.4(b). The sharp crystalline peaks appear over the broad background peaks 
even though some Mg peaks were disappeared and peak intensities were decreased compared to 
Figure 3.4(a) for the targets #2. These sharp peaks are distinctively identified as pure Fe and Mg 
in the XRD pattern of the thin film from target #2. The chemical composition of each thin film 
was measured by XEDS in Figure 3.4(b). Each chemical composition is close to the target 
composition. 
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These experimental results suggest that amorphous thin films cannot be produced by PLD 
from highly crystalline targets corresponding to Fe70Mg30 composition. However, it must be 
emphasized that there is no evidence that correlates any direct influence of the crystal structure 
of the targets on the characteristics of the deposited Fe-Mg films. This is due to the difficulty in 
separating the effect of target crystallinity from the other strongly coupled effects of the PLD 
process, including: physics of the plasma plume, flux kinetics at the substrate surface, 
geometrical relations, surface roughness, non-uniformity in the deposition rate, density of the 
target, and non-uniformity in the crystallinity of fabricated target, etc [138].  
Figure 3.5 shows the XRD patterns of PLD derived films for different deposition time 
(tPLD) and target/substrate distance (dtsd), back ground pressure and substrate temperature, 
respectively. The intensity of broaden amorphous peaks was increased with increasing deposition 
time and there is no emergence of crystalline peak in Figure 3.5(a). Additionally, no significant 
difference was found for the sample deposited with change of dtds between 58 and 80 mm as 
shown in Figure 3.5(b). 
For the deposited film under the 25 mtorr of Ar partial pressure shown in Figure 3.5(c), 
some narrow peaks were observed at around 45° and broaden peak became sharper than those 
under the vacuum atmosphere indicating the formation of small amount of crystalline phase. In 
contrast to dramatic influence of substrate temperature from pilot studies, we find no significant 
difference of deposited films between the normal and cold stage. Figure 3.5(d) shows the XRD 
patterns of the films deposited from #1 and #2 targets at a low temperature (-90oC) using a cold 
stage for 30 minutes by PLD, respectively. In both case, overall peak shape became more 
broaden compare to Figure 3.4(b) but the XRD pattern of the film deposited from target #2 still 
shows shape Fe phased even though all Mg peaks completely disappear. This result suggests that 
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substrate temperature during deposition is not a dominant parameter contributing to the 
formation of amorphous thin film of Fe70Mg30 composition when the substrate is cooled to -
90oC.  
Through the pilot and main study conducted to find the optimum process parameters for 
PLD, it is observed that different results are obtained from each sample systems. As outline 
above, PLD is a relatively simple experimental deposition technique. However, the deposition 
process is in fact rather complex and in order to deposit films of optimum quality, the process 
parameters must be controlled in an adequate manner.  
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Figure 3.5. The X-ray diffraction patterns of PLD deposited films under normal stage for (a) 
various deposition times and (b) target-substrate distance from the as-milled amorphous target 
(#1). (c) PLD derived films deposited for 30 minutes under the Ar and vacuum chamber 
atmosphere from amorphous target #1 and (d) PLD derived films deposited for 30 minutes using 
a cold stage from amorphous target #1 and blended mixture starting precursors powder target #2    
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Theoretical process parameters such as the deposition rate, the kinetic energy of ablated particles 
and the mobility of adsorbed particles may be controlled by experimental parameters such as the 
influence of target properties, the background gas pressure and the substrate temperature. In this 
study, an empirical approach was therefore adopted to find it. The optimum process parameters, 
however, vary from one material to another.  For the formation of Fe70Mg30 amorphous thin film 
layer derived by PLD, optimum process parameters are summarized as follow: The target to 
substrate distance is constant at 58mm and films is deposited at room temperature for a 
deposition time of 30 minutes. All further deposition of Fe based alloy in next aims will be 
follow these parameter conditions. Other specific conditions of PLD system are same which are 
described in previous section. 
3.3.3 Characterization of Fe70Mg30 amorphous thin layer by PLD  
 Thin layer samples were prepared by PLD on glass for 30 minutes from the Fe70Mg30 fully 
amorphous target.  Glancing angle XRD analysis was performed on this deposited layer, shown 
in Figure 3.6(a). This figure also shows a broad amorphous diffraction pattern. Figure 3.6(b) 
shows the TEM bright-field image and corresponding SAD pattern of the thin layer of Fe70Mg30 
deposited by PLD. The bright field image shows the presence of large agglomerates or particles 
(droplets) embedded in the continuous thin layer. This is a typical surface morphology of layers 
deposited by PLD. There is a diffusive halo typical of an amorphous phase in the corresponding 
overall SAD pattern even though it consists of few droplets on a thin layer in the TEM bright-
field image. In order to investigate the chemical composition of the thin layer, EDX 
measurement was also performed and results are given in the Table 3.1. The chemical 
composition of the amorphous thin layer is very similar to the target composition but some 
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deviation is seen for the particle composition. It is likely due to the varying diffusional kinetics 
of each element of the target during the PLD process [142]. 
 
Table 3.1. Chemical composition the continuous matrix and the particle from Fe70Mg30 films 
deposited for 30 minutes by PLD. 
Element 
Chemical composition 
Matrix Particle 
Fe K (at%) 72.56 ± 5.78 48.14 ± 5.37 
Mg K (at%) 27.44 ± 5.78 51.86 ± 5.37 
  
Figure 3.7 shows the corresponding DSC thermograms of the thin layer of Fe70Mg30. It 
is apparent from the DSC thermogram that the glass transition temperature (Tg), the 
crystallization temperature (Tx) and the super-cooled liquid region (∆T=Tx-Tg) are about 231.5°C, 
356.6°C, 125.1°C, respectively. Moreover, one exothermic peak, marked as Tp, is observed in 
the trace, and is identified as the crystallization reaction peak. 
 
   Table 3.2. Corrosion potential (Ecorr) and current density (icorr) values for Fe70Mg30 layer, both 
bulk and thin layer of pure iron. The corrosion current density is significantly higher for 
Fe70Mg30 than both pure iron samples (P<0.05). 
Element 
Corrosion potential, Corrosion current density. 
Ecorr(V) Icorr(µAcm-2) 
Fe70Mg30 amorphous thin layer -0.642 98.76±11.08 
Pure Fe (thin layer) -0.616 12.46±2.3 
Pure Fe (bulk) -0.592 14.14±4.35 
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Figure 3.6. Thin layer of Fe70Mg30 on glass deposited for 30min by PLD. (a) The X-ray 
diffraction pattern, (b) Bright field TEM image and corresponding overall SAD pattern with 
chemical composition. 
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Figure 3.7. DSC thermogram for the Fe70Mg30 amorphous thin layer by HEMA. 
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3.3.4 Corrosion characterization of Fe70Mg30 amorphous thin layer by PLD  
Potentio-dynamic polarization curves for the thin layer of Fe70Mg30 and pure iron on 
glass and polished bulk pure iron can be seen in Figure 3.8 as a representation of the multiple 
samples tested. Table 3.2 gives a summary of the corrosion potential and corrosion current 
densities as calculated from extrapolation of the Tafel plots. The Fe70Mg30 amorphous thin layer 
on glass (a) resulted in an icorr value approximately 8 times higher than both of Fe thin layer of 
same thickness (b) and bulk (c) samples as well as Ecorr values that are more cathodic. It can be 
inferred from the above results that the Fe70Mg30 alloy shows improved corrosion rates compared 
to the pure Fe sample.  The Fe70Mg30 alloy caused a large increase in corrosion current density 
over the pure iron samples, which were measured at 14.14 ± 4.35 µA cm-2 for bulk and 12.46 ± 
2.3 µA cm-2 for thin layer, respectively. There is no statistically difference in the value of icorr 
values between bulk and thin layer for pure iron.  
In order to identify the phases formed on Fe70Mg30 amorphous layer after the electro-
chemical corrosion tests, XRD analysis was performed, and is shown in Figure 3.9. Some oxide 
and hydroxide phases, likely representing the corrosion products, are observed. These crystalline 
peaks appear over the broad amorphous peaks, and are specifically identified as Mg(OH)2 
(Magnesium Hydroxide, Brucite, PDF# 01-084-2163), Fe+3(OH)3 (Iron Hydroxide, Bernalite, 
PDF# 00-046-1436), Fe2O3 (Iron(III) oxide, PDF# 01-076-1821) and FeO (Iron(II) oxide, 
Wustite, PDF# 01-079-2179). 
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Figure 3.8. Polarization curves of (a) Fe70Mg30 amorphous thin layer, (b) Pure iron thin layer on 
glass derived by PLD and (c) bulk pure iron. 
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Figure 3.9. The glancing angle X-ray diffraction patterns of the Fe70Mg30 thin layer sample after 
electrochemical corrosion test in DMEM with photo of corrosion sample   
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3.3.5 In vitro cytocompitability measurement of Fe70Mg30 amorphous thin layer by PLD  
Live/dead staining of MC3T3-E1, hMSCs, HUVECs and NIH3T3 after 1 and 3 days of post 
seeding on the Fe70Mg30 amorphous thin layer and plastic tissue culture surface (control) can be 
seen in Figure 3.10 and 3.11, respectively. After 1 day, for all cell cultures, fluorescence 
microscopy from the live/dead assay shows similar live cells (green) attachment with few dead 
(red) cells on the surface of Fe70Mg30 except HUVEC and NIH3T3 cells which show less live 
cell attachment compared to the control. After 3 days of culture (Figure 3.11), Fe70Mg30 
amorphous thin films, which were seeded with MC3T3-E1 and hMSCs, still again displayed a 
similar level of living cell attachment, comparable to the tissue culture plastic as control, with a 
higher cell density than day 1. Fewer HUVEC live cells attachment compared to tissue culture 
plastic was still observed after 3 days but the relative cell density was higher than day 1. At day 3, 
improved cell viability was observed for NIH3T3 when compared with day 1 as the cell density 
was higher and the cells were more evenly distributed. The live/dead staining indicates good cell 
viability and proliferation on Fe70Mg30 amorphous thin layer. 
SEM images of all cells attached to the surface of the Fe70Mg30 amorphous thin layer 
(Figure. 3.12) confirmed the live/dead assay results, with a high attached cell density on the 
surfaces. All cell types studied were able to attach on the Fe70Mg30 amorphous thin layer, and it 
was also evident that the cells had begun to proliferate on the surfaces. The cell spreading was 
uniform with filopodia formation, suggesting that Fe70Mg30 amorphous thin layer was stable in 
the physiological environment and was conducive for cell growth and proliferation. 
Figure 3.13 illustrates the cell viabilities of MC3TC-E1, hMSCs, HUVECs and NIH3T3 
expressed as a percentage of the viability of cell cultured in the negative control after 1, 3, and 
7days incubation in extraction mediums after 72 hours using the MTT assay. 
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Figure 3.10. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 1 of culture post seeding on the thin layer of Fe70Mg30 on glass and 
tissue culture plastics as control.   
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Figure 3.11. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 3 of culture post seeding on the thin layer of Fe70Mg30 on glass and 
tissue culture plastics as control.   
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Figure 3.12. SEM morphology of fixed (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblast at 24hrs post-seeding on Fe70Mg30 thin layer on glass.   
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These quantitative results of indirect cell viability support what was seen qualitatively in the 
live/dead staining, indicating good cell viability and proliferation on Fe70Mg30 amorphous thin 
layers. For 1, 3 and 7 days of culture periods, most cell viabilities of Fe70Mg30 were slightly 
lower but similar to that of pure Fe. There was no significant difference (P>0.05) between them 
except the viability values after 3days incubation in Figure 3.13(a) and the viability values after 3 
and 7days incubation in Figure 3.13(c). Several groups exhibited decreased cell viability 
compared to the negative control. This may be related to the ion concentration of the leaching 
solution as higher Fe ion concentration led to lower cell viability value. Based on Figure 3.13(a) 
and (b), values of cell viability for MC3T3 osteoblasts and hMSCs in amorphous Fe70Mg30 
extracts were nearly 100% after 1 day of exposure. However, viabilities decreased to around 
90% compared with that of negative control after 3 and 7 days’ incubation. For HUVEC cells, 
cell viability was about 90% after 1day incubation but also decreased then it was just about 70% 
compared to negative control after 7day’s incubation in Figure 3.13(c). The NIH3T3 cells 
displayed ~80% viability after 1 day of exposure and conversely exhibited increased viability up 
to ~85% of the negative control after 7days.  
Figure 3.14 shows the release of Fe and Mg ions after 72 hours immersion in αMEM, 
DMEM and EBM-2 growth media for the thin layer samples of Fe70Mg30 and pure Fe on glass 
by PLD. It can be seen that after 72 hours of immersion corrosion, the average released Fe ion 
concentrations from Fe70Mg30 sample were at most ~4 fold higher than that from pure Fe 
samples. According to the Figure 3.14, the mean amount of ion released from the Fe70Mg30 
sample is 48.84 ± 7.13, 51.31 ± 7.23 and 45.03 ± 6.06 ppm for Fe and 18.11 ± 3.56, 25.03 ± 4.53 
and 21.1 ± 2.84 ppm for Mg in αMEM, DMEM and EBM-2, respectively.  
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Figure 3.13. Cell viability of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) NIH3T3 
after 1, 3 and 7 days incubation in extract medium collected after 72 hours from Fe70Mg30 and 
pure Fe thin layer of ~1.3µm thickness on glass. * Significant difference compared to cell 
viability of the negative control group (P<0.05). 
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Figure 3.14. Ion concentration of Fe and Mg after immersion of the amorphous Fe70Mg30 and 
pure Fe thin layer of ~1.3 µm thickness on glass in cell culture media for each cell line for 72 
hours. The Fe70Mg30 sample shows statistically higher Fe ion concentrations (P<0.05) than pure 
Fe sample, indicated by asterisk (∗).  
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Figure 3.15. Dose-response cell viability of MC3T3-E1 and hMSCs for increasing concentration 
of Fe2+ ions after 3 days of culture. 
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3.4 DISCUSSION 
In this specific aim, it is a preliminary study aimed to investigate the feasility of Fe-Mg binary 
alloy for biodegradable implant device applications. It focused on the formation of an amorphous 
thin layer from HEMA derived amorphous Fe70Mg30 powder as target and  assessed these alloys 
in terms of  in vitro corrosion and cytocompatibility. In the conclusions, we provide the basis and 
direction for future study to develop this amphous Fe-Mg system as novel biodegradable 
material systems. 
3.4.1 Synthesis of amorphous thin layer by PLD in Fe-Mg system 
  In order to identify the potential use of Fe-Mg alloy as a biodegradable system using in vitro 
characterization methods in this study, it was necessary to form bulk shapes or thin layers from 
the HEMA derived Fe-Mg amorphous powders. Sintering by thermal treatment below the 
melting temperature of the main constituent material usually transforms a metallic powder into a 
bulk solid and is typically executed in powder metallurgy. However, a conventional sintering 
technique does not permit sintering of Fe-Mg amorphous powders due to the large melting 
temperature difference between Fe and Mg, which melt at 1530°C and 650°C, respectively. 
Hence, it is impossible to use a conventional sintering method to form substrates without 
inducing changes in composition and structure. Therefore, formation of thin layer is one of the 
solutions to generate dense structures from HEMA derived Fe-Mg amorphous powders shown in 
previously studies [202-205]. Studies have shown that this amorphous thin layer, while it is 
prepared by thermal co-evaporation, is focused for only specific field such as studies of atomic 
vibrational dynamics or Mӧssbauer spectroscopy [202-205]. However, amorphous Fe–Mg alloy 
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films may be formed over a narrow composition range under very severe conditions such as the 
limit of starting elemental material (Fe isotope, 57Fe), ultrahigh vacuum (lower than 1x 10-9 
mbar), stringent deposition rate (0.1~0.4 Å/s) and extremely low substrate temperature (-140°C) 
[204]. 
PLD was chosen to overcome the limitation of the sintering process for HEMA derived 
Fe-Mg amorphous powder. It expects that while the PLD process is controlled by optimal 
deposition parameters, amorphous Fe70Mg30 thin layers were successfully generated though still 
had embedded particles (droplets) in the continuous thin layer shown in Figure 3.6. As 
previously discussed for the deposited thin films in Mg-based amorphous alloys in pilot study, 
by controlling optimal deposition parameters in PLD, it is possible to tailor the structural 
properties of the deposited thin films in Fe-Mg amorphous alloys. The amount of unwanted 
liquid droplets, as seen in Figure 3.6(b), can be reduced by decreasing the laser energy density to 
the threshold of ablation, and increasing the target-substrate distance [206] or using other 
approaches such as utilization of dual laser, off-axis laser deposition, cross-flux method and 
implementation of velocity selection method [138]. Some of these approaches will be adopted in 
the future. 
3.4.2  Degradation rate of Fe70Mg30 amorphous thin layer by PLD 
The potentiodynamic polarization results in Table 3.2 of Fe70Mg30 amorphous thin layer 
show that corrosion current density significantly increased and corrosion potential is more 
negative compared to both bulk and thin layerd pure iron. Here, it should be noted that there is 
some limitation to preparing samples as thin layer by PLD for study of bio corrosion in this work 
because they are difficult or even impossible to make by conventional sintering or other 
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technologies in the Fe-Mg system. However, it indicates the benefical accelerated corrosion 
obtained from the Fe70Mg30 amorphous thin layer compared to pure Fe, though these results are 
indirect estimates from the potentiodynamic polarization results using the Tafel plotting (Figure 
3.8) and do not measure the actual corrosion values. These limitation of sample preparation in 
this study may be solved using new techniques, such as spark plasma sintering (SPS) [207, 208], 
selective laser sintering [209] or viscous sintering [210] in order to measure more accurate 
information for corrosion that we will explore in future work.  
 Within the aforementioned two alloying criteria for high degradation rate which were 
proposed by Schinhammeret al. [72] state, Mg is considered as a suitable alloying element to 
pursue based on the first criterion in this study where it can make the Fe matrix more susceptible 
to corrosion because the standard electrode potential of the reaction  Fe(s) ↔ Fe2++2e− is E1= 
−0.440V [211], whereas that of Mg(s) ↔ Mg2++2e− is E2= −2.372V [212]and then Mg is less 
noble element than Fe. Thus, the standard potential of Fe-Mg alloy is expected to decrease with 
increasing Mg content. Atoms in amorphous structures are thermodynamically unstable and 
should induce a higher dissolution rate compared to crystalline materials of same composition. 
Additionally, amorphous alloy compositions are not constrained by solubility limits and one can 
add higher concetrations of less noble alloying elements [213]. Accordingly, the Fe70Mg30 
amorphous thin layer presents more accelerated corrosion than pure Fe, as seen in Figure 3.8 and 
Table 3.2. This could be related to the contained high Mg concentration with extension of solid 
solubility limit, an approach described by  Hermawan et al. [7, 75] in the Fe-Mn system which 
causes accelerated corrosion through the formation of a solid solution.  
Under visual observation on the Fe-Mg samples after the corrosion test, it appears that 
red-brown and black color layers (in Figure 3.9) were formed, believed to be due to released Fe2+ 
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and Mg2+ ions from the anodic reaction reacting with the hydroxyl ion (OH−) relased from the 
cathodic reaction to form insoluble hydroxides (hydrous metal oxides) such as Fe+3(OH)3, Fe2O3, 
FeO and Mg(OH)2 [75, 90, 214] which matched well with the results in Figure 3.9. It was found 
that the alloying elements not only increase the degradation rate of Fe-based alloys, but also 
affect their cytocompatibility [35]. This may be caused either by the amount of released 
substances from the samples, or cytocompatibility of the added alloying elements. Therefore, 
these corrosion products and released metal ions may be strongly related to the cell toxicity. 
3.4.3 In vitro cytotoxicity of Fe70Mg30 amorphous thin layer by PLD 
Past studies have widely used cytotoxicity assays to determine the response of cells to 
different substances. Various biocompability tests must be completed prior to the approval of 
alloys for in vivo use, and secondary cell lines MC3TC-E1, murine fibroblast cells 3T3 and L-
929, rodent vascular smooth muscle cells (VSMC) as well as primary cells such as HUVECs, 
hMSCs and murine bone marow stem cells and have demonstrated positive biocompatibility and 
cytocompatibility of Fe and Fe based alloys [43, 54, 61, 75, 82, 158, 215, 216]. As a result from 
in vitro cell viability tests in the current study, Fe70Mg30 amorphous thin layer by PLD had no 
adverse effects on cell viability, proliferation and morphology. In the case of direct cell viability 
and adhesion test as seen in Figure 3.10-3.12, the Fe70Mg30 amorphous thin layer demonstrated 
good cell viability, with well adhered cells on the samples after 1 and 3 days of culture compared 
to control as well as 0~1 cytotoxicity grades by ISO 10993-5 [217]. The higher cell density 
observed after 3 days implied  that the cell proliferation on Fe70Mg30 amorphous thin layer was 
not inhibited by the substrate, changes in local chemical concentrations in culture media or the 
corrosion products.  
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The good morphological features and attachment ability of MC3T3-E1, hMSC, HUVEC 
and NIH3T3 cells was shown in Figure 3.12 and thus confirmed the cytocompabilitible nature of 
the materials. Since a great deal of research on Fe and Fe based alloys have been focused on 
cardiovascular biodegradable stents [2, 5, 218], the endothelialization process on these materials 
is very important. Thrombogenicity decreases as the stent surface is covered by regrowth of 
endothelium [77, 219] and thus the morphology of HUVECs on Fe alloys is very important. 
HUVECs spread out and grew on the thin layers with filopodia extending from the cell edges, 
forming physical contact with each other to create a dense cell layer a seen in Figure 3.12(c). 
This indicates that the Fe70Mg30 amorphous thin layer exhibited no inhibition on the vascular 
endothelialization process. The results of the indirect cytotoxicity tests using MTT assay show 
similar cytotoxicity as the investigated direct test for the Fe70Mg30 amorphous thin layer. When 
cells were exposed to the degradation products in 100% extraction solution, relatively high cell 
viabilities were still demonstrated after 7 days of cell culture in Figure 3.13 for all tested cell 
lines even though they were decreased compared to 1 and 3 days of cell culture periods.  
According to ISO 10993-5 [217], higher viability after longer cell culture time of more 
than ~70% compared to that of negative control indicated that cell metabolic activity was 
uninhibited by corrosion products and proves a material’s biosafety for further biomedical 
applications. In this study, despite cell viabilities being reduced compared to the negative control, 
their viability remained above 70% to indicate good cytotoxicity grades by ISO 19003-5. The 
reduction may be related to the concentration of material leaching into solution as higher metal 
ion concentrations may led to lower cell viability. In most cases, toxicity is provoked by metal 
elements derived from reactions between metal and body fluids acting as electrolytes. The metal 
ions, which formed by anodic reaction as M(s) ↔ M2++2e−, where M is a metal, readily catalyze 
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the generation of toxic effects [220] with higher concentration of metal ions exerting harmful 
behaviour. It has been generally found that Fe and Mg show acceptable to good 
cytocompatibility and the average concentrations of Fe and Mg ions in each collected extract 
used for indirect cell viability tests were shown in Figure 3.14. The total Mg2+ concentration 
range for mammalian cells is about 340ppm - 486ppm [221] and previous studies provided some 
information on the concentration of Mg ions after degradation of the alloys in vitro. For example, 
the critical Mg2+ ion concentrations were reported as ~245ppm for murine fibroblast cells [41], 
~231ppm for HUVECs [222] and Zhao et al. [223] reported that viability was not significantly 
affected when Mg2+ is less than ~730 ppm for human coronary aorta endothelial cells (HCAECs).  
As the corrosion extract concentration for Mg was found to be far below critical values 
from literature, without the concern of releasing other alloying elements, Mg seems not to be 
responsible for the decrease in cell viability which then may be attributed to Fe ion concentration. 
Fe is an essential element for fundamental metabolic processes in cells and organism with a high 
toxic level in serum. Extracellular Fe is exclusively bound to transferrin as the plasma iron 
carrier, which maintains Fe solubility and nontoxicity, binding to specific receptor on the cell 
surface to be transported across the endosomal membrane [45]. This internalized Fe is utilized 
for metabolic purposes but excess is detoxified by sequestration into ferritin [45]. These cellular 
Fe metabolism mechanisms explained the low inhibition of cell activity when cells were exposed 
to the range of Fe ion concentration in extraction solution [75]. The critical concentration of Fe 
ion for each cell line used in this study were found in the literatures and given as the half 
maximal inhibitory concentration (IC50) values corresponding to the concentrations of substances 
required to induce a 50% reduction in cellular response in comparison to untreated cells [216]. 
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Generally, the IC50 levels strongly depend on the cell type and experimental conditions. 
Therefore it only shows general trends and cannot be treated as absolute values [135].  
For HUVECs, the collected extraction from EBM-2 contained an average concentration 
of 45.03 ± 6.06 ppm for Fe (Figure 3.14) compared to 335 ppm [135] and 61 ppm [54]. For 
NIH3T3 fibroblast cells, Fe concentration in extract from DMEM was 51.31 ± 7.23, compared to 
389 ppm [158], 380 ppm [215] and 112 ppm [216]. Because the measured corrosion extract 
concentration of Fe for HUVECs and NIH3T3 were below these IC50 values found in literature, 
the cell viabilities of HUVECs and NIH3T3 for Fe70Mg30 sample was expected to be maintained 
as they were above 70% up to 7 days of incubation, indicating no cytotoxicity from the 
amorphous thin layer samples of Fe70Mg30. Additionally, for MC3T3-E1 and hMSCs, values of 
cell viability in our expermental materials extracts from αMEM were nearly 100% after cultured 
for 1 day and decreased to around 80% for MC3T3-E1 and 90% for hMSCs after 3 or 7 days 
incubation in Figure 3.13 (a) and (b). For hMSCs, there are few such studies for Fe based 
biodegradable materials in literature. Thus, we performed dose response experiments with 
soluble FeCl2 (Figure 3.15) revealing that Fe concentrations higher than ~112 ppm (2mM) had 
adverse effects on the metabolic activity and resulted in a reduced viability of hMSCs. The mean 
amount of Fe ion released from the Fe70Mg30 sample in αMEM was 48.84 ± 7.13 ppm. In this 
context, the high cell viability was observed due to the Fe ion concentration being lower than the 
critical concentration to cause toxicity in the extraction solution in this study. Yamamoto et al. 
[158] also studied MC3T3-E1 and determined an IC50 level of ~33 ppm for Fe, which is slightly 
lower than that of this study but in contrast, we found that high cell viability was demonstrated 
up to 7 days of cell culture as shown in Figure 3.13(a). These results seem counter-intuitive but 
recently, Hong et al. [224] performed dose response with soluble FeCl3 revealing that Fe 
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concentrations less than ~56 ppm had no adverse effects on the  cell viability of MC3T3-E1 cells, 
which suggests that it is in good agreement with those obtained from the Fe70Mg30 sample in 
αMEM. Furthermore, the presence of Mg(OH)2 as a corrosion product (Figure 3.9) can enhance 
osteoblast activity [225] and may facilitate high cell viability of MC3T3-E1 cells. The actual ion 
values was difficult to measure due to the complexity of extraction medium, variability with pH 
and temperature, and potential presence of undissolved corrosion products [41]. Thus for future 
experiments, we will consider concentrations of metal ions from extracts to be much higher level 
than would be observed in vivo due to exchange of permanent body fluids. These in vitro results 
suggest that the corrosion products are well tolerated by the cells, and that the newly developed 
Fe-Mg alloys show great promise as cytocompatible materials within the framework of the 
demanding conditions given in present work. 
3.5 CONCLUSIONS 
Thin films of this novel material demonstrated accelerated corrosion compared to pure Fe which 
is necessary for biodegradable medical applications. Furthermore, extensive in vitro cell studies 
conducted using cell lines relevant for cardiovascular and orthopedic applications demonstrated 
high cell viability in direct contact with these materials and in the presence of their degradation 
products. The combination of the degradation behavior and cytocompatibility of this novel 
amorphous Fe70Mg30 material make it a promising biodegradable material for cardiovascular, 
orthopedic, and other medical devices. Future work will pursue additional processing methods to 
produce different forms of the Fe70Mg30 alloy such as spark plasma sintering, selective laser 
sintering, or viscous sintering. 
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4.0  SPECIFIC AIM 3: STUDY THE EFFECT OF ADDITION OF MANGANESE 
(MN) AS AN ALLOYING ELEMENT IN THE FE-MG ALLOY SYSTEM AND 
UNDERSTAND THE IN VITRO RESPONSE TO EXPLORE THE POTENTIAL OF 
THESE ALLOYS AS NOVEL BIODEGRADABLE MATERIAL SYSTEMS. 
4.1 INTRODUCTION 
Recent years have seen increasing applications of biodegradable materials as a surgical implant 
or stent [14]. As outlined above, especially Mg alloys and Fe have been proposed for 
biodegradable materials. A number of Mg alloys have been proposed, including AE21 [22], 
AM60B [226], AZ91 [68], and WE43 [23]. The suitability of Fe as a degradable implant material 
has been studied in various in vitro and in vivo settings using variety of cells and animal models 
[13, 21, 26, 42, 43, 51-54]. However, the degradation rates were considered too rapid for Mg 
alloys and too slow for pure iron for biomedical application. From a structural point of view, the 
mechanical properties of iron are more attractive than those of magnesium alloys, if compared 
with stainless steel. Moreover, the properties of Fe alloys could be further improved by targeted 
alloying and by applying specific thermomechanical treatment. A careful selection of potential 
alloying elements could also result in non-ferromagnetic properties, thus increasing the 
compatibility of the resulting alloy with Magnetic Resonance Imaging (MRI), which is the 
default non–invasive imaging modality ubiquitously employed for coronary investigation and 
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screening of other of disease conditions. MRI is already quite used but is expected to rapidly 
become in the next decade a key diagnostic tool the post implantation monitoring of medical 
devices.  With the growing importance of MRI, the MRI compatibility is becoming essential or 
at least desirable [58]. As discussed above for Fe alloy category in introduction, Fe is a 
ferromagnetic metal, an important magnetic characteristic which can influence its interaction 
with MRI technique. Accordingly, in order to overcome this impediment, extensive materials 
analysis, and toxicological review were carried out to select the optimal alloying elements for 
iron. Industrials and clinicians agree to state that three main characteristics should be owned by 
biodegradable implant and stents [58]: (1) mechanical properties approaching those of SS316L 
alloy; (2) controlled degradation process beginning after the stented vessel is healed and 
remodeled (6–12 months [227]) but completed within a reasonable period (12–24 months [67]) 
and (3) during the degradation process, the stent material should not release substances having 
toxic effects. To approach the characteristics of SS316L, extensive materials analysis and 
toxicological review were carried out to select the optimum alloying elements for iron. The 
choice was narrowed to the selection of Ni and Mn that can enable conversion of ferromagnetic 
iron to its nonmagnetic alloy form (austenite–forming elements) [228, 229]. Ni is known to form 
compounds classified by the International Agency for Research on Cancer (IARC) as 
carcinogenic to humans [149, 230]. On the contrary, Mn is an essential trace element needed for 
the body function of all mammals, specifically for bone formation, calcium absorption, blood 
sugar regulation, and fat and carbohydrate metabolism [231]. Mn was finally selected for the 
following reasons. 
The present study is thus exploring the use of Mn as additional alloying element in the 
parent Fe-Mg alloy discussed in Chapter 2 and 3. Therefore reports the new alloying 
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composition of Fe-Mg amorphous systems synthesized by HEMA and accordingly, experiments 
were performed to synthesize thin film layers by PLD and evaluate these films using preliminary 
in vitro cytocompatibility and corrosion experiments for biomedical applications. 
4.2 MATERIALS AND METHODS 
4.2.1 Alloy powder preparation and synthesis of thin films 
Powders of elemental Fe (99.9+%, <10 μm, Alfa Aesar), Mg (99.8%, <325 mesh, Alfa Aesar) 
and Mn (99.3%, <325 mesh, Alfa Aesar) corresponding to Fe60Mg40-xMnx (х=0~40) atomic % 
compositions were milled in a planetary SPEX 8000 high energy Shaker Mill through a 
sequential process of dry and wet milling in this study. The ball to powder weight ratio (BPR) 
was 15 to 1, and the total weight of the starting mixture was 4g as powder. After dry milling, 
1.5ml of toluene (anhydrous, 99.8%, Sigma-Aldrich) was loaded in the vial and the as-dry milled 
powder was subsequently wet milled for a period of up to 17 hours to reduce the adhesion of 
powders on the balls and the inner surface of the milling vial. The post ball milled powders were 
dried and then compacted at a pressure of 60 kpsi using a Flow Autoclave System cold isostatic 
compaction press to produce 25.0 mm diameter discs to be employed as targets for PLD. All the 
thin films were produced by PLD utilizing a 248 nm KrF excimer laser (Lambda Physik EMG 
201) irradiation pulsed at 25 ns FWHM in a high vacuum chamber with a base pressure of 10-6 
Torr. In all depositions the spot size was approximately 1×3 mm, the fluence was 8.3~9.6 J/cm2, 
the laser pulse frequency was maintained at 10 Hz and the deposition rate was approximately 2.3 
Å/s determined as a mean value. The target to substrate distance was maintained constant at 58 
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mm, with targets rotated during deposition. Films were deposited at room temperature for a 
deposition time of 30 minutes on three different substrates corresponding to film thicknesses of 
~1.3 microns. The first was amorphous SiO2 thermally grown on Si wafer for use in glancing 
angle X-ray diffraction (XRD). The second substrate was a regular cell culture dish for 
cytocompatibility tests, and the third substrate was fused silica glass for bio-corrosion tests.  
4.2.2 Characterization of the synthesized powder and thin films 
X-ray diffraction (XRD) phase analysis was performed using PANalytical X’Pert Pro 
system employing the Cu Kα (λ=1.54056 Å) radiation source with a Si-detector for glancing and 
conventional measurements. X-ray generator was operated at 45 kV and 40 mA at a 2θ range of 
10-90°. PANalytical HighScore Plush version 3.5 software was used to identify the XRD 
patterns comparing to ICSD database. Morphological studies along with elemental compositional 
analysis were performed using a Jeol JSM-6610LV SEM equipped with an energy dispersive x-
ray spectroscopy (EDAX) analyzer.  
TEM was performed using a JEOL JEM 2000FX TEM (operated at 200 kV) to study 
additional morphological characteristics such as particle size, shape and distribution for 
conventional bright field images. High resolution (HR) TEM observations were carried out using 
a JEOL JEM-2100F and image processing was carried out using the software package Gatan 
Digital Micrograph for Fourier transform.  ICP-OES used to perform elemental analysis (ICP, 
iCAP duo 6500, Thermo Scientific) of the extracted solution from immersion test. Magnetic 
hysteresis loops were measured at room temperature with vibration sample magnetometer (VSM, 
Lakeshore 7400) with a maximum magnetic field of 2 T. The thermal properties of the final 
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milled powder and thin layer films were studied by differential scanning calorimetry (DSC, 
Netzsch STA 409) at a heating rate of 10°C/min under an ultra high purity Ar gas flow.  
4.2.3 Corrosion test of Fe-Mg-Mn alloy thin films 
The potentiodynamic polarization technique was used to test corrosion of the PLD derived Fe-
Mg-Mn amorphous thin layer compared to the film/bulk (99.8+%, 1mm foil, Good fellow) of 
pure Fe and Fe-Mg amorphous films which were studied and reported in Chapter 3. It was 
performed using a CH604A (CH Instruments Inc.) electrochemical work station. Following 
sample preparation as described in previous chapter in detail, length and width were measured 
and then one side of each sample was connected to a wire with silver epoxy and then electrically 
insulated with polymeric epoxy, such that only one side is exposed for electrochemical testing. 
Ag/AgCl reference electrode (4.0 M KCl, Accument) and a platinum wire counter electrode were 
employed. The test was performed in Dulbecco’s Modified Eagle Medium (DMEM, with 4.5 g/l 
glucose, L-glutamine, and sodium pyruvate, Cellgro, Manassas, VA) supplemented with 10% 
fetal bovine serum (FBS), 1% penicillin/streptomycin at pH 7.2 ± 0.2 and held at 37 °C. Before 
each measurement, the sample was immersed in the corrosion media to provide stability for 40 
minutes. The cathodic and anodic portions of the generated Tafel plots were fit linearly to allow 
calculation of corrosion potential, Ecorr, and corrosion current density, icorr. 
4.2.4 Cell culture for cytocompatibility test 
Murine pre-osteoblast cells (MC3TC-E1, American Type Culture Collection, Rockville, MD), 
Human Mesenchymal Stem Cells (hMSCs, Lonza, USA), human umbilical vein endothelial cells 
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(HUVECs, Linza, USA) and Murine fibroblast cells (NIH3T3, American Type Culture 
Collection, Rockville, MD) were utilized for cell culture studies. Cells were cultured under 37 °C, 
5% CO2, and 95% relative humidity in α-MEM (Gibco, Grand Island, NY) growth media 
containing 1% P/S (Gibco, Grand Island, NY) and either 10% FBS (Atlanta Biologicals, 
Lawrenceville, GA), for MC3TC-E1, or 20% FBS for hMSCs, EBM-2 bullet kit (Lonza, USA) 
for HUVEC and DMEM (Cellgro, Manassas, VA) growth media containg 1% P/S and 10% FBS 
for NIH3T3. The MC3T3 and NIH3T3 at third to seventh passage, hMSCs and HUVECs at 
second to third passage were used in this experiment. 
4.2.5 Direct Live/dead assay  
For direct cytocompatibility and cell adhesion testing, MC3TC-E1, hMSCs, HUVECs and 
NIH3T3 were cultured directly on the surface of Fe-Mg alloy thin layer by PLD. Fe-Mg alloys 
were deposited on fused silica glass by PLD with the film area approximately 9mm x 9mm. The 
samples were sterilized on all sides by UV for 60 minutes and incubated in cell culture media for 
10 minutes, after which time cells were seeded on the samples at a density of 80,000 cells per 
well. Live and dead cells were stained using live/dead staining kit (Life technologies, Grand 
Island, NY) on days 1 and 3 post seeding following the manufacturer’s protocol. Cells were then 
imaged by an inverted microscope with the fluorescence illuminator (CKX41, Olympus, 
Olympus America Inc.). For each substrate images were taken from three to six different 
locations to obtain an overview of the cell attachment. After fluorescence imaging, cells on the 
samples were fixed by 2.5% glutaraldehyde then subjected to alcohol dehydration. Fixed cells on 
samples were air-dried, after which they were imaged by SEM. 
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4.2.6 Indirect MTT assay  
Indirect cell viability test was assessed using the MTT activity assay (Vybrant MTT Cell 
Proliferation Assay Kit). Extraction medium was prepared using each cell growth media 
supplemented with serum in a surface area/extraction medium ratio 6 cm2ml-1, in accordance 
with the ISO 10993-12 [200], at 37 °C in a humid atmosphere with 5% CO2 for 72 hours. The 
extracted medium was stored at 4°C until cytocompatibility testing. This extraction was 
designated as 100% extract solution. The control groups involved the use of media without 
extract as a negative control and media containing 10% dimethyl sulfoxide (DMSO) as a positive 
control. The cells were seeded in 96-well plates at 6000 cells/well with 200μl media in each well 
and incubated for 24 hours to allow for attachment. After pre-cell culture, the media was then 
replaced with 100 μl of extract medium and incubated for 1, 3 and 7 days.  After that, media and 
extracts were replaced with fresh cell culture media and 10 μl of MTT were added to each well. 
The samples were incubated with MTT for 4 hours at 37°C and then 100 μl of 
formazansolubilization solution (10% sodium dodecyl sulfate in 0.01M HCl) were added to each 
well for 12 hours in the incubator under the cell culture atmosphere. The spectrophotometrical 
absorbance of the samples was measured with the Synergy 2 Multi-Mode Microplate Reader 
(Bio-Tek Instruments, Winooski, VT) at 570 nm, with a reference wavelength of 630 nm. 
4.2.7 Ion release  
The thin layer samples of Fe60Mg20Mn20 and pure Fe on glass were immersed in each cell 
growth media containing serum, equilibrated to 37°C for 72 hours. All conditions for immersion 
test are same with cell viability test including the surface area/extraction medium ratio 
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(according to ISO 10993-12 [200]).  After immersion for 72 hours, the media was collected and 
then diluted in 0.03 M Tris buffer solution to be analyzed using inductively coupled plasma 
optical emission spectroscopy (ICP-OES, iCAP duo 6500 Thermo Fisher).The Fe and Mg ion 
concentrations in solution were compared to media and each other. Samples were prepared in 
triplicate for each condition. 
4.2.8 Statistical analysis 
The experimental values were analyzed using the Student’s t-test and one-way analysis of 
variance (ANOVA) and then expressed by mean values ± standard deviation (SD) and statistical 
significance was considered at P < 0.05. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Microstructural characterization of Fe-Mg-Mn amorphous powder and thin layer 
The XRD traces presented in Figure 4.1 follow the structural evolution of as prepared post dry 
milled powder corresponding to the nominal compositions of Fe60Mg40-xMnx (х=0, 5, 10, 15, 20, 
25, 30, 35, 40 and 50). The sharp crystalline diffraction peaks of the blended raw mixture powder 
broadened progressively during HEMA associated with accumulated internal strain and 
refinement of grain size. For Fe40Mg60 (x=0) in Figure 4.1(a), The XRD patterns show a 
predominant α Fe phase up to x=20 (Fe60Mg20Mn20) and peak from hcp Mg is faintly observed 
around 37° for Fe60Mg40, Fe60Mg35Mn5 and Fe60Mg30Mn10. The dash lines in Figure 4.1(a) 
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indicate the position of the Fe (100), Fe (200) and (211) reflection. (PDF# 01-071-4648). For all 
samples in Figure 4.1(a), the crystalline α peaks displaced towards lower angles, compared to the 
dash lines indicating positions of pure α Fe, suggesting that Fe lattice expanded as Mg atoms 
diffuse substitutionally into the Fe lattice which was previously discussed in Section 2.  
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Figure 4.1. The X-ray diffraction patterns of Fe60Mg40-xMnx powder (a) x= 0~20, (b) x= 25~40 
after post dry milling and (c) the blended raw mixture Fe-Mg-Mn powder. 
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With increasing Mn content up to 20 at.% ( relatively decreased Mg content), the peak from γ 
phase emerges which is faintly visible around 43° and it yields γ phase (austenite) coexisting 
with the solid solutions of Mg in α-Fe. This result indicates that α phase is partially transferred 
to the γ phase with increasing Mn contents up to 20 at.% during post dry-milling.  
Interestingly, all of the supersaturated α-Fe solid solution transforms to the γ phase after 
Mn composition exceeds 25 at.%, as seen in Figure 4.1(b) from the complete disappearance of 
the Bragg peaks. The α→γ transformation is due to the higher content of austenite forming 
element, Mn, and the structure became completely austenite between x=25 amd 40 powders 
(Fe60Mg15Mn25, Fe60Mg10Mn30, Fe60Mg5Mn35 and Fe60Mn40 in Figure 4.1(b). These γ phases are 
specifically identified as γ Fe (PDF# 01-089-4185 and 03-065-4150). The discrepancies in the α 
and γ stability are likely caused by the energy stored in HEMA [122, 232]. HEMA is 
characterized by intensive plastic deformation of powder particles at extremely high strain rate 
and therefore, creation of a high density of lattice defects such as vacancies, interstitials, 
dislocations, stacking faults and grain boundaries. The energy associated with these defects can 
influence the thermodynamics of the phase transition during HEMA by raising the free energy of 
α and γ crystalline phases and thus changes the stability range of α and γ phases with respect to 
the equilibrium state. There is still much uncertainty regarding which defects play a major role in 
raising the free energy of the crystalline state. Nano-crystalline grain boundaries are more likely 
sources of energy storage in HEMA materials. 
Figure 4.2 shows the collected XRD patterns of as prepared milled powder after wet 
milling corresponding to Fe60Mg40-xMnx. Surprisingly, all of the Bragg peaks due to the solid 
solutions of Mg in α-Fe, γ phase and bcc- Mn after dry milling have disappeared at x= 20 and 25 
(Fe60Mg20 Mn20 and Fe60Mg15 Mn25) which are shown in Figure 4.1 and these formulations 
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exhibit the typical broad diffraction pattern corresponding to the fully amorphous phase with no 
indication of any residual crystalline phases. This implies that it has been completely 
transformed to a homogeneous amorphous phase and it was observed to be initiated by diffusive 
mixing mechanism [122, 176].  For x < 20 powders (Fe60Mg40, Fe60Mg35Mn5, Fe60Mg30 Mn10 and 
Fe60Mg25 Mn15), XRD patterns exhibit low intensity sharp peaks from a crystalline phase which 
were found together with a broad diffraction peak from an amorphous phase. These crystalline 
phases are identified as γ Fe (PDF# 03-065-4150) and γ Mn (COD# 96-900-8591) for 
Fe60Mg25Mn15, γ Mn and α Fe (COD# 96-901-2709) for Fe60Mg30Mn10 and Fe60Mg35Mn5, and 
the solid solutions of Mg in α-Fe. For Fe60Mg10Mn30, the XRD pattern also show the presence of 
γ (111) and γ Mn over the amorphous peak at around 45° and the peaks from residual γ (200) and 
(220) as seen in Figure 4.1(b) completely disappear. These unreacted peaks become sharper with 
increasing Mn content (x=35) and finally transform to the Fe95Mn5 (Iron Manganese, PDF# 01-
071-8287) for Fe60Mg40. However, some unexpected peaks were found for Fe60Mn40 and 
identified as Fe3C (Iron Carbide, ICSD# 98-011-6089) around 38° and 49° which were 
introduced by a process control agent (PCA) [233, 234].  
As outlined above, HEMA is a solid state process capable of obtaining metastable 
structures like amorphous and nano crystalline materials. During HEMA, powder particles are 
subjected to high-energy collisions, which causes the powder particles to be cold-welded 
together and fractured [122, 173]. It appears from the results following dry milling processing in 
Figure 4.1 that no pronounced amorphous phase formation was achieved at these milling 
conditions, suggesting that the current milling conditions were not intense enough to destabilize 
the crystalline phase and allow the formation of an amorphous phase because of the severe 
plastic deformation and welding of very ductile powders. There are two methods to prevent the 
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severe welding: one is to lower the temperature of the milling vial and the other is to add PCA to 
the powders [233]. Usually, the latter is more favored, thus, toluene was loaded in the vial after 
dry milling. As shown in Figure 4.1, only α and γ solid solution were formed by dry milling 
without PCA. However, PCA can reduce the effect of cold welding, thereby inhibiting 
agglomeration and welding on the vial wall during the seqent wet milling. In this case, 
supersaturated α-Fe solid solution and γ phase become unstable and transform to an amorphous 
phase for Fe60Mg20 Mn20 and Fe60Mg15 Mn25, as seen in Figure 4.2. In spite of the important role 
and multiple influences of PCA in HEMA of ductile materials, it could introduce contaminants. 
Organic PCA containing atoms such as O, C, H, etc. may affect the process of HEMA [235] and 
sometimes the atoms exist as impurities after consolidation of mechanically alloyed powders. In 
this study, Fe3C was found as a contaminant in Figure 4.2. Therefore, it is important to select an 
appropriate PCA and its amount in order to avoid complications. Some of these approaches will 
be adopted in the future. 
The morphologies of the as milled Fe60Mg20Mn20 powder by HEMA are shown in Figure 
4.3 (a). During the HEMA process, the powder particles are repeatedly flattened, cold welded, 
fractured and re-welded such that the final products usually show large changes in shape, size 
and distribution from their initial state [122]. Particle shapes also varied significantly after 
HEMA, with both spherical and plate-like particles being found in the starting powders in Figure 
2.4(a) and (b). The final Fe60Mg20Mn20 amorphous powder after wet milling consisted of 
irregular shaped particles which were smaller than ~5 μm with the presence of much finer 
particles (< 1 μm). Some agglomeration of particles was also found but the powder had a 
relatively homogeneous distribution due to the reachable in steady-state conditions is achieved, 
as shown in Figure 4.3(a). EDX analysis in Table 4.1 indicates that the chemical composition of 
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the amorphous powder is very similar to the starting composition. It is also found that the 
constituent elements are homogeneously distributed at the atomic scale. 
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Figure 4.2. The X-ray diffraction patterns of Fe60Mg40-xMnx powder (x = 0~40) after subsequent 
wet milling by HEMA 
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Table 4.1. Chemical composition the as milled Fe60Mg20Mn20 amorphous powder by HEMA and 
PLD derived Fe60Mg20Mn20 amorphous thin layer for 30 minutes of deposition time. 
Element 
Chemical composition 
Powder by HEMA 
Thin layer by PLD 
Film  Droplet 
Fe K (at%) 60.24 ± 1.32 62.33 ± 4.11 63.81 ± 3.01 
Mg K (at%) 20.03 ± 1.32 16.71 ± 4.11 18.21 ± 3.01 
Mn K (at%) 19.73 ± 1.32 20.96 ± 4.11 17.98 ± 3.01 
 
Figure 4.3(b) show the HRTEM image with the Fourier transform of the HRTEM image of 
Fe60Mg20Mn20 amorphous powder. The HRTEM image and the Fourier transform present a 
maze-like pattern/central halo and diffuse rings which is characteristic of an amorphous structure, 
also consistent with the XRD results of amorphous powders shown in Figure 4.2. Result from 
HEMA indicate that an amorphous phase is obtained through the sequential process of dry and 
then wet milling under the milling condition described for this study. The formation of the 
amorphous phase is verified and confirmed by XRD and TEM analysis. Therefore, we can 
summarize the amorphization process at the Fe60Mg40-xMnx (х= 20 and 25).     
Mixture of elemental powders → solid solution → amorphous 
In some instances, it has been reported that a solid solution forms first which on 
continued milling becomes amorphous [178-180]. Thin layer samples were prepared by PLD on 
glass for 30 minutes from the Fe60Mg20Mn20 fully amorphous target. Glancing angle XRD 
analysis was performed on this deposited layer, shown in Figure 4.4(a). This figure also shows a 
broad amorphous diffraction pattern. 
 
 115 
(a) (b)
 
Figure 4.3. (a) The SEM image of Fe60Mg20Mn20 following wet milling by HEMA; (b) bright 
field TEM image and FFT diffraction pattern showing the amorphous nature of the composition. 
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Figure 4.4. Thin layer of Fe60Mg20Mn20 on glass deposited for 30min by PLD (a) The X-ray 
diffraction pattern, (b) Bright field TEM image and corresponding overall SAD pattern.  
 
 
 116 
Figure 4.4(b) shows the TEM bright-field image and corresponding SAD pattern of the 
thin layer of Fe60Mg20Mn20 deposited by PLD. The bright field image shows the presence of 
large agglomerates or particles (droplets) embedded in the continuous thin layer. This is a typical 
surface morphology of layers deposited by PLD as seen for the other compositions in the Fe-Mg 
and Mg-Zn-Ca systems discussed earlier. There is a diffusive halo typical of an amorphous phase 
in the corresponding overall SAD pattern even though it consists of few droplets on thin layer in 
the TEM bright-field image. In order to investigate the chemical composition of the thin layer, 
EDX measurement was also performed and results are given in the Table 4.1. The chemical 
composition of the amorphous thin layer is very similar to the target composition but some 
deviation is seen for the particle composition. It is likely due to the varying diffusional kinetics 
of each elements of target during PLD process [142]. 
Figure 4.5 shows the corresponding DSC thermograms of the amorphous powder and 
thin layer of the Fe60Mg20Mn20. It is apparent from the DSC thermogram that the glass transition 
temperature (Tg), the crystallization temperature (Tx) and the super-cooled liquid region (∆T=Tx-
Tg) are about 276.06°C, 399°C, 112.94°C for powder and 261.63°C, 382.23°C, 120.6°C for the 
thin layer, respectively. Moreover, one exothermic peak, marked as Tp is observed in the trace, 
and is identified to be the peak corresponding to crystallization of the amorphous phase. 
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Figure 4.5. DSC thermogram for the Fe60Mg20Mn20 (a) amorphous powder by HEMA, (b) 
amorphous thin layer by PLD.  
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4.3.2 Magnetic properties of Fe-Mg-Mn powder by HEMA. 
Figure 4.6 presented the Magnetization (hysteresis) curves of as prepared post dry milled 
powder corresponding to the nominal composition of Fe60Mg40-xMnx (х= 5 and 35) with pure Fe 
and SS316L alloy. These two compositions are representative of Mg and Mn rich compositions, 
repetitively. Compared with SS316L alloy, the as dry milled Fe60Mg35Mn5 shows a higher value 
of M/H slopes with relatively larger hysteresis loop area but Fe60Mg5Mn35 composition exhibits 
a much lower and smaller area than those shown in Figure 4.6(a) which can be linked to the 
XRD patterns and the phase evolution shown in Figure 4.1. 
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Figure 4.6. (a) M-H curves of Pure Fe, SS316L alloy and Fe60Mg40-xMnx powder (x = 5 and 35) 
after dry milling by HEMA and (b) enlargement of the circled region of the M-H curve in (a). 
 
For as dry milled Fe60Mg35Mn5, it exhibited a typical ferromagnetic behavior with 
saturation magnetization (Ms) of 138.9 Am2/kg. It is inferred that the XRD pattern of 
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Fe60Mg35Mn5 shows a predominant α Fe phase in Figure 4.1(a). The α Fe, ferrite, is one of 
allotropes of Fe with bcc structure and the classic example of a ferromagnetic material which 
gives Fe based alloys their magnetic properties [236]. In this context, its ferromagnetic behavior 
was observed due to the formation of supersaturated solid solutions of Mg in α-Fe. For the 
Fe60Mg5Mn35, it has lower M/H slope and Ms value, 1.36 Am2/kg, compared to SS316L alloy 
(8.09 Am2/kg). It is likely due to the α→γ transformation during dry HEMA in Figure 4.1(b). 
The γ Fe, austenite, is a nonmagnetic allotrope of Fe with an alloying element [236]. It known 
that γ phase in Fe-Mn alloys a antiferromagnetic [146, 147], meanwhile the γ phase in SS316L is 
paramagnetic. Ferrite or ferritic steels are usually classified as magnetic materials, whereas 
austenite or austenitic steels are often described as non-magnetic, paramagnetic materials [237]. 
Following dry milling, the material consists of the major crystalline ferrite phase, α Fe phase as 
shown in Figure 4.1(a), providing a high saturation magnetization. With progressive mechanical 
alloying (MA), the ferrite phase disappears and the austenite phase, γ phase in Figure 4.1(b), 
begins to dominate and the saturation magnetization correspondingly decreases. 
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Figure 4.7. (a) M-H curves of Pure Fe, SS316L alloy and Fe60Mg40-xMnx powder (x = 0~40) after 
subsequent wet milling by HEMA and (b) enlargement of red circle on (a) M-H curve.   
 
The hysteresis loop for Fe-Mg-Mn alloy powder after subsequent wet milling is shown in 
Figure 4.7. As shown in Figure 4.2, their XRD patterns exhibit low intensity sharp peaks from α 
Fe, γFe and γMn phases which were found together with a broad diffraction peak from an 
amorphous phase up to 10 at.% Mn (x=0, 5 and 10). Due to the presence of unreacted α Fe 
phases within the amorphous phase, all the samples with Mn concentration below 10 at.% still 
exhibit the ferromagnetic behavior but with much reduced saturation magnetization compared 
with that of  Fe60Mg35Mn5 after dry milling shown in Figure 4.6(a). The Ms values were reduced 
to 83.82, 46.31 and 39.87 Am2/kg for Fe60Mg40, Fe60Mg35Mn5 and Fe60Mg30Mn10, respectively. 
Primary magnetic properties derived from the magnetization loops shown in Figure 4.6 and 
Figure 4.7 are summarized in Table 4.2. 
  A dramatic change in the magnetic properties of the Fe60Mg40-xMnx powder (x = 15~40) after 
subsequent wet milling by HEMA is shown in Figure 4.7(b). All the samples exhibit almost no 
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hysteresis loop and no area of loop compared to SS316L. Primary magnetic properties derived 
from the magnetization loops show that compared to SS316L, they have lower Ms, lower 
remnant magnetization (Mr), lower initial susceptibility (χo) and coercivity (Hc). It can also be 
seen that as the Mn content increases the slopes and the area of hysteresis loops decrease. Notice 
that the magnetic properties also continuously decrease with increasing Mn content in the as 
milled powder up to 40 at.% Mn as it should if the α phases were decreased. These observations 
therefore implies that most of the α-ferrite phase is transferred to the amorphous phase or γ phase 
during wet milling which is in good agreement with XRD patterns after wet HEMA as shown in 
Figure 4.2. The decrease in the magnetization of the Fe-Mg-Mn alloys can result from the 
amorphous structure produced during the high-energy milling process. Amini et al, reported a 
similar behavior in Fe-Cr-Mn-N alloy system [237]. With continued progression of the MA 
process, an amorphous phase is created growing along grain boundaries and consumes the 
crystalline lattice. With sufficient and extended milling, the amorphization process is thus 
completed and consequently, the saturation magnetization decreased. 
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Table 4.2. Magnetic properties of the as milled Fe60Mg40-xMnx powder (x = 0~40) powder 
derived by HEMA and SS316L. 
Materials 
Hc Mr Ms 
Mr/Ms 
χo 
(10-3T) (10-2A m²/kg) (A m²/kg) (A m²/(kg T)) 
Fe60Mg35Mn5 
(dry milling) 6.02 905.88 138.39 0.065 6.76 
SS316L 9.09 77.87 8.09 0.096 2.18 
Fe60Mg40 3.69 314 83.82 0.037 5.15 
Fe60Mg35Mn5 5.95 262 46.31 0.056 4.99 
Fe60Mg30Mn10 2.76 105 39.87 0.026 5.09 
Fe60Mg25Mn15 7 4.84 5.96 0.008 1.31 
Fe60Mg20Mn20 4.77 2.07 5.59 0.004 1.03 
Fe60Mg15Mn25 7.43 3.03 4.51 0.006 0.93 
Fe60Mg10Mn30 4.87 1.27 2.1 0.006 0.9 
Fe60Mg5Mn35 1.35 1.08 1.73 0.006 0.71 
Fe60Mn40 1.47 1.01 1.14 0.008 0.38 
Hc: coercivity. Mr: remanent magnetization. Ms: saturation magnetization χo: initial suscepitibility 
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4.3.3 Corrosion characterization of Fe60Mg20Mn20 amorphous thin layer by PLD. 
Potentio-dynamic polarization (PDP) curves obtained for the thin films of Fe60Mg20Mn20 
and pure iron on glass and polished bulk pure iron can be seen in Figure 4.8 as a representative 
scan of the multiple samples tested. Table 4.3 gives a summary of the corrosion potential and the 
corrosion current densities as calculated from extrapolation of the Tafel plots. The Fe60Mg20Mn20 
amorphous thin film on glass (a) resulted in an icorr value approximately 2 fold higher than that of 
both Fe thin layer of same thickness (c) and bulk (d) samples as well as Ecorr values that are more 
cathodic. It can be inferred from the above results that the Fe60Mg20Mn20 alloy shows improved 
corrosion rates compared to that of pure Fe samples. However, Ecorr of the Fe60Mg20Mn20 
amorphous sample is still less negative compared to that of Fe70Mg30 from Chapter 3, indicating 
that it has relatively slower degradation rate compared to Fe70Mg30 amorphous alloy. The 
Fe60Mg20Mn20 alloy exhibits an increase in corrosion current density over that of pure iron 
samples, which were measured at 14.14±4.35µA cm-2 for bulk and 12.46±2.3µA cm-2 for thin 
layer, respectively. There is however, no statistical difference in the value of icorr value between 
bulk and thin layers of pure iron.  
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Table 4.3. Corrosion potential (Ecorr) and current density (icorr) values for Fe60Mg20Mn20 layer, 
both bulk and thin layer of pure iron. The corrosion current density is significantly higher for 
Fe60Mg20Mn20 than both pure iron samples (P<0.05). 
Element 
Corrosion potential, Corrosion current density. 
Ecorr(V) Icorr(µAcm-2) 
Fe60Mg20Mn20 amorphous thin layer -0.621 27.07±3.3 
Fe70Mg30 amorphous thin layer -0.642 98.76±11.08 
Pure Fe (thin layer) -0.616 12.46±2.3 
Pure Fe (bulk) -0.592 14.14±4.35 
 
 
 
-0.9 -0.8 -0.7 -0.6 -0.5 -0.4 -0.3 -0.2
-10
-9
-8
-7
-6
-5
-4
-3
-2
(a)
(d)
(c)
(b)
Lo
g C
ur
re
nt
 de
ns
ity
 (A
/cm
2 )
Potential (V)  
Figure 4.8. Polarization curves of (a) Fe60Mg20Mn20 amorphous thin layer, (b) Fe70Mg30 
amorphous thin layer, (c) pure iron thin layer on glass derived by PLD and (d) mounted bulk 
pure iron.  
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4.3.4 In vitro cytocompitability measurement of Fe60Mg20Mn20 amorphous thin layer by 
PLD. 
Live/Dead staining of MC3T3-E1, hMSCs, HUVECs and NIH3T3 on day 1 and day 3 of 
post seeding can be seen in Figure 4.9 and 4.10, respectively. Figure 4.9 shows the fluorescence 
microscopy images of live/dead assay conducted on the amorphous thin layer and plastic tissue 
culture surface (control)  after 1 day.  For all the cell cultures, fluorescence microscopy from the 
live/dead assay shows similar live cells (green) attachment with few dead cells (red) on the 
surface of Fe60Mg20Mn20 layer except NIH3T3 which shows less live cell attachment and 
unususal shapes which are shrunk compared to the control. After 3 days of culture (Figure 4.10), 
the Fe60Mg20Mn20 amorphous thin films, seeded with MC3T3-E1, hMSCs and HUVEC still 
again displayed a similar or a slightly less level of living cell attached comparable to the tissue 
culture plastic as control, with a higher cell density than day 1 and cells more evenly distributed. 
NIH3T3 still however, showed fewer live cells attached than the tissue culture plastic. The 
live/dead staining overall indicates good cell viability and proliferation on Fe60Mg20Mn20 
amorphous thin layer for MC3T3-E1, hMSCs and HUVECs although showing some cytotoxicity 
for NIH3T3 fibroblasts cells. 
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Figure 4.9. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 1 of culture post seeding on the thin layer of Fe60Mg20Mn20 on glass 
and tissue culture plastic as control.   
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Figure 4.10. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 3 of culture post seeding on the thin layer of Fe60Mg20Mn20 on glass 
and tissue culture plastic as control.   
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Figure 4.11. SEM morphology of fixed (a) MC3TC-E1, (b) hMSCs and (c) HUVECs at 24h 
post-seeding on Fe60Mg20Mn20 thin layer deposited on glass.  
 
SEM images of all the cells except NIH3T3 fibroblast cell attached to the surface of the 
Fe60Mg20Mn20 amorphous thin layer (Figure. 4.11) confirms the live/dead assay results, with a 
high attached cell density on the surface. MC3T3-E1, hMSCs and HUVECs also exhibit good 
cell attachment on the Fe60Mg20Mn20 amorphous thin layer, and it was also evident that the cells 
started to proliferate on the surface. The cell spreading was uniform with filopodia formation, 
suggesting that Fe60Mg20Mn20 amorphous thin layer is stable under the physiological 
environment and is conducive for cell growth and proliferation. 
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Figure 4.12 illustrates the cell viabilities of MC3TC-E1, hMSCs, HUVECs and NIH3T3 
expressed as a percentage of the viability of cell cultured in the negative control after 1, 3, and 7 
days’ incubation in the extraction mediums after 72 hours using the MTT assay. These 
quantitative results of indirect cell viability support what was seen qualitatively in the live/dead 
staining, indicating good cell viability and proliferation on Fe60Mg20Mn20 amorphous thin layers. 
For all the 1, 3 and 7 days of culture periods, the cell viabilities for MC3TC-E1 and HUVECs on 
Fe60Mg20Mn20 was only slightly lower than the control but similar to that of pure Fe while the 
viability of the other two cell lines (hMSCs and NIH3T3) were lower than that of pure Fe. There 
was also significant difference (P<0.05) between the results shown in Figure 4.12(b) and (d). 
Several groups have also reported decreased cell viability compared to the negative control. This 
may be related to concentration of specific ions leaching out into the solution as higher Mn ion 
concentration are known to lead to lower cell viability. Based on Figure 4.11(a), values of cell 
viability for MC3T3 osteoblasts in amorphous Fe60Mg20Mn20 extracts was nearly 100% after 1 
day of exposure. However, viabilities decreased to ~ 90% compared with that of negative control 
after 3 and 7 days’ incubation. For NIH3T3 cells, the cell viability was however lowered to about 
40% after 1day incubation which is in good agreement with live/dead result on day 1 shown in 
Figure 4.9(d). The viability was also finally just below half the value compared to the negative 
control after 7day’s incubation shown in Figure 4.11 (d). The hMSCs and HUVEC cells 
displayed ~70% and ~80% viability after 1 day of exposure and continuously exhibited similar 
viability ~75% and ~85 of the negative control after 7days, respectively.  
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Figure 4.12. Cell viability of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) NIH3T3 
after 1, 3 and 7 days incubation in extract medium collected after 72 hours from Fe60Mg20Mn20 
and pure Fe thin layer of ~1.3µm thickness on glass. * Significant difference compared to cell 
viability of the negative control group (P<0.05). 
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Figure 4.13. Ion concentration of Fe, Mn and Mg after immersion of the amorphous 
Fe60Mg20Mn20 thin layer of ~1.3 µm thickness on glass in cell culture media for each cell line for 
72 hours.  
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As can be seen, based on the in vitro cell viability tests conducted in the current study, 
Fe60Mg20Mn20 amorphous thin film layers derived by PLD seemed to exhibit very good viability, 
proliferation and morphology for MC3T3-E1 cells. There was also no adverse effects on cell cell 
viability, proliferation and morphology for all the other cell lines except for NIH3T3 cells. In the 
case of the direct cell viability and adhesion test for MC3TC-E1, hMSCs and  HUVECs as seen 
in Figure 4.9-4.11, the Fe60Mg20Mn20 amorphous thin films demonstrated good cell viability, 
with well adhered cells on the samples after 1 and 3 days of culture compared to control as well 
as 0~1 cytotoxicity grades by ISO 10993-5 [217]. However, the Fe60Mg20Mn20 amorphous thin 
layer indicates much reduced cytocompatibility effect for NIH3T3 cells indicating a grade 3 
level of cytoxicity with not more than 70% growth inhibition observable and only ~40% cell 
viabiity for all three, day 1, day 3 and day 7 of the indirect MTT cell viability assay  [217]. 
As discussed earlier, toxicity of metal elements is provoked from reactions between metal 
and body fluids acting as electrolytes. The metal ions, which are formed by anodic reaction as 
M(s) ↔ M2++2e− , readily catalyze the generation of toxic reactions [220]. This depends on the 
character of the metal ions itself against cell metabolic activities. Hence, the toxicity of metal 
elements in this study, indicating low cell viability, is usually explained by higher concentration 
of metal ions that may exert harmful behavior. It has been generally found that pure Fe and pure 
Mg show acceptable to good cytocompatibility and this has already been evaluated  based on the 
cytocompatibility of Fe and Mg using the average concentations of their ions in each collected 
extract used in indirect cell viability test for Fe70Mg30 alloy in previous chapter. In this chapter, 
similar experiments were conducted to measure the effects of Fe60Mg20Mn20 alloy and the results 
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are shown in Figure 4.13. Compared to the results from Fe70Mg30,  the alloy exhibited  lower 
concnetration of Fe and Mg ions in each growth media in this study. However, the Fe60Mg20Mn20 
amorphous thin layer exhibited cytotoxic effect for NIH3T3 fibroblasts cells even though they 
have lower concentration value of Fe and Mg ions in media compard to previous results in 
Figure 3.14. As the corrosion extract concentration for Fe and Mg (Figure 4.12) was found to be 
much lower than the critical values from literature, with no other alloying elements being 
released, it appears that the decrease in cell viability is mainly due to the Mn ion concentration in 
extract solution in this study. 
   Mn is also an element essential for development and body functions, specifically for 
bone formation, calcium absorption, blood sugar regulation, and fat and carbohydrate 
metabolism [135, 238]. It forms part of several enzymes, glutamine synthetase and superoxide 
dismutase [238]. Manganese, like Fe, is a redox active species and can switch between Mn2+ and 
Mn3+. In addition, due to transport mechanisms that favor influx over efflux, intracellular Mn2+ is 
sequestered in the mitochondria and these are therefore the primary pool of Mn in the cells [238, 
239]. The role of Mn is hence ambivalent as regards to the generation and attenuation of 
oxidative stress [239, 240]. Finally, Mn is expected to show toxicity via oxidation of biological 
molecules, and by the influencing Ca and Fe homeostasis [241, 242]. These arguments therefore 
likely explain the limited cytocompatibility observed for Mn. Past studies have demonstrated 
positive biocompatibility and cytocompatibility of Fe and Fe-Mn, with iron degradation products 
shown to be cleared by macrophages without inducing any local toxic effects [42], and Mn 
appears to have the highest inhibition effect to the NIH3T3 fibroblast cells [75]. The critical 
concentration of Mn ion for each cell line used in this study were found in the literatures and 
given as the half maximal inhibitory concentration (IC50) values for compatibility corresponding 
 134 
to the concentrations of substances required to induce a 50% reduction in cellular response in 
comparison to untreated cells [216]. Generally, the IC50 levels strongly depend on the cell type 
and experimental conditions [135].  
For HUVECs, the collected extraction from EBM-2 contained average concentration of 
12.68±1.91 ppm for Mn after 72 hours immersion (Figure 4.13) and the IC50s of Mn for 
HUVECs were found to be ~60 ppm [135]. For NIH3T3 fibroblast cells, the Mn concentration in 
extraction from DMEM was 13.59±1.65 ppm, while for Mn the IC50s is about 2.52 ppm [158] 
and 5.5 ppm [75]. The cell viability of HUVEC for Fe60Mg20Mn20 sample is more than ~85% 
compared with that of negative control up to 7 days of incubation, indicating no cytotoxicity 
following the ISO 10993-5 [217] protocol. It can be interpreted that the measured Mn ion value 
is below the IC50s of Mn for HUVECs. In contrast with HUVECs, the Fe60Mg20Mn20 amorphous 
thin layer exhibited cytotoxic effect for NIH3T3 fibroblasts cells since the measured corrosion 
extract concentration of Mn was much higher than the IC50 values found in literature. However, 
it exhibited more than ~75% cell viability for MC3T3-E1 compared with that of negative control 
even though measured Mn concentration in αMEM (10.52±2.15 ppm) was higher than the IC50s 
of Mn (2.09 ppm) [158]. Therefore the IC50 levels only show general trends and cannot be 
treated as absolute values [135]. As mentioned in earlier chapters, it was difficult to measure the 
concentration of corrosion products due to the fact that the extraction medium is a very complex 
solution and sensitive to pH value and temperature. Therefore, it is difficult to measure the actual 
ion concentration in solution because of undissolved corrosion product in the solution. Assuming 
the corrosion products to be well tolerated by the cells, the newly developed Fe-Mg-Mn alloys 
can be considered to be cytocompatible within the framework of the demanding conditions given 
in the present work.    
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4.4 CONCLUSIONS 
In the present studies, the amorphous powder and amorphous thin film of Fe60Mg20Mn20 
composition have been successfully generated with non magnetic antiferromagnetic property by 
HEMA and PLD. Based on the results, it can be seen that the amorphization process is 
summarized for the Fe60Mg40-xMnx (х= 20 and 25) composition as follows:   
Mixture of elemental powders → solid solution (α,γ ) → amorphous 
Potentiodymamic polarization test in DMEM + 10% FBS shows that the Fe60Mg20Mn20 
amorphous thin layer on glass resulted in an icorr value approximately 2 fold higher than both of 
Fe thin layer of same thickness and bulk samples as well as Ecorr values that are more cathodic. 
However, the composition shows relatively slow degradation rate compared to the Fe70Mg30 
amorphous alloy which was discussed in Chapter 2 and 3. Preliminary in vitro cell viability tests 
also show that the Fe60Mg20Mn20 amorphous thin layer demonstrated good cell viability for 
MC3TC-E1, hMSCs and HUVEC cells as well as 0~1 cytotoxicity grades by ISO 10993-5 with 
comparatively lower viability and cytocompatibility with a grade 3 cytotoxicity for NIH3T3 cells 
due to the likely effects of Mn concentration released on the NIH3T3 cells. 
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5.0  SPECIFIC AIM 4: STUDY THE EFFECT OF ADDITION OF CALCIUM (CA) 
AND ZIRCONIUM (ZR) ALLOYING ELEMENTS TO FE-MG OR FE-MG-MN 
ALLOYS AND UNDERSTAND THE IN VITRO RESPONSE TO EXPLORE THE 
POTENTIAL OF THESE ALLOYS AS NOVEL BIODEGRADABLE MATERIAL 
SYSTEMS 
5.1 INTRODUCTION 
As discussed all along in the previous chapters, Fe and Fe based alloys have been widely 
researched as potential degradable metallic biomaterial with suitable mechanical properties and 
biocompatibility [14]. In particular, corrosion is the major degradation mechanism of 
biodegradable Fe alloys which need to be controlled or monitored to achieve the optimal device 
resorption rates desired by devices to be successfully used for different applications [39, 63]. 
Corrosion of Fe alloys as outlined in the earlier chapters is controlled by modifying various 
alloying elements, heat treatment, or surface modification as well as novel fabrication methods 
[61]. Attempts to accelerate the degradation kinetics of Fe is indeed the major cornerstone 
ultimately desired requiring proper design of the alloy composition as well as the processing 
conditions and parameters to achieve and maintain the optimal metal ion release rates to be 
within the accepted tolerable ranges. Successful achievement of the desired corrosion and 
 137 
degradation characteristics of Fe based alloys will provide a pathway for using these alloy 
systems ultimately for various device applications. 
In addition to the above, Fe is ferromagnetic in nature and it is therefore essential to 
identify ideally alloying elements that will alter this property to render Fe alloys compatible with 
high magnetic field such as that generated by Magnetic Resonance Imaging (MRI) to be widely 
used for post-implantation monitoring and diagnostic testing as well as universal acceptance as 
an implant material  [58].  Advanced clinical synergy is also anticipated and desired when 
biodegradable Fe alloys is used as bone fixation devices or cardiovascular stents. Fe alloys are 
attractive as outlined earlier primarily due to the excellent match in terms of its mechanical 
properties.  Bone fixation devices or implants while being very essential are also not preferred to 
remain in the body once bone healing and desired remodeling has been achieved. Permanent 
metallic devices as is the norm today are allowed to remain in the body as permanently 
implanted systems. In some instances, they are often removed from patients in the event of 
undesirable corrosion and wear of the devices leading to complications and inflammation. 
However, such removal surgeries are more prescribed by the clinicians due to complications or 
rejection of the implanted hardware leaving the patient very much compromised without a proper 
remedial treatment of the original medical problem.  
In most cases, once a solution has been provided and there is healing of the bone with the 
implanted inert and biocompatible hardware, the hardware is in general kept inside the patient 
due to the stiffness mismatch with normal bone causing residual stress and stress shielding 
problems. Removal surgery is more common in pediatric patients to avoid any interference or 
conflict with growing inherent pediatric bone plates with the implanted hardware causing major 
complications that run the risk of creating permanent damage. However, such removal surgeries 
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as outlined earlier have their own share of associated risks of recurring fracture, inflammation 
and other complications. Hence the option of having a degradable metal with mechanical 
properties matching natural bone renders the concept very attractive and highly lucrative. 
Therefore, iron-based materials are considered an interesting option for novel biodegradable 
medical implants due to their appropriate ductility and strength compared with their counterparts, 
magnesium alloys. Moreover, the properties of Fe alloys could be further enhanced by 
purposeful alloying and by applying specific thermo-mechanical treatments [243]. Recently, an 
alternative approach has been launched to develop Fe-based materials with improved 
degradation behavior and bioactivity for bone implant applications by incorporating various 
bioactive bio ceramics such as hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate 
and calcium phosphate/chitosan [218]. 
In this regard, Ca and Zr are favorable alloying elements used for biomedical research of 
Mg-based alloys. In the conventional steel industry, Ca or Zr additions have been used in order 
to enhance the mechanical and physical properties of steels but there is sparse information in the 
literature for the bio related applications of these alloys. In vitro corrosion test described earlier 
in Chapters 2 and 3 have shown that Fe70Mg30 amorphous film displays faster corrosion rate than 
pure Fe film (~9 fold). Especially, Ca is one of the elements that possesses a more negative value 
of the standard electrochemical potential. The electrode potential value for Ca is more negative 
than Mg and Fe. Usually, the more negative the standard electrode potential, the greater the 
tendency to form metal cations and hence, a greater propensity for these alloys to undergo rapid 
corrosion [244]. Therefore, addition of Ca is expected to enhance the corrosion rates of Fe-Mg 
alloys. As mentioned previously, Zr is an essential trace element in humans and is reported as 
one of the favorable alloying elements for biological applications. It has been widely used for 
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biomedical and nephrological applications [245]. Additionally, Zr is a representative element 
used for generating bulk metallic glasses and also has been widely studied in the materials 
science community because it usually imparts and facilitates the glass forming ability (GFA) to a 
very large extent thus leading to the generation of amorphous alloys.  
The present study is thus focused at exploring the use of Ca and Zr as additional alloying 
element in the parent Fe-Mg and Fe-Mg-Mn alloy discussed earlier in Chapter 1, 2 and 3. 
Accordingly, the Fe-Mg-Ca, Fe-Mg-Zr, Fe-Mg-Mn-Ca and Fe-Mg-Mn-Zr alloys have been 
synthesized through the process of HEMA followed by PLD to examine the corrosion and 
magnetic properties with preliminary in vitro cytocompatibility for bio applications. 
5.2 MATERIALS AND METHODS 
5.2.1 Preparation for alloy powders and thin films 
The alloys to be considered in this study are divided to two categories basically 
considering Fe70Mg30 and Fe60Mg20Mn20 as the parent alloy compositions. The alloy 
corresponding to Fe70Mg30-xMx (M=Ca, Zr wherein x= 3, 5, 8 for Ca and x=0.1~30 for Zr) and 
Fe60Mg20Mn20-xMx (M=Ca, Zr wherein x= 1, 5 for Ca and x= 0.5~20 for Zr) atomic % 
compositions were produced as for the parent alloy compositions using the process of HEMA 
followed by PLD. Accordingly, commercial powders of elemental Fe (99.9+%, <10 μm, Alfa 
Aesar), Mg (99.8%, <325 mesh, Alfa Aesar), Mn (99.3%, <325 mesh, Alfa Aesar), Ca (99.5%, -
16 mesh, Alfa Aesar) and Zr (99.8%, -325 mesh, Alfa Aesar) were chosen. These were weighed 
corresponding to 4g batch powder for each desired compositions and placed in to SS vials with 
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SS balls (BPR was 15 to 1). A planetary SPEX 8000 high energy Shaker Mill was used to 
perform up to 14 h of dry milling followed by 17 h of wet milling cycle with toluene. The post 
ball milled powders were dried and then compacted at a pressure of 60 kpsi using a Flow 
Autoclave System cold isostatic compaction press to produce 25.0 mm diameter discs to be used 
as targets for subsequent PLD. All the thin films will be produced by PLD utilizing a 248 nm 
KrF excimer laser (Lambda Physik EMG 201) irradiation pulsed at 25 ns FWHM in a high 
vacuum chamber with a base pressure of 10-6 Torr. In all depositions the spot size was 
approximately 1×3 mm, the fluence was 8.3~9.6 J/cm2, the laser pulse frequency was maintained 
at 10 Hz and the deposition rate was approximately 2.3 Å/s determined as a mean value. The 
target to substrate distance was maintained constant at 58 mm, with targets rotated during 
deposition. Films were deposited at room temperature for a deposition time of 30 minutes on 
three different substrates corresponding to film thicknesses of ~1.3 microns. The first was 
amorphous SiO2 thermally grown on Si wafer for use in glancing angle X-ray diffraction (XRD). 
The second substrate was a regular cell culture dish for cytocompatibility tests, and the third 
substrate was fused silica glass for bio-corrosion tests. 
5.2.2 Characterization of the synthesized powder and thin films 
X-ray diffraction (XRD) phase analysis was performed using PANalytical X’Pert Pro system 
employing the Cu Kα (λ=1.54056 Å) radiation source with a Si-detector for glancing and 
conventional measurements. The x-ray generator was operated at 45 kV and 40 mA at a 2θ range 
of 10-90°. PANalytical HighScore Plush version 3.5 software was used to identify the peaks in 
the XRD patterns comparing the data to the ICSD database. Magnetic hysteresis loops were 
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measured at room temperature with vibration sample magnetometer (VSM, Lakeshore 7400) 
with a maximum magnetic field of 2 T similar to the alloys as described in Chapter 4.  
5.2.3 Electrochemical bio-corrosion study 
Electrochemical corrosion characterization studies of the PLD derived Fe-Mg-X and Fe-Mg-Mn-
X (X=Ca and Zr) thin layers were performed using CH604A (CH Instruments Inc) 
electrochemical work station. Following sample preparation as described in the above section 
and previous chapters, one side of each sample was connected to a copper wire with silver epoxy 
and then electrically insulated, so that only one side is exposed for conducting the 
electrochemical tests. The length and width measurements were taken for corrosion current 
calculations. Ag/AgCl and a platinum wire were employed as the reference and counter 
electrodes, respectively. Testing was carried out utilizing a 3-neck jacketed flask (ACE 
Glassware) filled with 125 mL Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10 % 
fetal bovine serum (FBS, Atlanta Biologicals, Lawerenceville, GA) and 1 % 
penicillin/streptomycin antibiotics (P/S, Gibco, Grand Island,NY), equilibrated to at 37 °C. All 
the specimens were allowed to equilibrate to maintain stability and reach a stable open circuit 
potential (OCP) for 40 minutes, before initiating the polarization tests at a scan rate of 0.3 mV/s. 
The corrosion current was determined using the Tafel extrapolation of the polarization curve and 
normalized by the exposed surface area to yield a measurement of corrosion current density. The 
software program Origin with a Tafel packet was used to perform the Tafel extrapolation and 
plot the data. 
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5.2.4 Cell culture 
Murine pre-osteoblast cells (MC3TC-E1, American Type Culture Collection, Rockville, MD), 
human mesenchymal stem cells (hMSCs, Lonza, USA), human umbilical vein endothelial cells 
(HUVECs, Linza, USA) and murine fibroblast cells (NIH3T3, American Type Culture 
Collection, Rockville, MD) were utilized for cell culture studies similar to the earlier studies 
reported for Fe-Mg alloy films in Chapter 3 and for the Fe-Mg-Mn alloy films in Chapter 4. 
Cells were cultured under 37 °C, 5% CO2, and 95% relative humidity in α-MEM (Gibco, Grand 
Island, NY) growth media containing 1% P/S (Gibco, Grand Island, NY) and either 10% FBS 
(Atlanta Biologicals, Lawrenceville, GA), for MC3TC-E1, or 20% FBS for hMSCs, EBM-2 
bullet kit (Lonza, USA) for HUVEC and DMEM (Cellgro, Manassas, VA) growth media 
containing 1% P/S and 10% FBS for NIH3T3. The MC3T3 and NIH3T3 cells cultured at third to 
seventh passage, and hMSCs and HUVECs cultured at second to third passage were used in this 
experiment as the case for the alloy films described in Chapters 3 and 4. 
5.2.5 Direct cell viability and adhesion test (Live/dead assay) 
MC3TC-E1, hMSC, HUVEC and NIH3T3 cells were cultured directly on the surface of Fe-Mg-
X and Fe-Mg-Mn-X (X=Ca and Zr) thin layers deposited by PLD. These alloys were deposited 
on fused silica glass by PLD with the film area approximately 9mm x 9mm. The samples were 
sterilized on all sides by UV for 60 minutes and incubated in cell culture media for 10 minutes, 
after which time, cells were seeded on the samples directly at a density of 80,000 cells per well. 
After 24 and 72 h of incubation, the live/dead assay was performed using commercially available 
LIVE/DEAD viability/cytotoxicity kit (Invitrogen Inc. Karlsruhe, Germany) to stain the live and 
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dead cells to glow green (ethidium homodimer-1) for live and red (calcein-AM) indicating dead 
cells, respectively, imaged under a fluorescence microscope at the excitation wavelength of 495 
nm. For each substrate, images were taken from three to six different locations to obtain an 
overview of the cell attachment profiles. 
5.2.6 Direct cell viability and adhesion test (Live/dead assay) 
Indirect cell viability test was assessed using the MTT activity assay (Vybrant MTT Cell 
Proliferation Assay Kit). Extraction medium was prepared using each cell growth media 
supplemented with serum in a surface area/extraction medium ratio 6 cm2 ml-1, in accordance 
with ISO 10993-12 [200], at 37 °C in a humid atmosphere with 5% CO2 for 72 hours. The 
extracted medium was stored at 4°C until the cytocompatibility testing. This extraction was 
designated as 100% extract solution. The control groups involved the use of media without 
extract as a negative control and media containing 10% dimethyl sulfoxide (DMSO) as a positive 
control. The cells were seeded in 96-well plates at 6000 cells/well with 200μl media in each well 
and incubated for 24 hours to allow for attachment. After pre-cell culture, the media was then 
replaced with 100μl of 100% extract medium and incubated for 1, 3 and 7 days.  After that, 
media and extracts were replaced with fresh cell culture media and 10μl of MTT were added to 
each well. The samples were incubated with MTT for 4 hours at 37°C and then 100μl of 
formazan solubilization solution (10% sodium dodecyl sulfate in 0.01M HCl) were added to each 
well for 12 hours in the incubator under the cell culture atmosphere. The spectrophotometer 
absorbance of the samples was measured with the Synergy 2 Multi-Mode Microplate Reader 
(Bio-Tek Instruments, Winooski, VT) at 570 nm, with a reference wavelength of 630 nm. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Fe-Mg-X (X= Ca and Zr) 
As reported and discussed in Chapter 2 and 3, uniform corrosion of Fe70Mg30 amorphous thin 
layer was observed and the corrosion current density value was calculated to be approximately 8 
fold higher than pure Fe. The direct and indirect cytotoxicity results also indicated that Fe70Mg30 
amorphous thin layer exhibit no cytotoxicity to MC3T3-E1, hMSCs, HUVECs and NIH3T3 cell 
lines. Therefore, to further explore the system, Ca and Zr were added into the parent this alloy as 
additional alloying elements. Table 5.1 tabulates the abbreviated notation and the nominal 
chemical composition of the thin film systems deposited corresponding to Fe-Mg-X (X=Ca and 
Zr) alloy systems. 
5.3.1.1 Fe-Mg-Ca system 
Figure 5.1(a) shows the XRD patterns of as prepared milled powder following dry and wet 
milling corresponding to Fe70Mg30-xCax powder (x = 0, 3, 5 and 8). The Fe70Mg30 powder 
exhibits the typical broad diffraction pattern corresponding to the fully amorphous phase which 
was already discussed in chapter 2 previously. However, the XRD patterns show low intensity 
sharp peaks indicative of crystalline phase which were found together with a broad diffraction 
peak from the amorphous phase with increasing Ca content (up to 8 at.%). These crystalline 
phase are identified to be pure Fe and Ca for x=3, 5 while the two peaks characteristic of Ca 
appear to disappear for the composition corresponding to Fe70Mg22Ca8. These results thus 
indicate that Fe70Mg30-xCax powders (x =3, 5 and 8) are predominantly amorphous with a small 
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amount of likely unreacted Ca and Fe remaining in the resulting milled powder under the milling 
conditions employed.  
 
Table 5.1. Summary of the chemical formula of Fe-Mg-X (X=Ca, Zr) films. 
x 
Chemical formula 
Fe70Mg30-xCax Fe70Mg30-xZrx 
0 Fe70Mg30 Fe70Mg30 
0.1, 0.5 -- 
Fe70Mg29.9Zr0.1  
Fe70Mg29.5Zr20.5 
2 -- Fe70Mg28Zr2  
3 Fe70Mg27Ca3 -- 
5 Fe70Mg25Ca5 Fe70Mg25Zr5 
8 Fe70Mg22Ca8 -- 
10, 15 -- 
Fe70Mg20Zr10  
Fe70Mg15Zr15 
20, 25 -- 
Fe70Mg10Zr20  
Fe70Mg5Zr25 
29 -- Fe70Mg1Zr29 
30  Fe70Zr30 
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In order to study the effect of addition of Ca on the Fe-Mg system, further studies were therefore 
conducted on the Fe70Mg22Ca8 composition. This composition was selected since it represented a 
larger Ca content and hence, could likely have a stronger propensity towards exhibiting the 
higher desired degradation under in vitro conditions.  The starting powder, target generated for 
PLD studies, and the deposited films thus corresponded to this composition containing the 
highest amount of Ca. Thin layer samples of ~1.3 μm thickness were also prepared by PLD on 
glass substrates for 30 minutes from the milled and cold isostatic pressed (CIP) compact 
corresponding to Fe70Mg22Ca8 as the target that is largely amorphous with crystalline Fe.  
Glancing angle XRD analysis was performed on this deposited layer, which is shown in Figure 
5.1(b). The figure also shows that the deposited thin layer is predominantly amorphous with a 
small amount of likely unreacted Fe.  
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Figure 5.1. The X-ray diffraction patterns of (a) Fe70Mg30-xCax powder (x = 0, 3, 5 and 8) after 
dry and wet milling by HEMA and (b) thin layer of Fe70Mg22Ca8 (x=8) on glass deposited for 30 
minutes by PLD.     
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Figure 5.2. Polarization curves of (a) Fe70Mg22Ca8 thin layer, (b) Fe70Mg30 amorphous thin layer, 
(c) pure iron thin layer on glass derived by PLD and (d) mounted bulk pure iron.     
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The potentio-dynamic polarization (PDP) behavior of the thin layer of Fe70Mg22Ca8 has 
also been studied and the potentio-dynamic polarization curves (Tafel plot) of the Fe70Mg22Ca8 
thin layer, Fe70Mg30 amorphous thin layer and both, pure Fe thin layer and bulk Fe sample, 
recorded at a scan rate of ~1 mV/s are plotted in Figure 5.2. Table 5.2 gives a summary of the 
corrosion potential and corrosion current densities calculated from extrapolation of the Tafel 
plots shown in Figure 5.2.  
 
Table 5.2. Corrosion potential (Ecorr) and current density (icorr) values for Fe70Mg22Ca8 layer, 
Fe70Mg30 amorphous layer, both bulk and thin layer of pure iron.  
Element 
Corrosion potential, Corrosion current density. 
Ecorr(V) Icorr(µAcm-2) 
Fe70Mg22Ca8 thin layer -0.614 28.21±3.84 
Fe70Mg30 amorphous thin layer -0.642 98.76±11.08 
Pure Fe (thin layer) -0.616 12.46±2.3 
Pure Fe (bulk) -0.592 14.14±4.35 
 
The Fe70Mg22Ca8 thin layer on glass exhibited Ecorr value of -0.614V as and a corrosion current 
density which is ~2 fold higher than that of both pure iron samples of thin film and bulk iron, but 
is clearly lower than Fe70Mg30 amorphous film of similar thickness of ~1.3 μm (P<0.05). The 
addition of Ca thus does not appear to further enhance the positive attributes already induced by 
the addition of Mg to Fe as illustrated in Chapters 1-3. 
The direct live/dead assay was conducted on the PLD derived Fe70Mg22Ca8 thin film of 
~1-3-micron thickness on glass (Figure 5.3 and 5.4). Both figures display cell density of attached 
live MC3T3-E1, hMSCs, HUVECs and NIH3T3 fibroblasts cell on the thin layer after 1 and 3 
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days of culture. For MC3T3-E1, hMSCs and NIH3T3 fibroblasts cell, relatively few apoptotic 
cells compared to live cells and normal cell morphology was observed on each alloy, indicating 
the favorable, high cell viability due to the addition of Mg and Ca to the base Fe alloy. 
After 1 day, MC3T3-E1 and hMSC cell density appeared similar to that of the tissue 
culture plastic (TCP). HUVECs and NIH3T3 fibroblasts cells attached with few dead cells seen 
on the surface of Fe70Mg22Ca8 showing also less cells attached compared to the control. After 3 
days culture, MC3T3-E1, hMSC and NIH3T3 fibroblasts cells seem to attach very well on the 
Fe70Mg22Ca8 thin layer indicating live cell attachment densities very similar to that of the tissue 
culture plastic. Comparing the cell density on the alloys from 1 to 3 days, the increased number 
of cell density clearly indicated healthy cell proliferation. However, fewer HUVEC live cells 
appeared to attach compared to tissue cultrue plastic observed after 3days. Further, the shape of 
the cell also seemed to become more spread out with relativly increased cell density compared to 
1 day.      
Figure 5.5 shows the indirect cytotoxicity results of PLD derived Fe70Mg22Ca8 thin layers 
deposited on glass conducted using MC3T3-E1, hMSCs, HUVECs and NIH3T3 fibroblasts cell 
using the MTT assay. The MTT assay conducted on all the cells with the 100% extract taken 
from the Fe70Mg22Ca8 thin layer displayed low toxicity of the alloy extract, with at least ~80% 
cell viability observed for all days of culture.  Reduction in cell viability by more than 30% is 
typically considered to be cytotoxic according to ISO 10993-5 [217]. Thus the results presented 
here seem to indicate that all the alloys could be considered to be non-cytotoxic.  
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Figure 5.3. Live/Dead staining of MC3T3 osteoblasts, hMSCs, HUVECs and NIH3T3 fibroblast 
on day 1 of culture post seeding on the thin layer of Fe70Mg22Ca8 on glass and each tissue culture 
plastics as control.   
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Figure 5.4. Live/Dead staining of MC3T3 osteoblasts, hMSCs, HUVECs and NIH3T3 fibroblast 
on day 3 of culture post seeding on the thin layer of Fe70Mg22Ca8 on glass and each tissue culture 
plastics as control.   
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Figure 5.5. Cell viability of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) NIH3T3 
after 1, 3 and 7days incubation in extract medium collected after 72 hours from Fe70Mg22Ca8 and 
pure Fe thin layer of ~1.3µm thickness on glass. * Significant difference compared to cell 
viability of the negative control group (P<0.05). 
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5.3.1.2 Fe-Mg-Zr system 
Figure 5.6(a) shows the XRD patterns of the as prepared milled powder corresponding to 
Fe70Mg30-xZrx powder (x = 0~30). The XRD patterns of the powders for x=0, 0.1, 0.5 and 2) 
show the typical broad diffraction pattern corresponding to the fully amorphous phase although 
x>2 powders show a few narrow peaks that begin to emerge over the amorphous peaks at around 
34°, 40°, and 57°. This result indicates that the HEMA process can generate phases that are fully 
(or mostly) amorphous for these compositions. However, at other compositions, the x-ray 
diffraction patterns exhibit low-intensity sharp peaks indicative of a crystalline phase which are 
found together with a broad diffraction peak from an amorphous phase. These crystalline phases 
are identified to be an inter-metallic phase of unreacted pure Zr and Fe depending on the 
composition as indicated in Figure 5.6(a). The corresponding amorphous thin layer was 
synthesized by PLD on glass substrate for 30 min of deposition time to form films corresponding 
to the Fe70Mg28Zr2 fully amorphous composition from a corresponding fully amorphous target of 
the same composition. Glancing angle XRD analysis was performed on this deposited layer, 
shown in Figure 5.6(b) which exhibits the characteristic broad amorphous diffraction pattern.  
Potentio-dynamic polarization (PDP) curves for the thin layer of Fe70Mg28Zr2 and pure 
iron on glass and polished bulk pure iron can be seen in Figure 5.7 taken from representative 
samples from the multiple samples tested. Table 5.3 also gives a summary of the corrosion 
potential and corrosion current densities as calculated from extrapolation of the Tafel plots. The 
Fe70Mg28Zr2 amorphous thin layer on glass (a) resulted in an icorr value higher than that of both, 
Fe thin layer of same thickness of ~1.3 μm, (b) as well as bulk Fe (c) samples including, Ecorr 
values that are more cathodic and closer to that of amorphous thin layers corresponding to 
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Table 5.3. Corrosion potential (Ecorr) and current density (icorr) values for Fe70Mg28Zr2 layer as 
well as both bulk and thin layer of pure iron.  
Element 
Corrosion potential, Corrosion current density. 
Ecorr(V) Icorr(µAcm-2) 
Fe70Mg28Zr2 thin layer -0.636 21.33±2.31 
Fe70Mg22Ca8 thin layer -0.614 28.21±3.84 
Fe70Mg30 amorphous thin layer -0.642 98.76±11.08 
Pure Fe (thin layer) -0.616 12.46±2.3 
Pure Fe (bulk) -0.592 14.14±4.35 
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Figure 5.6. The X-ray diffraction patterns of (a) Fe70Mg30-xZrx powder (x = 0~30) after 
dry and wet milling by HEMA and (b) thin layer of Fe70Mg28Zr2 (x=2) on glass deposited for 30 
minutes by PLD. 
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Fe70Mg30 composition. It can be inferred from the above results that the Fe70Mg30 alloy 
shows indeed improved corrosion rates compared to pure Fe bulk and thin film samples. The 
corrosion current density corresponding to the amorphous layer of Fe70Mg28Zr2 is significantly 
higher than that of both pure iron samples but clearly lower than amorphous Fe70Mg30 and 
Fe70Mg22Ca8 thin layers (P<0.05).  
 
 
 156 
 
 
 
-0.9 -0.8 -0.7 -0.6 -0.5 -0.4 -0.3 -0.2
-10
-9
-8
-7
-6
-5
-4
-3
-2
(a)
(d) (c)
(b)
Lo
g 
Cu
rre
nt
 d
en
sit
y 
(A
/cm
2 )
Potential (V)
 
Figure 5.7. Polarization curves of (a) Fe70Mg28Zr2 amorphous thin layer, (b) Fe70Mg30 
amorphous thin layer, (c) pure iron thin layer on glass derived by PLD and (d) mounted bulk 
polished pure iron.     
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Live/dead staining of MC3T3-E1, hMSCs, HUVECs and NIH3T3 after 1 and 3 days of post 
seeding on the Fe70Mg28Zr2 amorphous thin layer and plastic tissue culture surface (control) can 
be seen in Figure 5.8 and 5.9, respectively. After 1 day, for all the cell cultures, fluorescence 
microscopy images collected from the live/dead assay shows similar levels of live cell (green) 
attached with few dead (red) cells on the surface of Fe70Mg28Zr2 compared to the control. After 3 
days of culture (Figure 5.9), amorphous thin films of Fe70Mg28Zr2, which were seeded with all of 
MC3T3-E1, hMSCs, HUVECs and NIH3T3, still again displayed a similar level of living cells 
attached comparable to that of the tissue culture plastic used as the control, with a higher cell 
density than day 1. The live/dead staining indeed indicates good cell viability and proliferation 
on Fe70Mg28Zr2 amorphous thin layer. 
Figure 5.10 illustrates the cell viabilities of MC3TC-E1, hMSCs, HUVECs and NIH3T3 
expressed as a percentage of the viability of cells cultured in the negative control after 1, 3, and 
7days incubation in 100% extraction mediums after 72 hours using the MTT assay. These 
quantitative results of indirect cell viability indicate good cell viability and proliferation on 
Fe70Mg28Zr2 amorphous thin layers. For 1, 3 and 7 days of culture, most of the cell viabilities 
were slightly higher or lower but by and large, similar to that of pure Fe. There is no significant 
difference (P>0.05) among them with however, a decreased cell viability compared to the 
negative control.  Based on Figure 5.10(a) and (b), values of cell viability for MC3T3 osteoblasts 
and hMSCs for the amorphous Fe70Mg28Zr2 extracts were nearly 90% after 1day of exposure. 
The viabilities slightly increased and were again similar ~90% compared to that of the negative 
control after 3 and 7 days’ incubation. For HUVEC cells, the cell viability was about 85% after 
1day incubation and remained at this value. The viability also remained just about 85% 
compared to the negative control after 7day’s incubation as shown in Figure 5.10(c). The 
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NIH3T3 cells displayed ~90% cell viability after 1day of exposure remained in the same range of 
~90% of the negative control without extract even after 7days. 
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Figure 5.8. Live/Dead staining of MC3T3 osteoblasts, hMSCs, HUVECs and NIH3T3 fibroblast 
on day 1 of culture post seeding on the thin layer of Fe70Mg28Zr2 on glass and each tissue culture 
plastic as control.   
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Figure 5.9. Live/Dead staining of MC3T3 osteoblasts, hMSCs, HUVECs and NIH3T3 fibroblast 
on day 3 of culture post seeding on the thin layer of Fe70Mg28Zr2 on glass and each tissue culture 
plastic as control.   
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Figure 5.10. Cell viability of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) NIH3T3 
after 1, 3 and 7days incubation in extract medium collected after 72 hours from Fe70Mg28Zr2 and 
pure Fe thin layer of ~1.3µm thickness on glass. * Significant difference compared to cell 
viability of the negative control group (P<0.05). 
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5.3.2 Fe-Mg-Mn-X (X= Ca and Zr) 
In Chapter 4 as described, the Fe60Mg20Mn20 amorphous powder and amorphous thin film layer 
have been successfully generated with non magnetic antiferromagnetic property derived by 
HEMA and PLD. Uniform corrosion behavior was observed and the corrosion current density 
value was approximately 2 fold higher than that of pure Fe. The direct and indirect cytotoxicity 
results however, indicated that Fe70Mg30 amorphous thin layer has no cytotoxicity to MC3T3-E1, 
hMSCs and HUVECs. As discussed above, Ca and Zr were added to this parent alloy as 
additional alloying elements. Table 5.1 tabulated the abbreviated notation and chemical 
composition of Fe-Mg-Mn-X (X=Ca and Zr) alloys which is also reproduced below in Table 5.4. 
 
Table 5.4. Summary of chemical formula for Fe-Mg-Mn-X (X=Ca, Zr) 
x 
Chemical formula 
Fe60Mg20Mn20-xCax Fe60Mg20Mn20-xZrx 
0 Fe60Mg20Mn20 Fe60Mg20Mn20 
0.5 -- Fe60Mg20Mn19.5Zr0.5 
1 Fe60Mg20Mn19Ca1 -- 
5 Fe60Mg20Mn15Ca5 Fe60Mg20Mn15Zr5 
10 -- Fe60Mg20Mn10Zr10 
15 -- Fe60Mg20Mn5Zr15 
20 -- Fe60Mg20Zr20 
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5.3.2.1 Fe-Mg-Mn-Ca system 
Figure 5.11(a) shows the XRD scans of blended mixtures prepared from the elemental powder of 
Fe, Mg, Mn, and Ca and as prepared milled powder corresponding to the nominal compositions 
of Fe60Mg20Mn20-xCax powder (x = 0, 1, 5). With increasing Ca of 1 and 5 at.% Ca, ), the XRD 
patterns exhibit low intensity sharp peaks from a crystalline phase which were found together 
with a broad diffraction peak from the amorphous phase. These crystalline phases are identified 
γ(PDF# 01-089-4185) for Fe60Mg20Mn19Ca1, Fe3Mn7 (PDF# 01-071-8284) and Fe8Mn2 (PDF# 
PDF# 01-071-8284) and pure Fe for the Fe20Mg20Mn15Ca5 alloy powder. Thin layer samples 
were prepared by PLD on glass for 30 minutes from the Fe20Mg20Mn15Ca5 partially amorphous 
target. Again, the higher Ca containing composition was selected due to the likely higher 
expected cytocompatibility and better corrosion characteristics that would be expected similar to 
the Fe-Mg-Ca system discussed earlier. Glancing angle XRD analysis was performed on this 
deposited layer, shown in Figure 5.1(b). This figure also shows that the as-deposited thin layer is 
predominantly amorphous with a small amount of unreacted Fe.   
Figure 5.12 presented the Magnetization (hysteresis) curves of as milled powder 
corresponding to the nominal composition Fe60Mg20Mn20-xCax powder (x = 0, 1, 5) and SS316L 
alloy. Compared to SS316L alloy, the as dry milled Fe60Mg35Mn15Ca5 shows a higher value of 
M/H slopes with high Ms value due to the formation of pure Fe as shown in Figure 5.11. This is a 
typical ferromagnetic behavior. This trend can be interpreted that nonmagnetic phase (x=0 or 1) 
disappear or transfer to the ferrite phase with increasing Ca content.  
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Figure 5.11. The X-ray diffraction patterns of (a) Fe60Mg20Mn20-xCax powder (x = 0, 1, 5) after 
dry and wet milling by HEMA; γ(PDF# 01-089-4185), Fe3Mn7 (PDF# 01-071-8284) and Fe8Mn2 
(PDF# PDF# 01-071-8284) and (b) thin layer of Fe20Mg20Mn15Ca5 (x=5) on glass deposited for 
30 minutes by PLD.     
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Figure 5.12. (a) M-H curves of SS316L alloy and Fe60Mg20Mn20-xCax powder (x = 0, 1 and 5) 
after dry and wet milling by HEMA.  
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Potentio-dynamic polarization (PDP) curves for the thin layer of Fe60Mg20Mn15Ca5, 
Fe60Mg20Mn20 and pure iron on glass and polished bulk pure iron can be seen in Figure 5.13 
taken from representative samples of the multiple samples tested. Table 5.5 give a summary of 
the corrosion potential and corrosion current densities as calculated from extrapolation of the 
Tafel plots.  
 
Table 5.5. Corrosion potential (Ecorr) and current density (icorr) values for Fe60Mg20Mn15Ca5 layer, 
both bulk and thin layer of pure iron. The corrosion current density is significantly higher for 
Fe60Mg20Mn15Ca5 than pure iron in layer samples (P<0.05). 
Element 
Corrosion potential, Corrosion current density. 
Ecorr(V) Icorr(µAcm-2) 
Fe60Mg20Mn15Ca5 thin layer -0.599 18.27±2.11 
Fe60Mg20Mn20 amorphous thin layer -0.621 27.07±3.3 
Fe70Mg30 amorphous thin layer -0.642 98.76±11.08 
Pure Fe (thin layer) -0.616 12.46±2.3 
Pure Fe (bulk) -0.592 14.14±4.35 
 
The Fe60Mg20Mn15Ca5 thin layer on glass (a) resulted in a icorr value higher than both Fe thin 
layer of same thickness of ~1-3 microns (b) and bulk (c) Fe samples but exhibit Ecorr values that 
are more anodic than Fe60Mg20Mn20 and Fe70Mg30 amorphous thin layer. It can therefore be 
inferred from the above results that the Fe60Mg20Mn15Ca5 alloy shows no improved corrosion 
behavior compared to the Fe60Mg20Mn20 amorphous thin layer. 
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Figure 5.13. Polarization curves of (a) Fe60Mg20Mn15Ca5 amorphous thin layer, (b) 
Fe60Mg20Mn20 amorphous thin layer, (c) pure iron thin layer on glass derived by PLD and (d) 
mounted bulk polished pure iron; blue dashed lines (Fe70Mg30) amorphous thin layer.     
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Live/Dead staining of MC3T3-E1, hMSCs, HUVECs and NIH3T3 fibroblasts cell on 1 
and 3 days of post seeding on the films of Fe60Mg20Mn15Ca5 can be seen in Figure 5.14 and 5.15, 
respectively. Figure 5.14 shows the fluorescence microscopy images collected following 
live/dead assay on the amorphous thin layer and plastic tissue culture surface (control)  after 1 
day.  For MC3T3-E1 and hMSCs cell cultures, fluorescence microscopy from the live/dead assay 
shows similar live cells (green) attachment with few dead cells (red) on the surface of 
Fe60Mg20Mn15Ca5. After 3 days of culture (Figure 5.15), Fe60Mg20Mn15Ca5 amorphous thin films, 
which were seeded with MC3T3-E1 and hMSCs still again displayed a similar level of living 
cells attached that is comparable to the tissue culture plastic used as the control, with a higher 
cell density than day 1. The cells were also more evenly distributed. The HUVECs also showed 
good cell attachment with few dead cells on the surface of Fe60Mg20Mn15Ca5 compared to the 
control after day1. The cells also displayed good cell attachment compared to tissue cultrue 
plastic even after 3 days of culture. The  cells also seem to spread with relativly increased cell 
density compared to 1 day. NIH3T3 fibroblasts cells on the other hand, showed less live cell 
attachment with considerable dead cells that were largely shrunk compared to the control of 
tissue culture plastic after 1day. The result thus indicates inferior cell viability and proliferation 
on Fe60Mg20Mn15Ca5 thin layer for NIH3T3 fibroblasts cells. This is also discussed in previous 
Chapter 4 and seems to arise due to Mn which appears to have a high inhibition effect to the 
NIH3T3 fibroblast cells [75]. 
Figure 5.16 shows the indirect cytotoxicity results of PLD derived the Fe60Mg20Mn15Ca5 
thin layer on glass performed using MC3T3-E1, hMSCs, HUVECs and NIH3T3 fibroblasts cell 
and the MTT assay. The MTT assay conducted with MC3T3-E1 and hMSCs with extract from 
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Fe60Mg20Mn15Ca5 thin layer displayed low toxicity of the alloy extract, with at least ~90% cell 
viability observed for all culture days.  In contrast the results for HUVEC are in the range of 
60% for day 1 with slight increment reaching ~65% for day 3 and day 7. Reduction in cell 
viability by more than 30% is considered to be a good indicator of cytotoxicity according to ISO 
10993-5 [217]. Thus the alloy film considered here may be construed to be non-cytotoxic based 
on the response seen for MC3T3-E1 and hMSC with HUVEC indicating acceptable 
cytocompatibility although more detailed cell culture studies will be desired to understand the 
response of HUVECs. However, values of cell viability for NIH3T3 fibroblast cell in amorphous 
Fe60Mg20Mn15Ca5 thin layer extracts was barely below 50% after 1 day of exposure. The 
viabilities slightly increased for the subsequent culture days of 3 and 7 but nevertheless still 
remain below ~50% compared with that of the negative control after 3 and 7 days’ incubation. 
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Figure 5.14. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 1 of culture post seeding on the thin layer of Fe60Mg20Mn15Ca5 on 
glass and tissue culture plastic as control.   
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Figure 5.15. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 3 of culture post seeding on the thin layer of Fe60Mg20Mn15Ca5 on 
glass and tissue culture plastic as control.   
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Figure 5.16. Cell viability of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) NIH3T3 
after 1, 3 and 7days incubation in extract medium collected after 72 hours from 
Fe60Mg20Mn15Ca5 and pure Fe thin layer of ~1.3µm thickness on glass. * Significant difference 
compared to cell viability of the negative control group (P<0.05). 
 173 
5.3.2.2 Fe-Mg-Mn-Zr system 
Figure 5.17 shows the XRD patterns for the as prepared milled powder corresponding to 
Fe60Mg20Mn20-xZrx compositions (x = 0.5, 5, 10, 15, 20). The XRD patterns of the powder for all 
ranges of x shows the typical broad diffraction pattern corresponding to the fully amorphous 
phase. Further studies were therefore focused on the Fe60Mg20Mn10Zr10 composition with a 
median value of x representing an optimal amount of Mn and Zr.  Based on the studies presented 
earlier, it is expected that a reduction in the Mn content for this composition offset by larger 
amount of the more cytocompatible Zr would likely have a more favorable response to the cell 
viability without compromising the magnetic behavior. The XRD patterns of the starting powder, 
target, and the deposited films as shown in Figure 5.17 (a) and (b) corresponding to this 
composition all confirm the amorphous nature. 
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Figure 5.17. The X-ray diffraction patterns of (a) Fe60Mg20Mn20-xZrx powder (x = 0 ~ 20) 
after dry and wet milling by HEMA and (b) thin layer of Fe60Mg20Mn10Zr10 (x=10) on glass 
deposited for 30 minutes by PLD. 
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The hysteresis loop for Fe60Mg20Mn20-xZrx (x = 0 ~ 20) alloy powder after dry and wet 
milling is shown in Figure 5.18. All the samples exhibit almost no hysteresis compared to 
SS316L. In contrast to the addition of Ca discussed earlier, all the alloys exhibit non-magnetic 
properties. An interesting result that can be seen in this study is the formation of nonmagnetic 
phase without the presence of Mn in the case of Fe60Mg20-xZrx(x=20) which is known to be the 
austenite stabilizing element. To the best of the known reported work in the literature, there are 
few studies reported with the inclusion of Zr and the austenite phase. The few reports on Zr 
relate to sulfide shape control in carbon steel[246] and as an austenite grain coarsening 
agent[246]. This interesting result certainly prompt future work to be conducted to further study 
the effect of Zr as an alloying element and its influence on the magnetic properties of the Fe-Mg 
system.  
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Figure 5.18. (a) M-H curves of SS316L alloy and Fe60Mg20Mn20-xZrx powder (x = 0~20) after 
subsequent wet milling by HEMA and (b) enlargement of red circle on (a) M-H curve.   
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Potentio-dynamic polarization curves (PDP) for the thin layer of Fe60Mg20Mn10Zr10 and 
pure iron on glass and polished bulk pure iron can be seen in Figure 5.19 as a representation of 
the multiple samples tested. Table 5.6 gives a summary of the corrosion potential and corrosion 
current densities as calculated from extrapolation of the Tafel plots. The Fe60Mg20Mn10Zr10 
amorphous thin layer on glass (a) yields an icorr value similar to that of Fe thin layer of similar 
thickness (~1-3 micron) (b) and bulk (c) Fe samples as well as Ecorr values that are more cathodic 
indicating its lower propensity for undergoing faster degradation compared to bulk Fe and 
Fe70Mg30 composition. 
 
 
Table 5.6. Corrosion potential (Ecorr) and current density (icorr) values for Fe60Mg20Mn10Zr10 
layer, both bulk and thin layer of pure iron.  
Element 
Corrosion potential, Corrosion current density. 
Ecorr(V) Icorr(µAcm-2) 
Fe60Mg20Mn10Zr10 thin layer -0.551 13.95±4.01 
Fe60Mg20Mn20 amorphous thin layer -0.621 27.07±3.3 
Pure Fe (thin layer) -0.616 12.46±2.3 
             Pure Fe (bulk) -0.592 14.14±4.35 
Fe70Mg30 amorphous thin layer -0.642 98.76±11.08 
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Figure 5.19. Polarization curves of (a) Fe60Mg20Mn10Zr10 amorphous thin layer, (b) 
Fe60Mg20Mn20 amorphous thin layer, (c) pure iron thin layer on glass derived by PLD and (d) 
mounted bulk polished pure iron; blue dashed line (Fe70Mg30) amorphous thin layer.     
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Live/dead staining of MC3T3-E1, hMSCs, HUVECs and NIH3T3 after 1 and 3 days of 
post seeding on the Fe60Mg20Mn10Zr10 amorphous thin layer and plastic tissue culture surface 
(control) can be seen in Figure 5.20 and 5.21, respectively. After 1 day, for MC3T3-E1, hMSCs 
and HUVECs cultures, fluorescence microscopy images collected from the live/dead assay 
shows similar live cells (green) attachment with few dead (red) cells seen on the surface of 
Fe60Mg20Mn10Zr10 films compared to the control. After 3 days of culture (Figure 5.21), 
Fe60Mg20Mn10Zr10 amorphous thin films, which were seeded with all of MC3T3-E1, hMSCs and 
HUVECs still again displayed a similar level of living cell attachment, comparable to the tissue 
culture plastic as control, with a higher cell density than day 1. The live/dead staining indicates 
good cell viability and proliferation on Fe60Mg20Mn10Zr10 amorphous thin layer. NIH3T3 
fibroblasts cells however, show lower live cell attachment with dead cells and shrunken 
morphology for the cells compared to the control after 1day with continued indication of reduced 
number of live cells attached to the thin fiom surface compared to the tissure culture plastic at 
day3. The live/dead staining results thus indicates relatively good cell viability and proliferationa 
for MC3T3-E1, hMSCs and HUVECs with some likely cytotoxicity for NIH3T3 fibroblasts cells. 
To further corroborate the live/dead assay results, indirect MTT assay studies were 
conducted. Figure 5.22 illustrates the cell viabilities of MC3TC-E1, hMSCs, HUVECs and 
NIH3T3 expressed as a percentage of the viability of cell cultured in the negative control after 1, 
3, and 7days incubation in 100% extraction mediums after 72 hours using the MTT assay. These 
quantitative results of indirect cell viability indicate good cell viability and proliferation on 
Fe60Mg20Mn10Zr10 amorphous thin layers. For 1, 3 and 7 days of culture, cell viabilities of 
MC3TC-E1 indicate slight variations although by and large similar to that of pure Fe. There is no 
significant difference (P>0.05) among them although there is consistently lower cell viability 
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compared to the negative control.  Based on Figure 5.22(b) and (c), values of cell viability for 
hMSCs and HUVECs on 100% extracts collected over amorphous Fe60Mg20Mn10Zr10 show 70% 
after 1day of exposure. The viabilities however, slightly increased indicating values ~75% 
compared with that of negative control after 3 and 7 days’ incubation for HUVECs and hMSCs 
while exhibiting ~80% or higher viabilities for HUVECs following day 3 and 7. For NIH3T3 cell 
however, cell viability was about 60% after 1day incubation and remained in the same range 
following day 3 and 7 incubation as shown in Figure 5.22(d). The MC3T3-E1 cells on the other 
hand displayed almost ~80% cell viability after 1day of exposure increasing to above ~90% of 
the negative control without extract after 7days of incubation. These results therefore indicate 
that the amorphous layers of Fe60Mg20Mn10Zr10 show good cell viability for all cells except for 
the NIH3T3 fibroblasts cell. 
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Figure 5.20. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 1 of culture post seeding on the thin layer of Fe60Mg20Mn10Zr10 on 
glass and tissue culture plastics as control.   
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Figure 5.21. Live/Dead staining of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) 
NIH3T3 fibroblasts on day 3 of culture post seeding on the thin layer of Fe60Mg20Mn10Zr10 on 
glass and tissue culture plastics as control.   
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Figure 5.22. Cell viability of (a) MC3T3 osteoblasts, (b) hMSCs, (c) HUVECs and (d) NIH3T3 
after 1, 3 and 7days incubation in extract medium collected after 72 hours from 
Fe60Mg20Mn10Zr10 and pure Fe thin layer of ~1.3µm thickness on glass. * Significant difference 
compared to cell viability of the negative control group (P<0.05). 
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5.4 CONCLUSIONS 
Results of the studies discussed above indicate that addition of Ca and Zr to Fe-Mg and Fe-Mg-
Mn systems can generate amorphous powders following HEMA as well as amorphous films by 
PLD. The in vitro effects of the alloying elements Ca and Zr on Fe-Mg and Fe-Mg-Mn alloys 
were also investigated. The results provide good insights into the future design of new 
biodegradable Fe-based alloys for use as medical device applications. The systems have been 
studied in terms of corrosion, magnetic properties as well as cytocompatibility.  
The results indicate that by addition of Ca as an alloying element to Fe70Mg30 amorphous 
alloy results in the successful generation of Fe70Mg22Ca8 thin layer by PLD from HEMA derived 
powders compacted to form targets of the same crystal structure and chemical composition. The 
powders and the films exhibit partial amorphous structures with unreacted pure Fe. The in vitro 
corrosion results indicate corrosion current density value was approximately 2 fold higher than 
pure Fe but slower compared to that of Fe70Mg30 amorphous thin layer. The direct and indirect 
cytotoxicity results also indicated that Fe70Mg22Ca8 thin layer exhibits no cytotoxicity to 
MC3T3-E1, hMSCs, HUVECs and NIH3T3 cell lines.  
Second, by adding the transition elemt, Zr to Fe70Mg30 amorphous alloy, the amorphous 
composition of Fe70Mg28Zr2 thin layer was deposited by PLD. For corrosion behavior, it was 
determined that the composition exhibits rapid corrosion compared to pure Fe although slower 
compared to the Fe70Mg30 amorphous thin layer. The MTT assay conducted with all the cell lines 
with 100% extract from Fe70Mg28Zr2 thin layer displayed low toxicity of the alloy extract, with at 
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least ~80% cell viability observed for all the three cell culture conditions of day 1, day 3 and day 
7. Thus the alloys may be considered non-cytotoxic. 
Third, for alloying elements Ca on Fe60Mg20Mn20 amorphous alloy, Fe60Mg35Mn15Ca5 
thin layer was successfully synthesized by PLD from HEMA derived powder compacted targets 
of the same crystal structure and chemical composition. The films exhibit partial amorphous 
phase and also exhibit ferromagnetic property in contrast to Fe60Mg20Mn20 amorphous alloy. 
Fe60Mg35Mn15Ca5 thin layer nevertheless, still exhibits rapid corrosion compared to pure Fe but 
is lower than Fe60Mg20Mn20 amorphous thin layer. The films show good cell viability results for 
all cells except NIH3T3 fibroblasts cell. 
Finally, Fe60Mg20Mn10Zr10 amorphous thin layer was successfully synthesized by PLD 
from HEMA derived compacted powders comprising the same crystal structure and chemical 
composition. All the powders exhibit nonmagnetic characteristics although the corrosion 
behavior appears to be similar to pure Fe. The direct and indirect cytotoxicity results indicated 
the Fe60Mg20Mn10Zr10 amorphous thin layer may be considered non-cytotoxic for MC3T3-E1, 
hMSCs and HUVECs except for the NIH3T3 cell lines. 
The results discussed above show that addition of Mn is critical to induce 
antiferromagnetic properties to the amorphous Fe70Mg30 system. However, cell viability appears 
to be variable due to the toxicity associated with Mn particularly, wit NIH3T3 and HUVEC lines. 
Addition of 20 at% Zr with the absence of Mn however, tends to transfer anti-ferromagnetic 
characteristics to the amorphous phase of Fe70Mg30 showing the potential of this system serving 
as a viable system that is indeed worthy of further studies. 
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6.0  OVERALL CONCLUSIONS AND FUTURE WORK 
The dissertation study was initiated to explore the concept of generating degradable thin film 
systems as a means to identify potential classes of materials that could serve as degradable 
materials systems to be generated in the bulk. As introduced earlier in this dissertation, 
biodegradable metals have been widely studied. Specifically, to date, iron (Fe) and magnesium 
(Mg) are the two main classes of metals that have been considered as promising candidates but 
most of the research on Fe and Fe based alloys have reported very slow degradation rates in 
physiological environments while Mg and Mg based alloys exhibit rapid degradation. Many 
research studies have been directed to overcome these limitations as outlined in the various 
Chapters of this thesis. However, despite these extensive studies, the degradation rates and 
cytocompatibility of the two main classes of metals are still far from levels necessary for 
implementation in the clinic for treating various trauma, congenital as well as battlefield injuries 
sustained by miltary, servicemen, and the common citizens. Although Fe and Mg have been 
studied separately as degradable implants, there are no reports to date on the Fe-Mg binary alloy 
system for use as biodegradable metallic materilas due to the inherent thermodynamic 
immiscibility of Fe and Mg under ambient conditions. The system has therefore not been 
considered further due to the extremely limited solubility of Mg in Fe [72]. This hypothesis thus 
formed the first aim of this dissertation. 
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In the first aim, as described, high energy mechanical alloy(HEMA) was explored as a 
solution to synthesize Fe-Mg binary alloys with high Mg content. The technique of HEMA, a 
solid state powder processing technique, known to generate and stabilize thermodynamic non-
equilibrium phases and systems was explored to identify alloys in this novel but esoteric system 
[122]. A variety of process parameters were modified to generate Fe-Mg alloys with varying Fe 
and Mg amounts, including the addition of a process control agent (PCA), milling containers, 
grinding media, and finally the ball to powder ratio (BPR). The alloy powders corresponding to 
Fe100-xMgх (х=20, 30, 45 and 50) atomic % compositions were produced by high energy 
mechanical alloying (HEMA). Through post dry milling and sequent wet HEMA, Fe100-xMgx 
(х=10, 20 and 30 at.%) alloy powders were generated in the fully amorphous state. The study 
reported for the first time to the best of the reported work to date exhibited the formation of solid 
solution of Mg in α-Fe during post dry milling which then subsequently underwent complete 
disorder resulting in solid state transformation to generate the amorphous phase by sequent wet 
milling. This amorphization process can be summarized as follows:  
Mixture of elemental powders → solid solution → amorphous 
Further studies were therefore focused on the Fe70Mg30 composition due to its highest Mg 
concentration. However, one limitation was identified to advance the study further into the next 
stage. In order to identify the potential use of Fe-Mg amorphous powders as possible 
biodegradable systems using in vitro characterization methods, it was deemed necessary to form 
bulk shapes or thin layers. It was soon realized that it is impossible to use conventional sintering 
method to form substrates due to the large melting temperature difference between Fe and Mg, 
namely, 1530°C and 650°C, respectively. Therefore, formation of thin film was considered as 
one of the solutions to generate dense structures of Fe-Mg alloys from the HEMA generated Fe-
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Mg amorphous powders. Therefore, pulsed laser deposition (PLD) was chosen to solve the 
limitation of the sintering process exploiting the known attribute of PLD to generate identical 
composition of the target by laser ablation. It was also soon realized that with minimal 
modification of the PLD parameters, it was also possible to generate the amorphous state of the 
target in addition to maintaining identical compositions of the target. This therefore formed the 
theme of the dissertation work leading to the four different aims that have been outlined in the 
work. 
In Specific Aim 2, based on the results from the pilot study conducted in the Mg-Zn-Ca 
system, optimal processing parameters were identified to synthesize amorphous thin film layers 
for PLD and applied to the Fe-Mg system to synthesize amorphous layers. Amorphous Fe70Mg30 
thin layers was successfully deposited by pulsed laser deposition (PLD) from the amorphous 
powder in aim 1 without inducing any change in the crystal structure and chemical composition 
compared to target and was then subjected to in vitro assessments to determine the corrosion 
behavior and cytocompatibility. It was determined that the amorphous alloy films of Fe70Mg30 
composition exhibited uniform corrosion and the corrosion current density value was 
approximately 8 fold higher than pure Fe. Furthermore, extensive in vitro cell studies conducted 
using MC3T3-E1, hMSCs, HUVECs and NIH3T3 cell lines relevant for cardiovascular and 
orthopedic applications demonstrated high cell viability in direct contact with these materials and 
in the presence of their degradation products. The combination of the degradation behavior and 
cytocompatibility of this novel amorphous Fe70Mg30 material render it a promising 
biodegradable material for further exploration for use in cardiovascular, orthopedic, and other 
medical devices. However, the system due to the large amount of Fe exhibits ferromagnetic 
properties. As introduced earlier chapter in this dissertation, this was therefore another challenge 
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that needed to be overcome if Fe based alloys were to be considered as biodegradable materials 
for various medical implant device applications. The ferromagnetic characteristics of these alloys 
can seriously limit magnetic resonance imaging (MRI) of Fe based alloy. Therefore, ideal 
alloying elements were needed to be identified to alter this natural magnetic property of Fe based 
systems to make Fe alloys compatible with high magnetic fields generated by MRI which has 
become widely used for post implantation monitoring and diagnostic testing [62]. Mn was thus 
considered finally as an alloying element to stabilize the austenite phase and render the system 
antiferromagnetic which became the focus of Specific Aim 3      
The study explored the use of Mn as additional alloying element in the parent Fe-Mg 
alloy system following the synthesis procedures outlined in Specific Aims 1 and 2. A variety of 
parameters were modified to achieve the formation of Fe-Mg-Mn alloys, including the addition 
of varying amounts of Mn from 0 to 40 at.% and the change in process parameter for HEMA and 
PLD. Finally, the amorphous powder and amorphous thin film of Fe60Mg20Mn20 composition 
were successfully generated with the desired non-magnetic property by HEMA for synthesizing 
the powders and PLD for generating the thin films. Based on the results, it can be seen that the 
amorphization process to form amorphous compositions in the Fe60Mg40-xMnx (х= 20 and 25) 
system can be summarized as under: 
 Mixture of elemental powders → solid solution (α, γ) → amorphous  
The Fe60Mg20Mn20 amorphous thin layer on glass resulted in an icorr value approximately 
2 fold higher than pure Fe but the composition shows relatively slow degradation rate compared 
to that of Fe70Mg30 amorphous alloy which was discussed in Specific Aim 1 and 2. Preliminary 
in vitro cell viability tests also show that Fe60Mg20Mn20 amorphous thin layer demonstrated good 
cell viability for MC3TC-E1, hMSCs and HUVEC cells with comparatively lower viability and 
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cytocompatibility for NIH3T3 cells due to the likely effects of higher Mn ion concentrations 
released when exposed to the NIH3T3 cells. 
Addition of Ca and Zr as alloying elements to Fe-Mg and Fe-Mg-Mn alloys were 
investigated to further improve the corrosion behavior and cell viability in Specific Aim 4. 
Addition of Ca shows improvement in the corrosion rate compared to pure Fe but relatively slow 
degradation rate compared to that of Fe70Mg30 and Fe60Mg20Mn20 amorphous alloy which was 
discussed in Specific Aim 1 – 3. Further, it was determined that there is no positive effect to alter 
and eliminate the magnetic properties and all compositions still exhibit the typical ferromagnetic 
behavior. Direct and indirect cytotoxicity results also indicate that there is no significant effect 
upon addition of Ca compared to the parent alloys. In the case of Zr when used as an alloying 
element, it was found to exhibit no deleterious effect on the cell viability compared to Fe70Mg30 
and Fe60Mg20Mn20 amorphous alloys. In contrast to addition of Ca, however, Fe-Mg-Mn-Zr 
alloys still displayed nonmagnetic behavior. Especially, an interesting result that was seen herein 
is the formation of nonmagnetic phase corresponding to Fe60Mg20Zr20 without the presence of 
Mn which is known as an austenite stabilizing elements. Based on the reported literature thus far, 
there are few studies reported on alloys containing Zr and the austenite phase. It has been studied 
largely for determining and controlling sulfide shape in carbon steels[246], austenite grain 
coarsening [246]. Future work will be conducted to determine the specific effects of Zr as an 
alloying element for studying the magnetic properties.  
Based on the studies conducted in this dissertation, this is the first report to demonstrate 
the formation of an amorphous Fe-Mg alloy, through the process of HEMA followed by PLD in 
order to overcome the limitations of the thermodynamic immiscibility of Fe-Mg. Through 
addition of Mn element, the nonmagnetic state has been achieved. Thin films of this novel 
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material demonstrated accelerated corrosion compared to pure Fe which is necessary for 
biodegradable medical applications. Furthermore, in vitro cell studies conducted using cell lines 
relevant for cardiovascular and orthopedic applications demonstrated high cell viability in direct 
contact with these materials and in the presence of their degradation products. However, there is 
still the problem to produce bulk shape eventhough thin film layer was synthesized PLD.  
Future work will thus focus on pursuing additional processing methods to produce 
different forms of these alloys exploiting techniques such as spark plasma sintering, selective 
laser sintering, or viscous sintering to generate amorphous alloys. At the same time, attempts will 
be made to combine heat treatment following the non-conventional sintering techniques to 
generate biphasic or multiphasic alloys as discussed in the various Chapters 2-4 to form fast 
degrading systems while also exhibiting good cytocompatibility. Additionally, work will focus 
on generating thin coating layers on the surfaces of various materials to generate smart structures 
for embedding carriers to deliver growth factors, antibiotics as well as signaling molecules since 
surface modification is one of possible approach to overcome limitations of achieving controlled 
release of these various agents. Lastly, based on the studies conducted herein, attempts will be 
made to identify the specific effects of Zr as an alloying element for exploring the ability to 
impart non-magnetic properties. Generally, Mn is known to have the highest inhibition effect on 
NIH 3T3 fibroblast cells [75] but it is also considered an essential alloying element to remove 
ferromagnetic property for Fe alloys. If Zr can be added for creating and imparting 
antiferromagnetic properties, it can certainly create a wider alloy design space for generating 
degradable Fe based alloys. These studies will be hopefully conducted in the near future. 
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APPENDIX A 
PERMISSIONS 
This dissertation has text, figures and tables reprinted / reproduced with permission from a 
publishing company and society. The journal paper listed here has been published in print and 
electronic form, wherein I (Sung Jae Chung) am a co-author. 
 
The journal paper listed below has been used in Chapter 3: 
 
1. Chung SJ, Roy A, Hong D, Leonard JP, Kumta PN. Microstructure of Mg–Zn–Ca thin 
film derived by pulsed laser deposition. Materials Science and Engineering: B. 
2011;176:1690-4. 
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